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Exercise and intestinal tumourigenesis in the Min mouse 
Abstract 
Colon cancer is the third most frequently diagnosed cancer in the UK and is often 
associated with a "Westenf' style of eating, high in fat and low in vegetables and fruits. 
There is strong epidemiological evidence that more physical activity is associated with 
reduced risk of colon cancer, but the amount or type of activity necessary to invoke this 
protection is disputed, and the mechanism responsible has not been elucidated. 
In this project, Min mice were used in studies of the impact of physical activity on 
development of intestinal neoplasia. These mice have a mutation at codon 850 in the Apc 
gene and develop multiple intestinal polyps spontaneously. The numbers, sizes and 
anatomical distribution of these lesions can be altered by dietary and pharmacological 
agents. From 5 weeks of age, male and female Min mice were exercised by running on a 
treadmill at up to 21 m/min for 30-60 min on a 5% slope for 5d/week for 10 weeks (TR). 
Additional groups of mice were provided with an exercise wheel (WH) or with no 
exercise (CON). Throughout the study, mice had ad libitum access to a Western-style 
high fat diet. Interleukin (IL)-6, IL-10, caecal transit time, colonic short chain fatty acids 
and natural killer cell cytotoxicity were investigated as potential protective mechanisms. 
On average, WH mice ran 2.99km/d (maximum 18.35km/d) compared with a maximum 
0.96km/d for TR mice. Female mice were more willing treadmill runners and ran further 
in the wheels than did males. There was no significant reduction in total number of 
turnours or tumour burden in TR or WH compared with CON mice. Molar proportion of 
butyrate was significantly greater in TR mice compared with CON (P = 0.002). None of 
the other investigated mechanisms were different between exercise groups, although sex 
differences were observed for transit time. Non-exercise physical activity (NEPA) 
undertaken by the TR and CON mice was quantified for 23h per day (i. e. excluding 
period associated with treadmill running) using an Inframot device. NEPA was 
significantly higher for TR compared with CON mice (P=0.00 1), and for females 
compared with males (P<0.00 1). 
This study demonstrates that the turnour load in Min mice fed a high fat diet is not 
modulated by an exercise regime. 
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I Introduction 
Chapter I 
In 2005,655 000 people died from colorectal cancer (WHO, 2006). It has been estimated 
that as many as 91700 of these deaths could have been prevented with increased physical 
activity (Slattery, 2004). 
1.1 Incidence 
In the year 2000,128 874 people in the US and 34 539 people in the UK in 2001 were 
diagnosed with colorectal cancer (cancer of the colon and/or rectum). This represents 
13% of UK total cancer cases for that year, and the third highest incidence, behind breast 
(15%) and lung cancers (14%) (Cancer Research UK, (CRUK) (2005)), and fourth most 
frequent in the US, behind breast, lung and bronchus and prostate (US Cancer Statistics 
Working Group, (USCSWG) (2003). Table 1.1 and Table 1.2 display specific figures 
relating to colon and colorectal, cancers. 
In 2003 there were 16 107 UK deaths from colorectal cancer, 10% of the total cancer 
mortality rate and second only to lung cancer (Cancer Research UK, 2005). In males, 
colorcctal cancer accounted for 8 564 deaths (i. e. 11 % of all male cancer deaths, behind 
lung, 25%, and prostate, 13%). In females the figure is 7 543, i. e. 12% lower than males. 
This represents 10% of all female deaths due to cancer, behind lung (18%) and breast 
(17%). 
Table 1.1 US* (2000) and UK (2001) cancer Incidence data, (US Cancer Statistics Working Group, 
(2003) and Cancer Research UK, (2005)) 
Cancer site US Male US Female UK Male UK female 
All sites 560333 533647 135372 135410 
Colon and 64967 63907 18500 16040 
rectum 
Colon only 45362 48738 10921 10689 
*US data are for Invasive cancer only 
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Table 1.2 Age-standardised US*(2000) and UK (2001) cancer incidence per 100 000 population (US 
Cancer Statistics Working Group, (2003) and Cancer Research UK, (2005)) 
Cancer site US Male US Female UK Male UK female 
All sites 546.9 409.4 404.2 339.6 
Colon and 65.0 47.0 54.9 35.5 
rectum 
Colon only 45.9 35.6 32.9 23.8 
* U. S. data are for invasive cancer only 
1.2 Pathology and prognosis 
Intestinal tumours arise from unrepaired damage to proliferative cells within the 
epithelium, which provides them with a competitive advantage. The first visible signs of 
neoplasia are aberrant crypt foci (groups of enlarged crypts), some of which may acquire 
further genetic or epigenetic damage and develop into non-malignant adenomas 
(characterised by dysplasia) (Hamilton, 1996). Approximately one in ten adenomatous 
polyps will become malignant after 10 years (Scholefield, 2000). Further genetic or 
epigenetic changes allow the carcinoma to metastasise. The degree of malignancy of 
bowel turnours is graded using Dukes' staging A-D, or the TNM staging system: 
eA- cancer is limited to the bowel wall with no spread to the lymph nodes 
eB- cancer extends though the muscle wall, no spread to lymph nodes 
*C- cancer has spread to nearby lymph nodes but not to other parts of the body 
*D- the cancer has spread or grown into other organs or parts of the body 
TNM staging system: 
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T- depth the tumour has grown into the bowel wall 
oN- the number of lymph nodes to which the cancer has spread 
eM- indicates any metastases (American Cancer Society, (ACS) (2005)) 
Between 1986 and 1999 five-year age-standardised survival rates have increased, with 
survival at almost 50% (Cancer Research UK, 2005). The earlier turnours are diagnosed 
the more favourable the prognosis, with 90% of patients with Dukes' stage A cancer alive 
5 years after diagnosis compared with 20% of Dukes' C patients where four or more 
lymph nodes have been affected (American Cancer Society, 2005). 
Figure 1.1 Example of a colonic cancer (left) and a polyp (right). 
(Cancer picture from http: //www. viahealth. org/body_surgical. cfm? id=473, polyp 
picture from http: //www. gihealth. com/htmUeducation/photo/colonPolypectomy. html) 
1.3 Genetic basis of colorectal cancer 
The majority (75%) of colon cancer cases are sporadic - due to the accumulation of 
multiple spontaneous somatic mutations which have not been repaired together with 
aberrant epigenetics e. g. hypermethylation of CpG islands in the promoter regions of 
tumour suppressor genes, causing gene silencing. The remaining proportions of cases are 
inherited or familial (Calvert & Frucht, 2002a). Specific inherited forms of colon cancer 
make up a very small percentage of total colon cancer cases, however, they provide 
valuable tools for studying the genetic basis for cancer. Mutations causing turnours 
usually occur in the genes controlling the cell cycle. Normal function is maintained with 
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one non-mutated allele - both alleles must be mutated to cause tumourigenesis. If one 
mutated allele is inherited (as with inherited forms of colon cancer such as Familial 
Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis Colorectal Cancer 
(HNPCC)), only one mutation to the normal allele is required to produce the phenotype, 
hence the younger age at presentation than sporadic cases. In FAP, only one gene (APQ 
is affected, making it easily identifiable and easy to study. In most cases of FAP, 
mutations in the APC gene result in the expression of a truncated protein, causing 
uncontrolled cell proliferation. In HNPCC cases, mutation occurs in any of six mismatch- 
repair (MMR) genes, though usually hMSH2 or hMLH1 is affected (Calvert & Frucht, 
2002a). This leads to an accumulation of errors in the genome and an increased risk of 
incorrect copying of genes involved in key cellular processes. 
Recent research has examined apparently normal colon tissue from both colon cancer 
patients and a mouse model of intestinal cancer (the Min mouse) and discovered that 
gene expression is altered when compared to tissue from cancer-free patients (Chen et al., 
2004). Cancer patients demonstrated highly variable expression levels compared to 
controls. Genes involved in the APC/fl-catenin pathway, inflarnmation pathway, cell 
cycle and cell communication were found to be upregulated 50-200 times greater than 
control values. In some patients, certain proteins were downregulated by 5 0-1 00-fold 
compared with cancer-free controls (Chen et al., 2004). The same group has 
demonstrated altered gene expression in macroscopically normal colon tissue from 
patients who have a family history of sporadic cancer (Hao et al., 2005). These findings 
demonstrate that abnormalities to gene expression can occur before any lesion is visible 
and could be used as a screening tool for at-risk patients. 
1.3.1 Familial Adenomatous Polyposis (FAP) 
FAP is a condition where patients can develop several thousands of intestinal adenomas 
by the second decade of life. It is an autosomal dominant condition, caused by a germline 
mutation to APC (adenomatous polyposis coli) turnour suppressor gene on chromosome 
5q21, usually resulting in frameshift mutations or stop codons (Shoemaker et al., 1997). 
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The most frequently detected somatic event is the mutation of the wild-type APC allele 
which allows easy detection by PCR (Reale & Fearon, 1996). 
Extracolonic manifestations including osteomas and CHRPE (congenital hypertrophy of 
the retinal pigment epithelium) when combined with FAP are known as Gardners 
Syndrome (Reale & Fearon, 1996). 
Patients show an increased incidence of desmoid turnours (a locally invasive fibrocytic 
growth), gastric cancers, thyroid cancers and hepatoblastoma, often demonstrating a 
mutation in the CTNNbl gene (which codes for P-catenin) (Polakis, 2000). 
1.3.2 Hereditary Non-Polyposis Colorectal Cancer (HNPCC) 
HNPCC is an autosomal dominant condition with colorectal cancer usually presenting at 
approximately 45 years of age. Extensive polyposis is absent and females with HNPCC 
are at increased risk of endometrial cancer (Burt & Peterson, 1996). 
The condition is caused by a defect in DNA mismatch repair (MMR) mechanisms leading 
to microsatcllite instability (Lengauer et al., 1998). Patients with HNPCC will usually 
have one normal allele, so MMR is normal. If the wild-type allcle is inactivated, there is 
no MMR so mutations arc allowed to accumulate, leading to turnourigenesis. MMR 
genes have been located to chromosomes 2p 16 and 3p2 1, MMR genes hMSH2 and 
hMLHl respectively. 
An association is often found with mutated transforming growth factor P (TGFP), which 
under normal conditions represses epithelial cell growth (Reale & Fearon, 1996). 
1.3.3 Sporadic colorectal cancer 
Somatic mutations in the turnour suppressor genes APC, DCC (deleted in colorectal 
cancer) and p53 (which normally halts the cell cycle in GI to allow DNA repair before 
replication or to induce apoptosis) are often found in sporadic colon cancers. Mutation in 
the K-ras gene (leading to decreased GTPase activity) is also frequently detected in 
colorectal cancers (Calvert & Frucht, 2002b). 
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Patients often demonstrate chromosome instability (CN (Lcngauer et al., 1998), when 
whole chromosomes can be lost or gained, including those responsible for controlling the 
cell cycle. Cell growth is therefore not controlled leading to aneuploidy. 
1.3.4 APC structure and function 
APC (adenomatous polyposis coli) can be classed as the "gatekeeper" of the 
gastrointestinal tract, controlling the cell cycle. Mutations to APC lead to stimulated cell 
birth, which, when it exceeds cell death, leads to the formation of small benign turnours. 
To advance to adenoma/adenocarcinoma stage, other factors and pathways are required. 
APC is a large multidomain protein of 8535 base pairs and 2843 arnino acid residues 
(Fcamhead et al., 2001). The N-terminus contains multiple regions of heptad repeats 
including a stretch of arm repeats (Dikovskaya et al., 200 1). Protein phosphatase 2A 
(PP2A) and APC-stimulated exchange factor (ASEF), a guanine nucleotide exchange 
factor (GEF) for Rac and Rho proteins, both bind to the arm region of APC (Dikovskaya 
et al., 2001). The central region of APC contains seven 20-amino acid repeat motifs 
which bind P-catenin, and also axin interaction sites. The C-terminal third interacts with 
structural proteins, including a basic region for microtubule binding. 
1.3.4.1 APC Mutations 
Nonsense and frameshift mutations account for 95% of germline APC mutations in FAP 
patients, with a third of all germline mutations occurring at either codon. 1061 or 1309 
(Feamhead et al., 2001). Other mutations occur between codons; 200 and 1600, but rarely 
past that. Somatic mutations are found concentrated in a mutation cluster region (MCR), 
between codons 1286 and 1513. 
Cells lacking the C-terminus of APC display aneuploidy and errors in chromosome 
segregation. This is thought to be due to the inability of the mutated APC protein to bind 
to microtubules and therefore is unable to attach to kinetochores during mitosis. 
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P-catenin is one of a family of intracellular catenins that bind directly to cadherins. This 
provides a link between the actin cytoskeleton and cell-cell junctions (Henderson & 
Fagotto, 2002). P -catenin interacts with E-cadherin (responsible for cell-cell adhesion in 
epithelial cells) to link it to a-catenin, and from there to the actin network (Fearnhead et 
al., 2001). APC competes with E-cadherin for a binding site on P -catenin, and can 
regulate P -catenin by binding to it. Mutations in specific regions of the gene coding for 
-catenin (CY7VNbl) make it more resistant to APC regulation and to degradation (Polakis, 
2000). These mutations occur in a variety of cancers, but are always mutually exclusive 
to APC inactivating mutations. Increased intracellular P -catenin can then bind to 
transcription factors which activate proliferative genes (Dikovskaya et al., 2001). 
catenin also participates in the wnt signalling pathway (see 1.3.6). 
1.3.6 Wnt 
The wnt proteins are secreted glycoproteins that are categorized according to their ability 
to promote neoplastic transformation (Polakis, 2000). Binding of a wnt to its receptor 
("frizzled") causes phosphorylation of the "dishevelled" protein, which prevents 
glycogen synthase kinase 30 (GSK3P) phosphorylating substrates that include axin, APC 
and P-catenin. Unphosphorylated P-catenin avoids degradation by ubiquitin ligase and 
translocates to the nucleus where it is able to activate transcription factors such as T-cell 
specific transcription factor (TCF) and lymphoid enhancer factor (LEF) (Polakis, 2000). 
There are at least 16 wnt ligands and at least 11 frizzled genes (Polakis, 2000). Function 
and ligand specificity differs between receptors and have not all been clarified. 
1.4 Epigenetics 
Epigenetics refers to the modulations of the genome which are copied from one cell 
generation to the next and which do not involve alterations to the DNA sequence. This 
includes histone modification by acetylation/deacetylation, chromatin remodelling and 
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methylation of CpG dinucleotides, which can alter the transcription rates of some genes 
(Nakao, 2001). Many CpG dinucleotides are found clustered together (CpG islands) in 
the promoter regions of genes. Methylation of these CpG islands silences gene expression 
and is a normal event in the cell (Davis & Uthus, 2004). Cancers display abnormal 
methylation patterns, with both hyper- and hypomethylation. The promoter regions of 
hMLHI and E-cadherin are hypermethylated in sporadic colon cancers (Wheeler, 2005) 
and tumours, demonstrate global DNA hypomethylation (Davis & Uthus, 2004). 
Hypermethylation of promoter regions are thought to be at least as common as the more 
recognized cause of tumour suppressor gene activation, mutation (Davis & Uthus, 2004). 
The mechanism behind the abnormal pattern of global hypornethylation is not fully 
understood, but is thought to include disruption to the action of DNA methyltransferases 
(Davis & Uthus, 2004). 
Methylation status of colon tissue is currently measured from tissue biopsies obtained 
from colonoscopy/flexible signioidoscopy, with some discomfort for the patient. If 
methylation patterns could be reliably detected in more accessible specimens it would 
reduce both patient anxiety and cost of the procedure. Extracting patient DNA from 
faecal samples is a pain-free method of assessing methylation in colonocytes, and levels 
of methylation in faecal DNA samples correlate well with methylation of certain genes in 
the mucosa, e. g. ESRI (Belshaw et al., 2004). Another option is measuring methylation 
status in serum samples, and one group is having some success with this technique, 
looking at a range of genes that are frequently methylated in colorectal cancer (Leung et 
al., 2005), though the test needs further refinement to increase the sensitivity. 
1.5 Diet and colorectal cancer 
Diet is known to play an important role in the pathogenesis of colon cancer. Foods such 
as fruits, vegetables and whole grains have been promoted as reducing colon cancer risk, 
but recent studies suggest this association may be weaker than originally thought 
(McCullough et al., 2003). 
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Table 1.3 is taken from the 1997 World Cancer Research Fund (WCRF)/American 
Institute for Cancer Research (AICR) review of diet and cancer "Food, Nutrition and 
Prevention of Cancer: a global perspective" (WCRF/AICR, 1997) and summarises the 
strength of the evidence linking specific foods and food components with risk of 
colorectal cancer. 
Table 1.3 WCRF summary regarding dietary components and risk of colorectal cancer (taken from 
(WCRF/AICR, 1997) 
Level of evidence Decreased risk No relationship Increased risk 
Convincing Vegetable intake 
Probable Red meat 
Alcohol 
Possible Non-starch Calcium Frequent eating 
polysaccharide/fibre Selenium Sugar 
Starch Fish Total fat 
Carotenoids Saturated fat 
Processed meat 
Eggs 
Heavily cooked 
meat 
Insufficient Resistant starch Iron 
Vitamins C/D/E 
Folate 
Methionine 
Cereals 
Coffee 
1.5.1 Evidence for the recommendations 
Fruit, vegetables, whole grains and dietary fibre 
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The Department of Health COMA report (1998) concluded that there was "moderately 
consistent" evidence for a reduced risk of colon cancer with increased fruit and vegetable 
intake from case-control studies, and that cohort studies presented weaker evidence. 
Since this report was published further studies have been completed, but the picture is 
still unclear. The Cancer Prevention Study II Nutrition Cohort of 62 609 males and 
70 554 females found a borderline inverse association between vegetable intake and 
colon cancer risk in men (rate ratio (RR) 0.69, Ptrend -= 0.10). However, men with the 
lowest consumption of vegetables and dietary fibre were at increased risk of colon cancer 
compared with those in the highest four quintiles (RR = 1.79 Ptrend = 0.04 and RR = 1.96 
Ptrend`: '10-01, respectively). Women in the lowest category of fruit consumption were at 
increased risk of colon cancer (RR = 1.86, Ptrend = 0.06) (McCullough et al., 2003). 
The evidence for non-starch polysaccharide (NSP), or dietary fibre, protecting from colon 
cancer is considered "moderately consistent" by COMA (1998). Bingham et al. (2003), as 
part of the European Prospective Investigation into Cancer and Nutrition (EPIC) a 
Europe-wide cohort study, measured the association between dietary fibre (non-starch 
polysaccharides) and colorectal cancer. They found that risk of colon cancer decreased as 
total fibre intake increased (P = 0.06). However, individual sources of fibre (fruits, 
cereals, vegetables and legumes) did not significantly affect risk. No association with 
rectal cancer was observed. 
These studies suggest that although higher intakes of fruit and vegetables may not 
decrease the risk of developing colon cancer, low intakes may increase risk and the 
overall composition of the diet may be more important than the individual components. 
Meat 
The evidence of a positive association between increased consumption of red and 
processed meat and CRC is considered "moderately consistent" from cohort studies, 
although the relative risks in all studies were less than 2 (COMA, 1998). Since then, the 
relationship between meat intake and CRC risk has been examined as part of EPIC (Norat 
et al., 2005). CRC risk was positively associated with intake of red and processed meat 
(Ptrend -'ý 0.03,0.08 and 0.02 for red and processed meats separately) and negatively 
associated with fish intake (Ptrend <0.001), although when specific type of meat was 
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adjusted for intake of other meats, a significant risk was found only for increased pork 
intake (Ptrend -'ý 0.03). There was no association between intake of poultry and CRC risk. 
Dietary fats 
The evidence for increased risk of CRC with increased consumption of total fat intake is 
"weakly consistent" (COMA, 1998), and this may be due to this different types of fat in 
the diet and the foods that contain them. 
Vitamin D and calcium 
The WCRF/AICR table from 1997 considered there to be insufficient evidence of a 
protective effect of Vitamins C, D and E, and possible decreased risk from intake of 
carotenoids, although a case-control study from that year provided more evidence of 
protection (La Vecchia et al., 1997). They studied the diets of 1953 CRC cases and 4 
154 controls. A decreased risk was observed to occur with increased intake of carotenoids 
(Ptrend<0.001), vitamin C (Ptend<0.01) and vitamin E (Pte,, d<0.00l). When intake of 
antioxidants, vitamin D and calcium were in the upper tertile of consumption, risk was 
decreased by more than 50%. The protective effect was generally seen more in women 
than in men, with positive interactions with calcium and vitamin D (women) and carotene 
(men) (La Vecchia et al., 1997). 
As part of EPIC, Kesse et al. (2005) examined the effect of vitamin D, calcium and dairy 
products on colorectal adenoma and cancer risk among a subset of French women. A 
trend towards decreased risk of both adenoma and cancer was observed with increasing 
calcium intake, and of dairy products on adenoma. No effect of Vitamin D intake on risk 
of adenoma or carcinoma was identified. 
A more recent 3 year calcium and antioxidant intervention study found no association of 
nutrients on polyp growth (though several odds ratios were below 1.0), or adenoma 
recurrence (Almendingen et al., 2004). 
1.5.2 Dietary patterns 
Interest in the effect of diet on colon cancer has recently focussed on dietary patterns, to 
test the hypothesis that colon cancer risk is increased or lessened when certain foods are 
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combined in the diet. However, the evidence for a protective effect from a "prudent" diet 
as opposed to "western" is so far mixed, with some studies finding a positive but non- 
significant risk with a western diet in large cohorts (Wu et aL, 2004; Kim et A, 2005), 
whilst a case-control study (Slattery et al., 2000) found an increased risk of developing 
colon cancer with increased consumption of a western style of eating. The effect of 
dietary combinations on CRC risk deserves further study. 
1.5.3 Obesity 
The increased prevalence of overweight and obesity has been well publicised, and is 
linked to readily available, energy dense, palatable foods and a decrease in habitual 
physical activity (Calle & Thun, 2004). The problems associated with being obese are 
many and varied, including increased risk of cardiovascular disease, stroke and type 2 
diabetes. Cancer can be added to this list, as obese people are more at risk of cancer of 
the kidney and oesophagus, and women are more at risk of post-menopausal breast 
cancer and endometrial cancer (Calle & Thun, 2004). Indeed, one study has estimated 
that overweight and obesity could account for 14% of male and 20% of female deaths 
from cancer in the US (Calle et al., 2003). 
Obesity has consistently been positively associated with colorectal cancer in both cohort 
(Giovannucci et A, 1995; Giovannucci et aL, 1996; Terry et aL, 2002; Calle et aL, 2003; 
Lin et al., 2004; Engeland et al., 2005; Otani et al., 2005) and case-control (Otake et al., 
2005) studies, though not in a study of polyp recurrence (Sass et al., 2004). The 
mechanism linking obesity and CRC is likely to be multifactorial, as many candidates 
have been suggested, including insulin and insulin-like growth factor (IGF), elevated 
blood glucose levels and inflammatory proteins such as C-reactive peptide, tumour 
necrosis factor (TNF)-a and interleukin-6 (IL-6). Inflammatory markers are of interest as 
they are elevated with obesity (and decrease with weight loss (Esposito et al., 2003)), and 
sufferers of ulcerative colitis show an increased occurrence of colon cancer in both 
animal (Bertone et al., 1998) and human (Biasco et al., 1995) studies. 
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1.6 Epidemiology of links between physical activity and bowel 
cancer in humans 
1.6.1 Exercise or physical activity? 
The terms physical activity and exercise are often used inter-changeably but it is 
important to distinguish between the two. Physical activity encompasses all bodily 
movements requiring energy above the basal rate whilst exercise refers to structured, 
deliberate, often repeated movements. 
1.6.2 Benefits of being active 
The benefits confeffed by physical activity have been well documented and include 
physical, mental and social aspects, all of which are equally important as individual needs 
will differ. Some of the positive aspects of being physically active follow: 
* Lowered blood pressure, reduced risk of stroke and coronary heart disease 
Changed body shape - increased muscle tone, decreased fat storage, weight 
control 
9 Decreased diabetes risk 
" Releases endorphins, improved mood, general psychological benefits 
" Boosted circulatory and immune systems 
" Increased fitness, mobility and flexibility 
" Improved cardiovascular health 
" Improved appetite 
" Social aspects - team building, increased confidence, make new friends 
In contrast to the benefits of being active are the problems induced by inactivity, which 
can contribute to obesity and the problems associated with it, such as diabetes, sleep 
-24- 
Laura Basterfield Chapter I 
apnoea, joint pain and immobility. In addition to the physical detriment is the cost to 
health authorities when treating problems that could otherwise be solved by a lifestyle 
change. According to the Department of Health's Health and Social Care Information 
Centre (HSCIC) (2005), in 2004 just 35% of men and 24% of women in England were 
meeting the government recommendation of 30 minutes of moderate intensity activity on 
at least 5 days of the week, figures that decrease with age. A recent study of a health 
insurer in America attributed $35.3million to treating diseases caused by physical 
inactivity in a group of 1.5 million people in 2000 (Garrett et al., 2004) and this figure is 
thought to be an underestimate. 
1.6.3 Measuring physical activity 
There are three factors to consider when measuring physical activity. Total daily energy 
expenditure (TDEE) consists of- 
RMR (resting metabolic rate), basal and sleeping conditions plus the added cost of 
arousal 
* Thermogenic effect of consumed food 
* Energy expended during physical activity and recovery 
These parts contribute approximately 60-75%, 10% and 15-3 0% to TDEE, respectively 
(McArdle et al., 2001). 
There are several methods for measuring energy expenditure in humans. These include: 
o Direct calorimetry 
This method utilizes the heat produced by the body as a result of metabolism. During 
airflow calorimetry, the subject is kept in a sealed room and energy intake (food, or 
"gross energy") is carefully measured using a bomb calorimeter. The walls of the 
room contain thermocouples to measure the change in room temperature as a result of 
body heat. The change in humidity of air leaving the room compared with air entering 
the room allows heat lost from the lungs and body surface as water to be quantified. 
Energy expended through excreta is also measured, and when subtracted from energy 
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intake provides the amount of energy available for use by the body ("metabolisable 
energy"). Other forms of direct calorimetry are available, all of which have several 
drawbacks: the subject is not free-living and therefore is not undertaking their normal 
daily tasks, so energy expenditure is not reflecting a real-life situation. 
e Indirect calorimetry 
This involves measuring the quantities Of 02 consumed and C02 produced by the 
subject as an estimate of energy expenditure. This method is based on the knowledge 
that combustion of different metabolic substrates produces a different proportion of 
C02 produced to 02 consumed, or RQ (respiratory quotient), where RQ = moles C02 
produced/moles 02 consumed, e. g. for glucose, RQ = 1.0, for fat RQ = 0.7. A blend 
of lipid, protein and carbohydrate burned in one litre of oxygen produces 
approximately 4.82 kcal (20.20 U) energy, and varies only slightly with different 
metabolic mixtures (McArdle et al., 200 1). Drawbacks to this method are similar to 
those of direct calorimetry, but the results produced are very similar to those as 
measured by direct calorimetry. 
* Doubly-labelled water (Lifson & McClintock, 1966) 
This technique is an example of indirect calorimetry, is relatively simple to carry out 
and has the major advantage of being a feasible way to study TDEE in free-living 
creatures. The subject is fed a known quantity of "labelled" water, containing 2H and 
180. This equilibrates readily with the H20 already in the body. 180 canleavethe 
body in the form of H2 180 or C180 2.2 H can only leave the body as 2 H20 (sweat, urine 
and pulmonary water vapour). Urine samples are taken at specified intervals and the 
ratio of rates Of loss Of 2H to 180 provides an estimate of how much additional 180 has 
been lost from the body via the lungs as C02, and therefore how much activity has 
been undertaken (assuming an RQ of 0.85). This method is suitable for measuring 
over long periods and during extreme activities (e. g. the Tour de France). The major 
drawback to this method is the cost of the isotopes and their subsequent 
quantification. 
9 METs (Metabolic equivalents) 
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MET's attempt to quantify the amount of energy required to undertake specific 
activities in multiples of the resting metabolic rate. This is usually expressed as 
millilitres of oxygen per kilogram of body mass per minute (ml-kg7l -min") with 5 kcal 
approximating to I litre of oxygen consumption. 1 MET is equivalent to the resting 
oxygen consumption (-- 250 ml-min7l for men and 200 ml-min" for women). 
Therefore, exercise at 2 METs requires twice the resting oxygen consumption, 3 
MET's requires 3 times the oxygen consumption, and so on. With this technique it is 
more accurate to consider variations in body size, with I MET = 3.5 H-kg7l-min7l 
(McArdle et al., 2001). Difficulties with this technique include duration and intensity 
of exercise and fitness differences between individuals. When assessing lifetime 
activity through the form of detailed exercise questionnaires, this technique has some 
value, although omission of light or daily activities or exaggeration can introduce 
recall bias and inaccuracy. 
* V02max 
'Ibis technique is the "gold standard" for current fitness levels, by measuring 
maximal oxygen uptake. It is possible to obtain an estimate of RQ from this 
technique, by measuring exhaled C02, but cannot be used to assess lifetime activity 
levels and would not be a suitable method of measuring total energy expenditure. 
Table 1.4 shows comparisons between V02max and METs. 
Table 1.4 Comparison Of V02.,, and MET quantification (adapted from (McArdle et al., 2001)) 
Absolute intensity (METs) 
Relative 
intensity Middle 
Category (%V02max) Young aged Old Very old 
Rest <10 1.0 1.0 1.0 1.0 
Moderate <70 <9.0 <7.0 <5.0 <2.8 
Heavy >70 >9.0 >7.0 >5.0 >2.8 
Maximal 100.0 13.0 10.0 7.0 4.0 
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Increasing the intensity of aerobic exercise shows a linear relationship between heart 
rate and oxygen consumption. Heart rate readings can therefore be used to estimate 
oxygen consumption and therefore energy expenditure during exercise. Drawbacks to 
this otherwise simple technique are the specificity of the heart rate-consumption 
linearity to individuals, with different subjects requiring different amounts of oxygen 
at different heart rates, and also heart rate being affected by things other than 
exercise, such as emotional state, environmental temperature, etc. 
* Accelerometers/pedometers 
Uni-axial or tri-axial accelerometers are small, portable devices that measure velocity 
changes in I or 3 axes. Data is accumulated frequently and allows estimation not just 
of total activity and activity pattern but also intensity of activity (Cooper et al., 2000). 
Pedometers count the number of steps taken, and are therefore more useful for less 
active subjects. 
As many intervention trials are first performed on animals, several methods of 
assessing activity have been developed: 
9 Biotelemetry 
Devices are available that monitor gross activity of individual animals via an 
implantable transmitter (e. g. Mini Mitterg). The strength of the signal alters 
depending on the distance of the transmitter from the receiver. Changes in signal are 
interpreted as activity counts. Additional physiological parameters such as body 
temperature and heart rate can be measured simultaneously. 
o Infrared (1) 
IR beams are set up around the cage in one, two or three dimensions and coupled to a 
computer. Every time a beam is broken the activity level can be measured, and 
depending on the number of beams broken at any given time, different activities such 
as rearing can be identified (e. g. Opto-Max from Columbus Instruments, Ohio, US). 
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A single sensor placed on top of the home cage that detects infrared (body heat) 
movement greater than Sms in length and records them in a spreadsheet. This gives 
information about general activity but does not distinguish between animals or types 
of activity (e. g. InfraMot from TSE Systems, Bad Homburg, Germany). 
* Doppler radar 
Low power electromagnetic waves are beamed through the cage and reflected by 
skin. The returning waves can be amplified and filtered allowing movement to be 
recorded (Kropveld & Chamuleau, 1993). 
9 Video analysis 
This is the crudest method of monitoring activity, by constantly videoing the animals 
in their cages and scoring any movements. Problems occur when attempting to 
quantify different movements/activities, such as rearing, nest building, feeding etc, 
especially if there are several animals per cage. 
1.6.4 Exercise/physical activity and cancer risk 
There is substantial evidence (at least 50 studies (Lee, 2003)) to suggest that being 
physically active can reduce the risk of developing cancer, particularly of the breast and 
colon (McTieman et al., 1998), indeed one report suggests that high levels of physical 
activity may reduce the risk of colon cancer by up to 50% (Stein & Colditz, 2004). 
1.6.4.1 Cohort studies 
The Framingham Study of 1906 men and 2308 women found an increased risk of large 
bowel cancer in men with low levels of activity, but no effect for women (Ballard- 
Barbash et al., 1990). However, few women reported intense activity, and fewer women 
than men reported moderate activity. 
The Health Professionals Follow-up Study of 31055 men in the USA found that men in 
the highest quintile of physical activity had half the incidence of colon cancer as men in 
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the lowest quintile (Giovannucci et al., 1995). The authors concluded that a moderate 
level of activity can reduce risk - the median activity level in this study was low, possibly 
due to the majority of the participants being retired and was equivalent to three hours 
walking per week. 
A large study (over 80 000 participants) in Norway found that, for females, the equivalent 
of walking or cycling for at least four hours per week decreased risk of developing colon 
cancer, especially for the proximal colon, by almost 40% compared with a sedentary 
group (Tbune & Lund, 1996). The same effect was observed in males aged 45 or older, 
and a protective effect of occupational activity was also observed in males. An inverse 
dose-response relationship was observed in both sexes (Thune & Lund, 1996). 
The Nurses Health Study in 1997 found that increased leisure-time activity was 
associated with decreased colon cancer incidence, especially of the distal colon (Martinez 
et al., 1997). Moderate intensity activity for one hour per day reduced risk by 46%. 
Chao et al. (2004) analysed the effect of recreational activity on colon and rectal cancer 
in older adults in the Cancer Prevention Study II Nutrition Cohort (70 403 men and 80 
771 women) and observed a decrease in risk of colon cancer with increased time spent in 
activity (Ptrend =0.007). This response was particularly due to walking plus other 
activities, as opposed to just walking. This may infer a requirement for more strenuous 
activity to offer protection, or an inability to accurately measure the pace of walking. 
A recent Scandinavian study assessed the impact of leisure-time physical activity on 
cancer (Schnohr et al., 2005). The cohort of 13 216 women and 15 043 men generated 
180 and 215 colon cancers respectively, and an inverse association between vigorous 
activity and colon cancer risk was observed for men Only (Ptrend _"ý 0.06). 
1.6.4.2 Case-control studies 
Slattery et al. (I 997a) conducted a large case-control study investigating more closely the 
effect of long-term physical activity. They found that decreased risk was associated with 
long-term vigorous activity (odds ratio 0.68), and that the length of each individual 
session was more important than the number of sessions per week. This inverse 
association was slightly weaker in those with a family history of colorectal cancer. A 
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family history of colon cancer or polyps is known to increase risk of colon cancer and 
may reduce the protective effects of activity (Kerber et aL, 1998; Slattery et aL, 2003). 
A smaller case-control study of 177 cases and 228 controls (Hauret et al., 2004) 
confirmed the results of Slattery et al., with odds ratios of 0.63 when comparing the 
highest and lowest quintiles of physical activity. 
Commuting physical activity was included in a study of physical activity and colon 
cancer risk in Shanghai (Hou et al., 2004). The high level of bicycle commuting among 
the subjects was unusual compared with other studies and led to high levels of activity 
even in the lowest tertile. This could have obscured any findings, but the authors still 
observed a trend of decreased risk of colon cancer with increased activity of all kinds, but 
particularly commuting for both sexes (Pt,,,, d= 0.007 in women and <0.00 I in men) and 
occupational activity for women (Ptrend = 0.009), particularly when continued over a 
lifetime. 
Steindorf et al. reached similar conclusions in a Polish study of colon cancer (Steindorf et 
al., 2005), where lifelong high exercisers had an odds ratio of 0.28 compared with 
lifelong non-exercisers. No consistent association was observed for rectal cancers. 
1.6.4.3 Polyp prevention 
The Polyp Prevention Trial examined this association further by assessing polyp 
recurrence in a group of patients who had had at least one polyp which was removed 
before the start of this dietary intervention study (Colbert et al., 2002). Subjects were 
assigned to either a low-fat, high-fibre, fruits and vegetables diet or their normal diet. The 
study found that physical activity was not associated with polyp recurrence over the three 
years of the study, but note, however, that the intervention did not involve a change in 
physical activity and only activity in the preceding year was assessed. However, the 
Calcium Polyp Prevention Study (a trial of calcium carbonate supplementation on polyp 
recurrence) found an inverse association between level of physical activity and risk of 
polyp recurrence in men (Wallace et al., 2005) (Ptrend -_"ý 0.005). No such association was 
observed in women, where the 95% CI was large for all variables (e. g. middle tertile of 
activity (MET-h/wk) 0.534.27 for women compared with 0.16-0.67 for men). 
-31- 
Laura Basterfield Chapter I 
Project PREVENT used mail and phone contact to change risk factors in polyp patients to 
reduce the chances of recurrence (Emmons et al., 2005). Behaviours such as physical 
inactivity, smoking, fruit and vegetable and red meat consumption were targeted. The 
authors found that the intervention was effective in helping patients to change risky 
behaviour compared with patients who received usual care, although the recurrence of 
polyps was not reported. Future interventions of this nature may find a reduction in polyp 
recurrence in patients who change their behaviour. 
1.6.4.4 Confounding factors 
Several reviews have collated the many available data (Colditz et aL, 1997; McTiernan et 
aL, 1998; Giacosa et aL, 1999) and also considered other factors that may influence any 
physical activity-bowel cancer risk relationships. These confounders are important, and 
should be included in the statistical analyses. Several confounders have been described 
which can increase the risk of developing colon cancer, including diet (as discussed in 
1.5), alcohol consumption (Sharpe et al., 2002) and smoking (Kuper et al., 2002). High 
total energy intake, increased body mass index (BMI) (Terry et al., 2002) and a high 
waist-to-hip ratio are all positively associated with colon cancer (Giacosa et al., 1999) as 
discussed in 1.5.3. People with these characteristics may also be less physically active 
(Boutelle et al., 2000). Given the implication of obesity in colon cancer, and the 
relationship between physical inactivity and colon cancer risk, this could be a causative 
or a confounding factor. However, a raised BMI and high energy intake had a 
nonsignificant effect on colon cancer risk in those who were physically active (Slattery et 
al., 1997b) suggesting that physical activity exerts its effects independently of BMI. 
Conversely, a recent study of caloric restriction in humans has found positive outcomes 
relating to the development of atherosclerosis, such as lowered serum triglycerides, 
fasting glucose, fasting insulin and BMI (Fontana et al., 2004). As these are important 
factors in colon cancer development, further study may reveal beneficial results of caloric 
restriction with respect to colon cancer prevention. 
A recent study examined the effect of several potential confounders (Slattery & Potter, 
2002), including total energy intake, red meat, fruit, vegetables, whole grains, calcium, 
alcohol, BMI and non-steroidal anti-inflammatory drug (NSAID) use. These were 
-32- 
Laura Basterfield Chapter I 
considered both singly and collectively. The study revealed no confounding with physical 
activity and concluded that physical activity is an independent factor modifying colon 
cancer risk, with long term vigorous activity consistently producing a 40% reduction in 
risk compared with no vigorous activity (in accord with Thune and Lund (1996)). 
1.6.5 Comparing studies 
Studies to date have used various methods of data collection, different time points and 
different criteria to assess previous and current levels of physical activity (see Table 1.5). 
This inevitably leads to a lack of comparability between studies due to the limitations of 
observational epidemiology. 
Table 1.5 Summary of the different methods of data collection and activity categories of 4 studies 
Reference Method of data 
collection 
Categories 
Giovannucci et al. (1995) Questionnaire 8 moderate and vigorous activities. 
Report time/week spent on each. 
Converted to MET-hours/week 
Thune and Lund et al. (1996) Questionnaire 4 levels of activity for both 
occupation and recreation 
Martinez et al. (1997) Questionnaire As Giovannucci et al. plus number of 
flights of stairs climbed daily 
Slattery et al. (1997a) Interview Converted time and frequency spent 
on each activity to energy expenditure 
and ranked 1-4 (low expenditure-high 
expenditure) 
1 MET (metabolic equivalent) = sitting quietly, 1 hr/week running - 10.2 MET-hours In Glovannuccl 
et al. but 12 MET-hours In Martinez et al. 
Differences in analyses include use of occupational or leisure-time activity; self-reported 
as opposed to interviewer-administered questionnaire; different time references, such as 
recent activity, activity in the past year, or lifetime activity; confounding factors such as 
BMI and family history; diet; and method of estimation of activity. This is possibly the 
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variable that is most different between studies, as mentioned in 1.6.3. Whilst the data 
need to as complete as possible, the procedure should not be an ordeal for the participant. 
Ideally, the type, duration and intensity of activity should be recorded, including 
occupational and leisure-time activities, as well as the time in life it occurred. 
Standardisation of these measures would be ideal, and help researchers and health 
officials to determine true exercise effects. 
One current intervention study will attempt to quantify more precisely the amount of 
activity that is beneficial with respect to colon cancer markers (McTieman, 2003). Few 
intervention studies of this type have been attempted as the imposition of a long-term 
exercise regime can be difficult for patients to adhere to. The Physical Activity for Total 
Health (PATH) study assessed the effect of a1 -year exercise intervention on sex 
hormone levels in post-menopausal women, and whilst excellent adherence to the 
exercise was achieved, there was variability between participants (Irwin et al., 2002). 
APPEAL (A Programme Promoting Exercise and an Active Lifestyle) is a study 
involving 100 men and 100 women aged 40-75 years who are at increased risk of 
developing colon cancer (McTieman, 2003). The intervention group will be asked to 
complete 60 minutes of aerobic exercise 6 days per week for 12 months. Various 
activities are available for use by the participants, such as treadmills, stationary bicycles 
and elliptical machines, in addition to walking and outdoorjogging. These choices, 
combined with other incentives, offer variability to the programme and should help to 
retain participants. The study will measure the effect of exercise on colon and rectal cell 
proliferation, apoptosis and prostaglandins. Fat mass, weight, insulin, IGF-1 and IGFBP- 
3 will also be under observation. The results had not been published at the time of 
writing. 
1.6.6 Mechanisms 
The potential mechanisms involved in reducing the risk of colon cancer by being 
physically active were reviewed recently by Quadrilatero and Hoffman-Goetz (2003). 
Potential candidates include faster intestinal transit time, enhanced immune function, 
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lowered cholesterol and prostaglandins concentrations, increased levels of anti- 
inflanumatory cytokines, and enhanced insulin sensitivity. 
1.6.6.1 Intestinal transit time 
The theory behind the protective effects of decreased transit time (time taken for food to 
travel through the gut) comes from the idea that increased physical activity speeds up 
transit as evidenced by the marathon runners' condition of runners' diarrhoea and from 
the converse observation of increased constipation in bed-bound patients. (Bingham & 
Cummings, 1989; Oettle, 1991; Liu et al., 1993; Robertson et al., 1993; Rao et al., 1999; 
Dukas et al., 2003; Sanjoaquin et aL, 2004). It is thought that by decreasing the amount 
of time that the gut contents are in contact with the mucosa, potential carcinogens and 
mutagens are less likely to cause damage, though no evidence appears to exist in support 
of this theory. 
The problem with the transit time theory is the lack of consistent evidence. 
Holdstock et al. (1970), whilst measuring the effect of a meal on propulsion in the colon, 
observed that activity of the subject led to the expulsion of markers in the stool that had 
otherwise been in a fixed position in the colon while the subject was stationary. This 
suggested that activity n-ýight speed up the passage of colon contents. 
Bingham and Cummings (1989) assessed the effect of a 7-9 week physical training 
programme on total gut transit time and stool weight in subjects fed a constant diet. 
Transit time increased in 9 subjects but decreased in 6' so overall no change in transit 
time (55h v. 54h for sedentary v. exercise) or stool weight was observed. However, the 
exercise intervention was inconsistent and uncontrolled, with some subjects wallcing and 
some jogging, for different lengths of time. 
OettI6 (199 1) also investigated effects of exercise on gut transit time, in free-living 
subjects who followed a3 week protocol of Ih/d of cycling/jogging or resting. Both 
jogging and cycling significantly decreased whole gut transit time, from 51.2 h at rest to 
36.6h when cycling and 34.0 h when jogging (P<0.01). Stool weight and frequency were 
unchanged, and although diet was not controlled, fibre intake was unchanged. 
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Coenen et al. (1992) measured effect of moderate exercise on total transit time (oro-anal) 
in healthy young men given a specific diet. The 61an ofjogging did not consistently alter 
transit time, as in one third of the volunteers it was unchanged, in one third it increased 
and in the remaining subjects transit time decreased. In contrast with the previous studies, 
stool weight increased, even though stool frequency and fibre intake were unchanged. 
This could have been explained by faster transit time, as there would have been less time 
for absorption of water, but no consistent effect on transit time was observed. 
Robertson et al. (1993) studied the effect of moderate exercise on colon transit time in 
young males and did not find any consistent difference from resting, as in some patients it 
increased, in some there was a decrease and in some transit time was unchanged. 
Liu et al. (1993) demonstrated that two weeks of inactivity in otherwise active elderly 
subjects almost doubled colonic transit time from 10.9±2.7 hours to 19.5±2.9 hours, 
while mouth-to-caecurn transit time remained unaffected. 
Dukas et al. (2003) used information from the 62 036 women aged 36-61 who took part 
in the Nurses Health Study 1980-1982. They observed that increased physical activity 
was associated with decreased prevalence of constipation. Sanjoaquin et al. (2004) 
published a study using data from the European Investigation into Cancer and Nutrition, 
Oxford Cohort (EPIC-Oxford) which involved 20 630 male and female participants aged 
20-97 years. A positive association was found between the amount of vigorous exercise 
undertaken and the mean number of bowel movements per week. Significantly higher 
odds of a daily bowel movement were found in females who exercised vigorously for 
seven or more hours per week compared with females who took no vigorous activity. No 
significant association was observed in men (Sanjoaquin et al., 2004). 
The highly individual responses of transit time to altered physical activity suggest that 
perhaps this is not an important factor in colon cancer prevention. 
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1.6.6.2 IGF-I and insulin 
Chapter I 
Insulin and insulin-like growth factors (IGFs) are increasingly being examined for their 
potential involvement in CRC, due to the insensitivity of the body's tissues to insulin that 
occurs with physical inactivity and obesity. Insulin and IGFs are also recognised as 
stimulators of cell proliferation and inhibitors of apoptosis (Quadrilatero & Hoffman- 
Goetz, 2003). In addition, insulin and IGFs are also thought to promote angiogenesis, and 
taken together, these functions are important in the generation of turnours (Quadrilatero 
& Hoffman-Goetz, 2003). Therefore, reduction of these peptides by physical activity 
would reduce the risk of abnormal cell growth. IGFs in the circulation are usually bound 
to insulin-like growth factor binding proteins (IGFBPs) (Renchan et al., 2004), and so 
levels of binding proteins may also indicate the availability or otherwise of IGFs to 
promote cell proliferation. 
Meta-regression analysis by Renehan et al., (2004) of five cohort studies of CRC found a 
positive association between increased IGF-I and risk of CRC, but not with IGFBP-3, 
whilst Renehan et al., (2000) observed an increased in serum IGF-II in patients with 
colorectal adenoma, although no association was found for serum IGF-I or IGFBP-3. 
Chadan et al., (1999) found no change in IGF-I concentration with physical activity in a 
group of healthy 62-67 year old women, though moderate exercise for 50 min resulted in 
decreased IGFBP I and increased IGFBP2 and 3. Rosendal et al., (2002) also found no 
effect of previous vigorous physical activity on plasma IGFI or IGFBP-3 concentrations 
in the Seattle Colon Cancer Family Registry, a population-based study of colorectal 
cancer cases, relatives and cancer-free controls. 
Evidence for the role of IGFs and insulin in CRC is somewhat mixed, and further study in 
larger trials is warranted. 
1.6.6.3 Cytokines 
Cytokines are small polypeptides that are released by cells in response to infection or 
tissue injury and act with cytokine inhibitors and soluble cytokine receptors to regulate 
the immune response (Opal & DePalo, 2000). Whether a cytokine has a pro- or anti- 
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inflammatory action depends on many factors, including the timing of release, local 
milieu, presence of agonists/antagonists, receptor density and tissue responsiveness (Opal 
& DePalo, 2000), but most fall into either the pro- or anti- inflammatory category. 
Anti-inflammatory cytokines are immunoregulatory molecules which control the 
response of the pro-inflammatory cytokines (Opal & DePalo, 2000). Anti-inflammatory 
cytokines include interleukin- I receptor antagonist (IL- I ra), IL-4, IL-6, IL- 10, IL- 11, IL- 
13 and TGF-P. In a normal state, anti-inflammatory cytokines help to limit any injury 
caused by excessive inflammatory reactions, but a diseased state may demonstrate a lack 
of control over pro-inflammatory mechanisms or too much control, with over-suppression 
of the inflammatory response increasing the risk of systemic infection. 
IL-6 
IL-6 is considered to be primarily a pro-inflammatory cytokine and is the third cytokine 
released in the inflammatory cascade, mediating the acute-phase response. Persistent 
activity leads to chronic inflammation, which encourages further IL-6 release from 
lymphocytes and thus providing a boost in the generation of a chronic inflammatory state 
(Caruso et A, 2004). However, it has also been suggested that IL-6 regulates 
concentrations of TNF-a and stimulates production of IL-1ra and IL-10 (both anti- 
inflammatory cytokines), thus acting in an anti-inflammatory manner (Petersen & 
Pedersen, 2005). 
Strenuous exercise causes an acute increase in plasma levels of IL-6, which can increase 
100-fold, though clearance from the circulation is rapid (Pedersen, 2000). However, 
resting IL-6 concentrations are decreased in those who undertake physical activity 
(Colbert et aL, 2004; Panagiotakos et aL, 2005a). IL-6 is often elevated in colon cancer 
patients, although the severity and prognosis appear to be related to genotype (Caruso et 
aL, 2004) 
IL-10 
IL- 10 is a Th2 cytokine, so-called because it is secreted by CD4+ T-helper subset 2 
lymphocytes. It is also secreted by monocytes and B cells. II-10 is considered to be the 
most important human anti-inflammatory cytokine (Opal & DePalo, 2000) and is 
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responsible for many actions, including i) inhibition of monocyte and macrophage 
derived cytokines, including IL-1, IL-6 and TNF-a, ii) inhibition of cytokines produced 
by neutrophils and natural killer cells, iii) promoting degradation of pro-inflammatory 
cytokine mRNA, and iv) inhibiting cell surface expression of MHC class II molecules 
and CD14 (LPS recognition and signalling molecule). 
An IL-10 knockout mouse has been generated which demonstrates chronic enterocolitis 
with over-production of pro-inflammatory cytokines (TNF-a, IL-1, IFN-'Y) suggesting 
that the primary defect of IL- 10 knockout mice is a failure to control the non-nal intestinal 
immune response to enteric antigens (Kuhn et al., 1993). However, the effect of IL-10 on 
cancer development depends on the milieu of growth factors and cytokines in the tumour 
microenvironment, with some studies showing a protective effect and others showing a 
turnour-promoting effect of high IL- 10 concentrations (Caruso et al., 2004). This may be 
due to the dual function of IL-10 both limiting the inflammatory signal and also being 
able to stimulate B-cell activity (Caruso et al., 2004). IL- 10 is also produced by turnours, 
and studies have demonstrated an increase in serum IL-10 concentration in colon cancer 
patients compared with controls (Galizia et al., 2002), and that IL- 10 from stimulated 
blood cultures is positively correlated with both tumour proliferation and apoptosis 
(Evans et al., 2006). 
TNF- a 
TNF-a is the first cytokine released in the pro-inflammatory cascade that occurs after 
injury (Petersen & Pedersen, 2005) and induces endothelial adhesion molecules which 
allow leucocytes to adhere to the endothelium. before migrating into the tissue (Dinarello, 
2000). TNF- a acts synergistically with IL-I. Both cytoldnes activate the same portfolio 
of genes, and result in actions including insulin release and P-islet cell death, insulin 
resistance and loss of lean body mass but only TNF- a induces apoptosis (Dinarello, 
2000). The production of TNF- a is suppressed by IL-10, among others, and the outcome 
of the balance between pro- and anti-inflammatory cytokines will often determine the 
outcome of a disease (Dinarello, 2000). 
TNF- a is increased with obesity, as the adipose tissue increases expression of the Y7VF- a 
gene (You et al., 2005), which may contribute to the chronic inflammatory state observed 
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in many obese individuals (as discussed in 1.5.3). Reduction of adipose tissue and the 
resulting decrease in inflammation may be a possible mechanism through which physical 
activity is protective, although TNF- a generally works locally and circulating levels of 
this cytokine may not be reduced correspondingly (Petersen & Pedersen, 2005). Greater 
leisure-time physical activity has, however, been linked to lower serum TNF- a (Colbert 
et aL, 2004; Panagiotakos et aL, 2005a) and TNF- a receptor (TNF-R) (Pischon et al., 
2003) concentrations. The receptor is thought to act as a binding protein and/or a "slow 
release reservoir", prolonging the half-life of TNF- a in the circulation (Pischon et al., 
2003). 
Reduced inflammation has been postulated to be a mechanism by which greater physical 
activity is protective, as MAID use masked any effect of physical activity on decreased 
risk of CRC in a case-control study (Hauret et al., 2004). 
1.6.6.4 Immune function 
Exercise in known to modulate the immune system, and in moderation these alterations 
are generally beneficial, however, exhaustive exercise can be detrimental, decreasing 
resting monocyte, T cell and natural killer (NK) cell count, and decreasing B cell function 
and the phagocytic function of nasal neutrophils (Nieman, 1997). 
The beneficial effects of chronic exercise of moderate intensity include increased 
macrophage phagocytic and lysosomal enzyme activity (observed in mice), increased 
resting monocyte count, increased monocyte phagocytosis and increased NKC activity 
(Nieman, 1997). 
Table 1.6 summarises several studies of exercise and immune function. The general 
outcome from the studies was an increase in cytotoxicity of the immune cells with 
moderate exercise, although none of the studies could give a definitive mechanism for 
this effect. These studies, however, have not investigated the effect of exercise on 
tumourigenesis. Zielinski et al., (2004) injected female BALB/c mice with EL-4 
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lymphoma cells and assigned the mice to either control or treadmill-exercise group. 
Changes in tumour mass and in the intra-tumoural cellular composition were then 
measured. The authors observed a delay in turnour growth in exercising mice and a faster 
time of rejection, compared with controls (Zielinski et al., 2004). Exercised mice also 
displayed a lower blood vessel density in the tumour, higher numbers of host 
lymphocytes and a lower number of inflammatory cells (neutrophils and macrophages) 
and mitotic cells. This apparent increase in effectiveness of immunosurveillance with 
increased exercise could help to explain the effect of exercise on other cancers, especially 
given the large immune network of the intestinal tract. However, while the data from 
animal studies is encouraging, there has been no systematic evaluation of immune 
function in reports of physical activity and colon cancer. 
Studies into mechanisms by which exercise protects from colon cancer have produced 
conflicting findings. This suggests that decreasing risk of CRC through physical activity 
is likely to be multifactorial. 
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1.7 Animal studies 
1.7.1 Mechanism of action of commonly-used carcinogens 
Azoxymethane (as AOM per se or via endogenous metabolism of administered 
dimethylhydrazine (DMH)) has been used in all the rat studies included in this review. 
DMH is metabolised in the liver to AOM, which is converted to methylazoxymethanol 
(MAM), from which comes CH3+ (methylcarbonium ion) which binds to the DNA of 
colonic stem cells (Corpet & Pierre, 2003). AOM induces turnours, through this aberrant 
DNA methylation, which produces 06-methylguanine (06MeG), a marker of exposure to 
methylating agents that can cause mutations in mismatch repair genes (Jackson et al., 
1997). The mutations also reflect many characteristics of human turnours, such as 
mutated K-ras and P-catenin (Ctnnbl) genes (Takahashi & Wakabayashi, 2004). Mutated 
Kras activates the MAPK and P13 K pathways and upregulates expression of Cyclin DI 
and cyclooxygenase-2 (COX-2). It also enhances inducible nitric oxide synthase (NOS) 
expression in the presence of inflammatory stimuli (Takahashi & Wakabayashi, 2004). 
iNOS increases concentrations of nitric oxide (NO), which causes DNA damage and 
angiogenesis and activation of COX-2. Increased COX-2 leads to increased levels of 
prostaglandins which in turn lead to increased cellular proliferation and decreased 
apoptosis (Takahashi & Wakabayashi, 2004), both important factors for neoplastic 
transformation. In male F344 rates administered with AOM, Takahashi and Wakabayashi 
(2004) found G--+A transitions in both K-ras andfl-catenin genes which caused P-catenin 
to be found throughout the cell cytoplasm and in the nucleus, when it is normally 
localiscd to the cell membrane where it is involved in cell-cell adhesion (Takahashi & 
Wakabayashi, 2004). Mutation of P-catenin stabilises the protein in the cytoplasm and 
activates transcription of its signalling targets, which are thought to include the increase 
in expression of NOS. However, AOM-induced turnours never induce p53 gene 
mutations and rarely cause Apc gene mutations (Erdman et aL, 1997; Sohn et aL, 1999; 
Corpet & Pierre, 2003). Sohn et al., (1999) found only a small number of Apc mutations 
in male Sprague-Dawley rats treated with DMH. All 6 mutations were single base 
substitutions which did not truncate the protein, and 516 of the mutations were upstream 
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of the mutation cluster region (MCR), unlike human CRC where a large proportion of 
mutations are truncating mutations and occur in the MM No mutations were found in 
the p53 gene, although rat p53 has a different structure to human p53 (Erdman et al., 
1997), so mutations may have occurred in parts of the gene that were not investigated, or 
the altered structure may have been protective. 
The disadvantages of chemical carcinogen models include i) they are genetically less site- 
specific than deliberately introduced genetic mutations and ii) they require injection into 
the animal, and may produce different effects if the quantity of carcinogen or site of 
injection varies (Hoffman-Goetz, 2003). In addition, mouse studies have demonstrated 
strain and dose-dependent variations in tumour generation in response to AOM 
administration (Bissahoyo et al., 2005). 
1.7.2 Mouse models 
Several mouse models of intestinal cancer are now available that do not require use of 
carcinogens. In 1990, Moser et al described the introduction of a germline mutation in B6 
male mice by exposing them to ethylnitrosourea (Enu) (Moser et al., 1990). The treated 
males were then mated with AKR females and a circling trait was noticed in one of the 
progeny. This mouse was mated with a B6 male to see if the circling was hereditary. The 
offspring demonstrated progressive anaernia, which often led to death. On dissection, 
visible turnours were noticed in the intestine, but only in anaernic animals. It became 
clear that the primary phenotype of the animals was the formation of multiple adenomas 
with anaemia as the secondary phenotype. The gene responsible for the turnours was 
named "multiple intestinal neoplasia", or Min (Moser et al., 1990). The Min trait was 
transmitted to 50% of the progeny with an unbiased sex distribution, an autosomal 
dominant characteristic. 
Min-/Min- pregnancies are embryonic lethal. They are able to form blastocysts and to 
implant but severe defects occur during primitive ectoderm development. Similar 
findings have been shown in mice homozygous for loss of P-catenin and E-cadherin, both 
important molecules in the process of cell adhesion (Shoemaker et al., 1997), and 
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demonstrate the requirement for functioning versions of these molecules, as discussed in 
1.3.5. 
In 1992, Su et al demonstrated using linkage analysis that the responsible gene was the 
murine homologue of APC (mApc), linked to the Min locus. A nonsense mutation was 
found at codon 850 of the Apc gene (Su et al., 1992), (TTG to TAG) which changed a 
leucine to a stop codon. This is the same gene that is mutated in FAP patients and in the 
majority of sporadic colorectal cancers (Calvert & Frucht, 2002b). 
Oshima et al reported the production of a mouse that developed multiple intestinal 
neoplasias (Oshima et al., 1995). The mApc gene was truncated by inserting a DNA 
cassette at codon 716 (APC4716). All mice developed polyps by seven weeks of age and 
most (7 of 8) had polyps by 5 weeks of age. Polyps in the gut of 3 week old mice were 
detectable under a microscope, the authors postulate that initiation occurs before the third 
week. The number of polyps increased with age and varied in size and stage. By week 16 
of post-natal life the mice had an average of 254 polyps. A dissecting microscope was 
used to score the turnours, counting all bigger than 0.2mm. The small intestinal polyps 
had a layer of normal villous epithelium covering the tumour. It was discovered that the 
microadenomas originated from single crypts - the proliferation zone of the crypt grew 
and formed outpockets which expanded into the inner (lacteal) side of neighbouring villi, 
but not into the lumen of the intestine. After dissecting out the intestinal microadenomas 
and performing PCR, it was discovered that the wild-type Apc allele had been lost but the 
mutant allele was unchanged. From this the authors postulated that loss of heterozygosity 
led to the formation of intravillous microadenomas (Oshima et al., 1995). 
Further study of the mechanism of polyp formation in Apc A716 mice suggests that the 
same mechanism is responsible for producing colon polyps (Oshima et al., 1997). The 
authors suggest that a functioning, normal Apc protein is required for cell migration 
along the crypt-villus axis of the small intestine, as the cells containing the mutation were 
not growing upwards towards the lumen as in normal tissue. 
Mice with mutations at other locations in the mApc gene also exist, including Apc 13 09 
(Corpet & Pierre, 2003), Apc 163 8N and Apc 163 8T (Fodde & Smits, 2001) and 
comparisons of the various models have established a genotype: phenotype relationship. 
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The length of mApc protein produced from the mutated allele of the Apc gene is inversely 
associated with the number of turnours produced in the intestine (see Table 1.7), i. e. 
mutations that result in larger amounts of the Apc protein cause the mildest phenotype. 
The exception to this is the Apc 163 8T mouse, which does not produce any turnours, 
although the cells are predisposed to chromosomal instability (Fodde & Smits, 2001). 
The lack of turnour formation is due to the ability of the Apc protein to regulate 0-catenin 
levels (see 1.3.5) despite being truncated (Fodde & Smits, 2001). 
Table 1.7 Number of tumours produced by mice with different mAPC mutations 
Mouse strain Number of tumours; produced in the gut (mean: L SD) 
APC Al 16 250 ± 95 
Min (mutation at codon 850) 40± 20 
Apc1309 30 
Apc1630 3 
Apc1638 T0 
Data from Corpet and Pierre (2003) 
1.7.2.1 Further details on the Min mouse 
The characteristics of spontaneous multiple neoplasias make Min n-iice a useful choice as 
an animal model for human intestinal cancer. Each cell of the Min mouse contains only 
one copy of the mApc gene, so only one further mutation is required for aberrant cell 
growth. This is unlike "normal" mucosa in the human intestine where mutations to both 
alleles are required to cause disease. This leads to rapid formation of turnours in the Min 
mouse (within the first few weeks of life), compared with the normal human state, where 
intestinal turnours may not form until middle age or older. The growth of colorectal 
tumours is due to both increased proliferation (Wong et aL, 2002) and decreased 
apoptosis (Bedi et aL, 1995) of the epithelium. Spontaneous apoptosis in the crypts of 
normal tissue is approximately ten times more common in the small intestine than the 
colon, which may explain the difference in cancer distribution in humans between small 
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intestine and colon (Potten & Grant, 1998). Proliferation is greater in Nfin mouse small 
intestine than in the colon, reflecting the distribution of turnours found there (Bashir et 
aL, 2004). 
Table 1.8 shows some of the pros and cons of the Min mouse model. 
Table 1.8 Advantages and limitations of the Min mouse model 
Advantages Limitations 
Polyp number can be altered by dietary 
and pharmacological agents, e. g. NSAIDs 
Most Min polyps are in the small 
intestine, whilst being used to simulate 
colorectal turnours 
Polyps develop rapidly 
Share the same genetic mutation as many 
human colon cancers 
Turnours are easily located and measured 
1.7.3 Exercise and animal models 
ACF are not observed 
Adenomas do not progress to 
carcinomas, nor metastasise 
Mice have to be killed to allow 
localisation of tumours 
Animal models of colon cancer can provide insights into the impact of exercise (or other 
factors) on risk of human disease because they allow more controlled manipulation of the 
factor(s) under study, greater invasiveness of experimental approach for study of 
underlying mechanisms and a shorter timescale of disease progression. The majority of 
studies have used rats and have induced carcinogenesis through chemical means, as rates 
of spontaneous colon tumour formation in rats are low. Table 1.9 (rats) and Table 1.10 
(Min mice) summarise the different rodent studies of exercise on intestinal 
turnourigenesis. The exercise interventions differed between studies, utilising both 
voluntary wheel-running (Andrianopoulos et A, 1987; Reddy et aL, 1988) and forced 
treadmill running or walking (Klurfeld et aL, 1988; Thorling et A, 1993; Thorling et aL, 
1994; Colbert et aL, 2000). 
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A reduction in tumour number was achieved with exercise in all the carcinogen-treated 
rat studies, but not in the genetically altered Min mice (Figure 1.2). The greatest 
protection was seen in the Thorling et al. study (1994), where the corn oil-fed exercising 
rats had no colon carcinomas compared with 37% of the control animals, and no small 
bowel carcinomas compared with 5 carcinomas in control rats (Thorling et al., 1994). 
This group also reported a difference in tumour generation that was diet-dependent, as 
coconut oil-fed rats suffered fewer turnours; than com oil-fed rats, but no significant effect 
of exercise was seen with coconut oil-fed rats. 
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Table 1.10 Effects of exercise on intestinal neoplasia in Apc, "" mice 
Chapter I 
Typeof Exercise Study 
exercise protocol duration 
Total intestinal polyps (polyps/mouse) Reference 
Males 
Control Exercise 
Females 
Control Exercise 
Treadmill 60 min/d 7 wk 36.8 ± 4.9 24.8 ±3.6 38.0 ±6.3 40.9 ± 3.7 Colbert et 
@ (4wk old al., (2000) 
18-21 at start) 
m/min No significant effect of exercise for either sex 5% 
gradient, 
5 d/wk 
Adapted from Basterfield et al., (2005) 
The other rat studies demonstrated reductions in tumour number with exercise of 20- 
64% (Table 1.9), with all sedentary rats generating at least I tumour (with the 
exception of the coconut oil-fed animals). In contrast, the Min mice generated far 
more tumours (< 41), but demonstrated a non-significant reduction in number for 
males only (Table 1.10). Indeed, exercising females generated slightly more tumours 
than control females. 
1.2 - 
1- 
0.8 - 
0.6 - 
0.4 
0.2 
* Reddy (1988) - colon 
* Reddy (1988) - Sl 
* Andrianopoulos (1987) - total 
13 Andrianopoulos (1987) - colon 
0 Klurfeld (1988) - colon 
M Colbert (2000) - male colon 
M Colbert (2000) - male Sl 
D Thorling (1993) - colon 
13 Colbert (2000) - female colon 
M Colbert (2000) - female Sl 
Figure 1.2. Ratios of tumour numbers between exercising and control animals, i. e. the number of 
tumours in control animals divided by the number of tumours in exercised animals. This allows 
studies generating different numbers of tumours to be compared easily. The references left to 
right correspond with the legend top to bottom. 
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1.7.4 Comparing animal studies 
Chapter I 
Several differences existed between the studies, including mode of exercise, duration, 
carcinogen used (or not) and rat strain. 
Exercise mode 
Mode of exercise can be separated into forced or voluntary, with 2 of the studies using 
the voluntary approach and 4 using the forced. The forced exercise varied from 
running for an hour to walking for 5 hours. This may be significant for several reasons 
- animals run great distances in wheels to which they have free access, up to 20km 
per day in mice in one study (Koteja et al., 1999) and may be more compliant with an 
unforced activity. A problem with the voluntary approach is that some animals will 
naturally run more than others and this inter-animal variability in exercise exposure 
may contribute to variability in tumour outcomes. For example, Reddy quotes highs 
of 10 000 and lows of 300 revolutions per day (Reddy et al., 1988) for rats allowed 
access to exercise wheels. In addition, the distance run per day may also decline with 
the duration of the study (Goodrick, 1980). This may, however, generate a "dose- 
response", with different running distances generating different amounts of tumours. 
The use of a treadmill is one way of ensuring that all animals are receiving equal 
amounts of exercise, but it may also produce an adverse stress response in the animals 
or cause injury. The stress response to forced exercise has been measured in animals 
and results in chronic stress-like changes to the hypothalamic-pituitary-adrenal (HPA) 
axis and enlarged adrenal medullas (reviewed in Basterfield et al., (2005)). In 
contrast, these extreme changes are not seen with voluntary exercise, rather the HPA 
axis reorganises to present a differentiated response to different types of stressful 
stimuli (Droste et A, 2003; Penalva et aL, 2003). Mice allowed voluntary exercise 
also show decreased anxiety-related behaviour (Binder et al., 2004) and improved 
sleep quality (Lancel et al., 2003) compared with sedentary mice. Taken together, 
these findings present a case for the use of voluntary as opposed to forced exercise. 
Length of study 
The studies also varied in length, with the rat studies 20-3 8wk in length and the Min 
study 7 wk long. Long-term studies with Min mice are not feasible as the animals 
become noticeably ill by around four months of age and rapidly decline in health, 
whereas the rat studies must allow time for the carcinogen to work. To allow 
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comparison of the different strains, rat studies (after carcinogen administration) could 
be the length of the Min lifespan. 
Strain differences 
As mentioned in 1.7.1, strain and dose-dependent differences have been reported for 
the action of carcinogens (Bissahoyo et al., 2005), and differences in tumour number 
in rat studies may reflect this. Strain differences in metabolic adaptation to high fat 
diets have been reported in mice (Funkat et al., 2004), and therefore a species 
difference may also occur, accounting for differences in results between mice and 
rats. It must be noted that while the rats and Min mice produced tumours in both the 
colon and small intestine, rats have mostly colonic tumours and Min mice produce 
mostly SI tumours. 
Sex balance 
Another difference is the use of males only in the rat studies (Table 1.9), whilst the 
Min study used both males and females (Table 1.10). There was a tendency towards 
protection in the male Min mice (P = 0.06 overall, P=0.08 for the SI and 0.06 for the 
colon). The possibility of a sex effect in the rat studies could not be examined as only 
males were used, and the presence of female rats may have negated the beneficial 
effects of exercise observed in those studies. 
1.7.5 Dietary factors 
A difference between the studies that may have an effect on the outcome is diet. Of 
the studies that mention diet, all but one used standard low fat rodent diets. However, 
to reflect the current human pattern of colon cancer incidence a Western-style high fat 
diet would be most suitable. 
High fat diets 
Fischer-344 rats fed a "high risk diet" (HRD) high in fat and low in fibre and calcium 
developed more AOM-induced ACF than rats fed a "low risk diet" (LRD, low in fat, 
high in fibre and calcium) (Shivapurkar et al., 1992), and 92% of the rats fed the 
HRD also developed colon tumours, whilst none of the LRD-fed rats did. 
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Wasan et al., (1997) reported that 10%- and 15%-fat diets increased polyp number 
and size in Min mice when compared with standard 3% fat diets. A LRD was found 
to suppress polyp formation in Apc A716 mice by 36% in the small intestine and 56% in 
the colon compared with mice fed a HRD (Hioki et al., 1997). 
Newmark et al., (2001) fed a western-style diet (high in fat, low in calcium, vitamin D 
and methyl donors) to C57BU6 mice for 18 months and found that 42% of the mice 
generated intestinal tumours, compared with none in the control diet group. This 
demonstrated the ability of western-style diets to induce tumourigenesis in mice 
without the use of carcinogens or genetic modifications. 
A high fat diet may cause an increase in body fatness, and obesity caused an increase 
in AOM-induced tumours in male Zucker rats (Weber et al., 2000). A leaner body 
composition (as achieved by physical activity) may be protective as increased 
adiposity is associated with increased risk of colon tumour occurrence (Calle & Thun, 
2004). The reasons for this are believed to be due to increased circulating levels of 
insulin and free IGF-1 and decreased IGFBP-3 which all occur with increasing 
adiposity (see 1.6.6.2). 
The extra energy expenditure of exercising animals may lead to a compensatory 
hyperphagia (Mehl et al., 2005b) which does not translate to increased body fat 
(Thorling et al., 1993), even when fed a high fat diet (Cohen et al., 1988), though 
others (Colbert et al., 2000) have not observed this effect. 
1.7.6 Mechanisms 
Several of the studies have examined the effect of lean body mass, body fat and food 
intake with respect to activity. 
Body mass and food intake 
Some animal studies of exercise and colon cancer have reported a decrease in body 
mass with exercise (Andrianopoulos et aL, 1987; Klurfeld et A, 1988; Thorling et A, 
1993; Thorling et aL, 1994), but others have reported little (Reddy et al., 1988) or no 
(Colbert et al., 2000) difference. 
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The lower body weight of the exercised animals as reported by Andrianopoulos et al. 
(1987) was assumed to be due to increased energy expenditure alone, as the food 
intake of these animals was not measured. Klurfeld et al. (1988) also found decreased 
body weights in exercised animals, but noted that both exercised and sedentary 
animals consumed equal amounts of energy. The exercised animals had a similar 
percentage of body fat to sedentary animals (21.6 v. 21.8%), but half the tumour 
incidence. However, Reddy et al. (1988) found that body weights in both sedentary 
and wheel-running groups were comparable throughout the study with exercising rats 
weighing slightly more at death. The exercising rats consumed approximately 
264kJ/day and the sedentary group 234kJ/day (Reddy et al., 1988). 
Thorling et al. (1993) found a slower rate of weight gain in exercised compared with 
sedentary animals. Exercising animals weighed significantly less at the end of the 
experimental period even after consuming about 20% more food. The sedentary 
animals had considerably more body fat than exercising animals (96 :L 7g compared 
with 28 ± 5g or 22% v 8%). Thorling et al. (1994) reported that exercised rats ate 25% 
more than sedentary rats but still weighed less and had fewer tumours. 
Colbert et al. (2000) found no difference in body weight or food intake between 
treatment groups in Min mice and also no difference in polyp number. 
As 415 studies reported a decrease in body mass, the lower tumour incidence in 
exercising rats may therefore be due to the lower fat mass, and is probably not due to 
total energy intake but may be related to energy balance. A future Min mouse study 
that was able to show a reduction in tumour number may also demonstrate a 
difference in body mass, however, species or carcinogen effects may result in 
different mechanisms. 
Other mechanisms 
The only other potential mechanism examined was transit time. Klurfeld et al., (198 8) 
used the indigestible marker chromic oxide and found a reduced intestinal transit time 
in exercised compared with sedentary animals (P<0.05), although no further details 
were given. 
Investigations of other postulated mechanisms for tumour prevention in humans, such 
as enhanced immune surveillance (Armstrong & Mathers, 2000), prostaglandins and 
cytokines, have not been reported. 
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1.7.7 Non-exercise physical activity (NEPA) 
One observation missing from all studies to date is the amount of activity undertaken 
by animals when not in the wheel/treadmill. Animals given/undertaking low levels of 
exercise may be more inclined to continue high levels of activity in the cage (nest 
building, rearing, climbing etc) which may obscure the effect of an imposed exercise 
regime. Animals receiving high/exhaustive levels of exercise may be much less 
inclined to undertake such activities than their sedentary counterparts. Golden 
hamsters housed with wheels show significantly less cage-bar climbing and 
stereotypic bar-mouthing than sedentary controls (Gebhardt-Henrich et al., 2005), and 
wheel-running mice show fewer but longer periods of sleep time (Lancel et al., 2003) 
both of which may indicate less NEPA. 
1.7.8 Other modifiers of tumour number in animals 
Diet and activity are not the only means by which turnourigenesis in animal models 
can be modified: 
Caloric Restriction - Klurfeld et al., (1988) found a decrease in turnourigenesis in 
rats on a 25% calorie restricted diet, with tumour incidence reduced from 75% to 
35%, and incidence was reduced to 21% with a 40% restricted diet. Reddy et al., 
(1987) also found a decrease in turnour number in rats with treated with AOM, with 
incidence decreasing from 83% to 33% with a 30% CR diet. A 40% calorie restricted 
diet in Min mice decreased intestinal polyp frequency by 57% (Mai et al., 2003), and 
Kakuni et al. (2002) found a significant decrease in polyps >2mm. in mice with a 20% 
food restriction compared with control (similar decreases as those observed by Mai et 
al., 2003), though a rise in smaller (<2mm) polyps was observed. 
Moml - Modifier of Min I (Dietrich et aL, 1993; Shoemaker et aL, 1997). 
Backcrossing Min with B6 mice produced mice with fewer tumours, suggesting that a 
genetic modifier was present. Moml was located to mouse chromosome 4 and found 
to be a semi-dominant modifier of intestinal tumour size and multiplicity in Min. The 
gene responsible codes for secretary phospholipase A2 (Pla2g2a), involved in the 
synthesis of prostaglandins by the release of arachidonic acid from membrane lipids 
(Fodde & Smits, 2001). 
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Mom2 - Modifier of Min 2 (Silverman et al., 2002). Silverman et al. showed that one 
resistant allele at the Mom2 locus reduced intestinal polyps in Min by up to 95%, 
suggesting that it acts in a dominant fashion. The identity of Mom2 has yet to be 
proven. 
Msh2 - mutS homolog 2 (Shoemaker et al., 1997). Msh2 is the murine equivalent of 
hMSH2 in humans, mentioned previously with respect to HNPCC (section 1.3.2). A 
homozygous mutation in Msh2 in mice produced skin turnours and lymphomas as 
well as intestinal turnours. When crossed with Min, the number of intestinal tumours 
increased by a factor of 3.4 (Shoemaker et al., 1997). 
Dnmt - DNA methyltransferase (Shoemaker et al., 1997). Dmnt are knockout strain 
of mice. They display a 50% reduction in DNA methylation levels, with homozygotes 
dying in utero. When Min mice were also Dnmt heterozygotes the number of tumours 
generated was reduced by 2.5 fold. When Min mice were treated with 5-aza-2'- 
deoxycitidine (5-aza-dC -a potent DNA methyltransferase inhibitor) a 5.7 fold 
reduction in tumour number was seen. When 5-aza-dC treatment was given to Min 
that were heterozygous Dnmt, the tumour load was reduced by 57 times (Laird et al., 
1995). The hypornethylation affects gene expression, which then alters expression of 
oncogenes or turnour suppressor genes and contributes to neoplastic transformations 
by affecting somatic mutation rates at 5-methylcytosine residues (see 1.4). 
1.7.9 Relevance of rodent models to human bowel cancer 
The relevance to humans of these studies depends on whether the exercise regimes 
can be translated into human equivalents. Colbert et al. used a value of 55-65% 
V02max for the mice (equal to speeds of 18-21 m-min"), and studies using mice to 
study the immune effects of exercise also use speeds between 15 and 30 m-min" 
(MacNeil & Hoffman-Goetz, 1993; Woods et aL, 1993; Woods et aL, 1994; Lu et aL, 
1999). Neither of the papers by Thorling gives a reason for the activity level chosen 
but it is of a low intensity over a long time period, which contrasts with the faster, 
shorter exercise of Klurfeld et al., (1988), which was estimated to be equivalent to 
25% of the daily energy intake, performed 5d/wk. 
Laura Basterfleld Chapter I 
25% of daily energy intake is equivalent to 2.7MJ in a 74kg man and 2. OMJ in a 60kg 
woman, given a daily energy intake of 10.6MJ and 8.1 MJ, respectively (estimated 
average requirements for adults aged 19-50 with light energy requirements 
recommended by COMA (199 1)). This equates to approximately 2 hours of 
walking'/ 1-1.5h j ogging2/1.5h cycling3 , all at a moderate pace (McArdle et al., 2001). 
This compares favourably with recommendations from the World Health Organisation 
of lh walking per day (WHONAO, 2003), with the findings of Thune and Lund of 4h 
cycling per week (1996), and with Martinez et al., (1997) of 4-5h/wk moderate 
intensity activity. As the intensity of the exercise increases, the time spent in activity 
will decrease accordingly. Each of these activities is at an intensity and duration that 
can be fitted into everyday life. As all of the rat studies showed a decrease in tumour 
number with exercise, these are potentially achievable levels for humans. 
A reduction in turnour number in the Min mouse would be the most exciting find, 
given the genetic similarity with some human conditions. The lack of evidence found 
so far in this model might indicate the overwhelming strength of the genetic 
predisposition, or that by week 3/4 of age when the exercise was started the turnour 
initiation process is too advanced to be slowed or reversed by exercise. This would be 
in accordance with a study by M. L. Slattery and R. Burt who examined the effect of 
physical activity in a group of patients with attenuated familial adenomatous 
polyposis (AAPC; the phenotype is less severe than with classical FAP but retains an 
elevated risk of colon cancer (Spirio et al., 1993)). No effect was seen (unpublished 
data, M. L. Slattery, personal communication). No other studies examining the effect 
of physical activity on FAP patients appear to have been published, and this group of 
patients is generally omitted from epidemiological studies of physical activity due to 
the strong disposition to cancer. 
1 18-39kJ/min required for 59kg woman at 3mph, 22. OOkJ for 74kg man 2 33.44kJ/min required for 59kg woman running 11.5 min/mile, 41.800 for 74kg man 3 24.66U/min required for 59kg woman cycling at 9.4mph, 30.93kJ for 74kg man 
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1.8 Objectives of thesis 
The main objectives of this thesis are: 
e To investigate the utility of the Min mouse model in studies of exercise on 
tumourigenesis 
9 To quantify the types and durations of exercise which are beneficial in 
reducing intestinal tumourigenesis 
* To investigate the possible mechanism for the protective effects of exercise 
9 To examine the effect of exercise combined with diets of different fat content 
on body fatness and non-exercise physical activity (NEPA) 
The remainder of this thesis is set out in the following order: Chapter 2- General 
Methods and Materials. Chapter 3- detailed reports of three experiments using the 
Min mouse. Each experiment is reported individually, with a summary of the results 
followed by a brief discussion of points specific to that experiment. The collated 
results are then presented and discussed in detail. Chapter 4- describes a study of the 
effects of two diets differing in fat content and of exercise on body fatness and NEPA. 
Chapter 5- contains the conclusions from these studies and suggestions of how this 
research area could be taken forward. 
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2 General Methods and Materials 
2.1 Animals 
All mice used in this study were bred in the animal facility of Newcastle University, 
the Comparative Biology Centre. Female C57BL/6 either from the colony or 
purchased from Harlan (Oxon, UK) were mated with male colony Min mice. Parent 
animals were fed standard rodent chow (SDS, Essex, UK) ad libitum. Water was 
freely available. 
Tail snips were taken from 4 week old mice and genotyped using an established PCR 
method (based on Su et al., (1992)) to distinguish those carrying the Apc mutation 
characteristic of Min mice (see Appendix 6.1). 
2.2 Min PCR results 
Min fragments were separated on an 8% polyacrylamide gel. Wild types are cut twice 
on both strands by the restriction enzyme Hind III and produce one band at 123 bp 
(see Figure 2.1 and Figure 2.2) and a digest product of 1 lbp. Min heterozygotes show 
a distinctive double band at 123 and 144bp as the mutated strand is cut only once, 
producing the longer fragment (144bp) as well as the shorter wild-type fragment 
(123bp). 
Wild type Min 
Z%4 X- wt 34 ZN4 wt 2%ý 
wt Min 
123 b. p. 144 b. p. 
Figure 2.1 Diagram of fragments produced during enzyme digestion stage of genotyping 
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Figure 2.2 Example of genotyping results, showing Min and wild-type fragments 
2.2.1 Housing 
Chapter 2 
Mice were housed in cages containing 1-6 mice. A 12 hour light: dark cycle was 
maintained (with the light period 7am-7pm) in a room with 15 changes of air per 
hour. Room temperature was 20'C ± 2'C. 
2.2.2 Experimental diet 
Mice were weaned at four weeks of age and offered 6g of the "Western" diet each, 
daily (see Appendix 6.2 and Williamson et al., (1999)). This diet was relatively rich in 
animal fat, animal protein and sucrose. Refusals were removed and weighed daily to 
obtain food intake, which was also calculated on a per gram body mass basis using tile 
weight of each mouse at the beginning of each week. Water was freely available. 
Mice were weighed weekly. 
2.2.3 Treadmill 
Treadmill mice (TR) were run on an Exer-3/6 rodent treadmill (Columbus 
Instruments, Ohio, USA, supplied by Linton Instrumentation, Norfolk, UK). The 
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treadmill consisted of a rubberised running surface, connected to a motor whose speed 
was controllable in increments of 0.1 meters per minute up to a maximum of 99.9 
meters per minute (Figure 2.3). 
Figure 2.3 The treadmill and a male mouse running 
The running surface was divided into 6 individual lanes measuring approximately 
37cm long x 6cm wide by removable plastic slats and the incline could be increased 
from 0% to 20% in increments of 5%. There was a non-moving area at the rear of the 
running surface where an electric shock grid could be placed but this was not used in 
these studies. A brush-covered gap of approximately I cm between the running surface 
and the non-moving rest area allowed faeces and urine to drop from the running 
surface to be collected on a tray under the treadmill. To prevent mice from stopping 
unnecessarily, a barrier was cut from I cm thick foam rubber which slotted onto the 
lane dividers at the back of the running surface. This also prevented any tails or feet 
slipping into the gap between running surface and rest area. The barrier was not used 
for mice that ran competently. The treadmill was cleaned thoroughly after every 
session by scrubbing with hot water. 
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2.2.4 Wheel-running mice 
Chapter 2 
Wheel-running mice (WH) were housed individually in cages containing a running 
wheel. Twelve wheels were borrowed from Barrie Sandells (Novartis Institute for 
Medical Sciences, London, UK) and 12 were purchased separately ("51/2" Comfort 
Wheel", Pets International, Ltd., IL, USA). A magnet (Abel Magnetics, Sheffield, 
UK) was attached to the wheel which actuated a magnetic counter (RS Components 
Ltd, Northants, UK, product # 260-375) on every revolution. The counter was 
fastened to the top of the cage and was actuated by wheel movements in both 
directions. The wheels had internal diameters of I Ocm (borrowed wheels, (Fig. 2.4)) 
and 13cm (purchased wheels) producing internal circumferences of 62.8cm and 
81.7cm (i. e. 62.8/81.7cm travelled per wheel revolution). 
Figure 2.4 Example 
of small running 
wheel showing the 
counter attached to 
the cage lid 
Daily revolutions were recorded for all mice. Free access was allowed to the wheel 
which was cleaned weekly. Other housing and feeding conditions were identical to 
TR. " were kept in the same room as the treadmill to subject them to similar 
environmental conditions as TR. 
2.2.5 Control mice 
Control mice (CON) were kept under the same conditions as TR and fed the same 
diet. While TR were on the treadmill, CON were placed in individual control lanes for 
the same period of time, to subject them to the same handling, noise and isolation 
-62- 
Laura Basterfield Chapter 2 
stresses as TR. Control lanes were constructed from laminated paper and placed in a 
large plastic box next to the treadmill. Mice were unable to climb out of the lanes. The 
lane dividers and box were cleaned with hot water after each use. 
2.3 Necropsy 
Mice were killed within one week of finishing the study (see specific chapters for 
details of study length). Total anaesthesia was obtained using 3% isofluorane in 
oxygen followed by cardiac exsanguination and cervical dislocation. Each mouse was 
weighed before a midline section was made and organs dissected out. Tumours were 
scored in millimetres diameter by the same person who was unaware of the exercise 
protocol of each mouse (A. Kitching, CBC, Newcastle University, UK). Tumour 
location and size were noted for each mouse and tumour burden calculated by 
summing the individual tumour diameters to produce total diameter of tumour 
present. 
2.3.1 Blood 
Blood was collected into an EDTA tube and mixed by inversion. A haernatocrit was 
obtained from the whole blood and the remaining blood was centrifuged to obtain the 
plasma. To measure the haernatocrit, blood was drawn up into two glass capillary 
tubes per mouse, sealed with plasticine and centrifuged for 10 minutes in a micro 
haematocrit-centrifuge (Hawksley, Sussex, UK). Haematocrits were read on a micro 
haematocrit reader (Hawksley, Sussex, UK). Both plasma and whole blood portions 
were stored at -801C. 
2.3.2 Stomach 
The stomach was weighed with its contents, then opened and digesta. was removed 
and discarded. The tissue was examined for turnours and then re-weighed. The tissue 
was snap frozen in liquid nitrogen and stored at -80'C. 
2.3.3 Small intestine 
The small intestine was weighed intact and the length measured. It was then cut into 
two equal parts - proximal and distal. Each part was opened longitudinally and the 
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contents removed and discarded. Each section was examined for the presence of 
tumours, with site and size being recorded. Two cm of normal tissue was taken from 
the top of the proximal section and placed in Carnoy's fixative for future crypt cell 
proliferation analysis (if a tumour was present the normal sample was taken from the 
nearest section of tissue free of tumours). The tissue was re-weighed, snap-frozen and 
stored at -800C. 
2.3.4 Caecum 
The caecum was weighed intact and then opened. The contents were placed into an 
eppendorf and stored at -80'C for use in determination of transit time. The presence 
of tumours was noted and the tissuc re-weighed, snap-frozen and stored at -80'C. 
2.3.5 Colon 
The colon was weighed and then opened longitudinally. The contents were placed in 
an eppendorf and deproteinising solution (DPS) (Mathers et aL, 1990; Mathers & 
Fotso Tagny, 1994) added half weight by volume and stored at -20"C for future short 
chain fatty acid (SCFA) analysis. The colon was examined for turnours, with size and 
site being recorded. The tissue was then reweighed, snap-frozen and stored at -80'C 
2.3.6 Other organs 
The liver, heart and spleen were removed and weighed. The spleen was placed in ice- 
cold PBS for Natural Killer (NK) cell assay (pilot study only), whilst the heart and 
liver were snap-frozen and stored at -80'C. 
2.3.7 Carcass 
The carcass was stored at -201C until body composition analysis was performed. 
2.4 Statistical analysis 
Analyses were performed with SPSS for Windows v12.0 and Minitab vl3. 
Data were tested for normality (Anderson-Darling) and normally distributed data were 
tested using the General Linear Model (GLM) of analysis of variance (ANOVA), 
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Table 2.1. Means and standard errors (SEM) are given for these variables. Pooled 
SEM are presented where appropriate, calculated as ý(mean square error/n). Non- 
normal data were transformed using a suitable transformation, usually Log 10, natural 
log or square root. Data that have been transformed are indicated in the text thus: 
variable LogIO, variablenawg, variable SqI. Means were back-transformed and are 
displayed with 95% confidence intervals (Q. Where a table contains both normal and 
transformed values, the CI is given for the normal values instead of the SEM, for 
clarity. 
Any data that remained non-normal were tested using a suitable non-parametric test 
(Kruskal-Wallis) and are indicated as variableKw. The data generated by this method 
are median values, and are displayed with the range of the variable. 
Unique tests are indicated and described in the text. 
P values less than 0.05 were taken to be significant. 
Table 2.1 Skeleton ANOVA table from study 2 
Source of Degrees of Sum of Adjusted Mean Fp 
variation freedom squares Sum of square 
squares 
Sex 1 
Exercise 2 
Sex*Exercise 2 
interaction 
Error 56 
Total 61 
2.5 Analytical methods 
2.5.1 Body composition analysis 
2.5.1.1 Body fat 
Mouse carcasses were transferred to a -80'C freezer for 24 hours and then placed in a 
vacuum freeze drier (Edward's Modulyo freeze drier). Weights were recorded every 3 
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days for 2 weeks until constant weight was achieved and all water assumed to have 
been removed. The proportion of fat in the freeze-dried carcasses was measured using 
the Soxhlet procedure (see Appendix 6.3). 
2.5.1.2 Mineral content 
A sample of fat-free freeze-dried carcass (typicallyl-2g) was ashed in a crucible at 
450'C overnight in a Muffle furnace (Carbolite, Sheffield, UK) to remove all organic 
matter in the dry, fat-free carcass. After cooling in a dessicator, the ash was weighed. 
This represents the mineral portion of the carcass. 
2.5.2 Crypt cell proliferation 
Crypts were microdissected from macroscopically normal sections of proximal small 
intestine. The tissue was initially fixed in Carnoy's and then transferred to 70% 
ethanol for storage. The tissue was then rehydrated in 50% ethanol, hydrolysed in 
O. IM hydrochloric acid, stained in Schiffs' reagent (Sigma) and groups of crypts 
separated for examination of mitotic bodies (see Appendix 6.4). Number of mitoses in 
the 3 compartments of the crypt (upper, middle, lower) were recorded, as well as 
width and length. 10 crypts were counted for each sample. 
2.5.3 Transit time determination - caecal chromic oxide 
concentration 
Caecal contents were freeze-dried before use and the micromethod for determination 
of chromic oxide was used (see Appendix 6.5) as described by Mathers and Fotso 
Tagny (1994). Briefly, the rate of Cr203 input is known (the amount of food eaten per 
day), and the concentration of Cr203 in the caecal contents is calculated. The amount 
of Cr203 in the caecum. is then divided by the rate of input to give an estimation of the 
time taken for the digesta to travel through the caecum. For this method, the flow of 
digesta into the caecum. is assumed to be constant, as mice have constant access to 
their food (Mathers & Fotso Tagny, 1994). 
The calculation for the transit time (in days) of digesta through the caecum. is as 
follows: 
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Mass of dry matter in the caecum x Cr, )O concentration in the caecum 
Daily food dry matter intke x Cr, )O.; concentration in dietM d1y matte 
2.5.4 Short chain fatty acid (SCFA) determination 
Short chain fatty acids in the colon contents were determined using gas 
Chapter 2 
chromatography (see Appendix 6.6). Only samples with complete duplicates with 
discernable peaks were analysed. 
Concentrations of SCFA in samples were calculated relative to the standards and 
internal standard (3 methyl-valerate, 3MV), present in DPS in the samples. 
e. g. Response factor (RF) for acetate in the standard: 
Peak area 3MV x racetatej 
Peak area acetate x [3MV] 
Concentration of acetate in the sample: 
RF for acetate (std) x r3MVI x peak area acetate (sample) 
Peak area 3MV (sample) 
2.6 Non-exercise physical activity (NEPA) 
An infrared-sensing device ("Inframot", TSE Systems, Germany) was used to 
quantify cage activity performed by singly housed mice (see Figure 2.5). The 
Inframot senses movements of 5milliseconds length and greater and stores the data 
accumulated in set timescales in a spreadsheet. The data can then be manipulated to 
display activity at different times of day. There were four sensors available for four 
simultaneous recordings. Further details are given in 6.7. 
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Figure 2.5 Example of an Inframot device in place on the home cage. 
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3 Investigations into treadmill- and wheel-running 
exercise 
3.1 Pilot study 
3.1.1 Introduction 
At the start of this project, there was only one published study on effects of exercise 
on intestinal polyp development in Min mice (Colbert et al., 2000). The use of a 
treadmill (to quantify the amount of exercise imposed and to ensure that equal 
amounts of exercise were undertaken by each mouse) was considered to be the best 
way to test for an effect in this study. In addition, this approach provided a means of 
replicating aspects of the Colbert study. 
This pilot study was designed to learn the best ways of using the treadmill, to develop 
techniques to get the micc to run and to develop standardiscd exercise protocols. 
3.1.2 Aims 
* To understand the best way of getting mice to run on the treadmill 
* To follow the treadmill protocol as used in published studies 
9 To establish assays which could be used to investigate possible mechanisms 
for any change in tumour number 
3.1.3 Hypotheses 
* The number of tumours in treadmill-exercised mice will be reduced compared 
with non-exercised mice as a result of decreased transit time 
* Treadmill running will reduce body fat content, increase plasma Interleukin-10 
concentrations, decrease plasma Interleukin-6 concentrations and produce 
fewer mitoses in cells in the top third of small intestinal crypts 
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9 Decreased tumour number will be associated with increased butyrate in colon 
samples 
3.1.4 Materials and Methods - Pilot Study 
3.1.4.1 Treadmill regime 
From 4-5 weeks of age, treadmill-running mice (TR) were run 5 d-wk71 for 12 weeks. 
Males and females were initially run separately to prevent the males fighting when 
returned to their cages. When two different speed groups developed, the sexes were 
run together. Weeks 1-2 were used to train the mice, and started with relatively slow 
speeds (10 m-min-) for short time periods (10 min) on the target gradient of 5%. 
Speeds and times were gradually increased over the two weeks until the mice could 
run at 16m-min" for 60 minutes (three periods of 20 minutes with five minutes rest in 
between). The target speed was 20 m-min", and whilst several mice were capable of 
achieving this speed, several suffered damaged hind toenails, or became morose and 
refused to run. Mice that refused to run in the training weeks were swapped with 
control mice. After the 2 weeks training period, mice that refused to run were not 
replaced and were removed from the study. 
Due to the number of problems encountered attempting to achieve the target of 60 
minutes non-stop running at 20m-miri" on a 5% gradient (Colbert et al., 2000), 
modifications were made to the exercise protocol. Mice ran in 10 min bursts with five 
minutes rest in between. A speed of 16m-miri" was maintained by the majority of 
mice initially but by week 5 mice were running in two separate groups: a "fast" group 
running at 16m-min"l and a "slow" group running at 11-12 m-min". The slow group 
ran for 15 minutes at a time. This continued to the end of the study, with mice 
changing groups as necessary. The lid was not used on the treadmill when it was 
necessary to use the rubber barrier to prevent the mice stopping, to make it easier to 
move any mice that became trapped at the rear of the treadmill after refusing to run. 
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3.1.4.2 Control mice 
Chapter 3 
Control mice (CON) were placed in control lanes for the same length of time that the 
TR mice spent on the treadmill, as described in the General Methods and Materials 
section (Chapter 2). 
3.1.4.3 Necropsy - specific sample collection 
Mice were on study for 12 weeks, and were killed when aged 16-17 weeks. Tissues 
were collected as detailed in General Methods and Materials (Chapter 2). 
3.1.4.4 Colon tumour Scanning Electron Micrograph (SEM) 
Two large colon tumours were chosen at random and placed in 2% gluteraldehyde to 
be processed for scanning electron microscopy (see Appendix 6.8). 
3.1.4.5 Interleukin-6 and Interleukin-10 determinations 
Interleukin-6 (IL-6) and Interleukin- 10 (IL- 10) concentrations in plasma were 
determined by Enzyme-Linked Immunosorbent Assay (ELISA, Insight Biotechnology 
Ltd, Wembley, UK) using plasma samples obtained at death (see Appendix 6.9 for 
details. ) The minimum concentrations of IL- 10 and IL-6 in mouse plasma which 
could be detected reliably were 15 and 4 pg/ml respectively. Standards were assayed 
in triplicate for each concentration. Samples were assayed once due to the small 
quantities of plasma available. 
Absorbances for standards were averaged for each concentration and then plotted. 
Regression analysis was used to calculate the equation of the line of best fit and 
sample absorbances were converted to concentration of IL-6/IL-10 using the relevant 
equation. 
3.1.4.6 Natural Killer (NK) cell assay 
Cell culture 
A K562 leukaemic cell line (donated by Matthew Henry, School of Surgery and 
Reproductive Sciences, Newcastle University) was used in all immunological assays. 
Cells were maintained in an incubator at 370C 5% C02 and split twice a week. 
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Principle of isolation of NK cells 
Chapter 3 
Spleen cells were labelled magnetically with Anti-NK cell (DX5) microbeads and 
passed through a separation column which was placed in the magnetic field of a 
MACS separator. The magnetically labelled NK cells were retained in the column 
while the unlabelled non-NK cells ran through (the unlabelled cells were depleted of 
NK cells). After removal of the column from the magnetic field, the magnetically 
retained NK cells were eluted as a positively selected cell fraction. For further details 
see 6.10 and Arase, Saito et al., (2001). 
MACS Anti-NK (DX5) microbeads, MS Separation Columns, MiniMACS Magnetic 
Separator were all from Miltenyi Biotec Ltd, Surrey, UK. 
3.1.5 Results -Pilot study 
23 Min mice started the study (9 female 14 male), but only 18 completed the 12 
weeks (see Table 3.1 for details). Of the 5 males that did not finish the study, 3 were 
treadmill mice that stopped running after the 2-week training period when there were 
sufficient animals in the control group and so removed from the study. The other 2 
male treadmill mice lost weight and ate less from week 7, became moribund and were 
killed in week 11. One mouse had 28 turnours and a tumour burden of 95mm, the 
other had 16 turnours, a tumour burden of 60mm and an intussusception (prolapse of 
part of the intestine into an adjacent part), most probably caused by the tumours. 
These 2 mice are excluded from growth curves and analysis of tumours and organs 
but are included in exercise analysis. 
Table 3.1 Distribution of mice completing the pilot study 
Exercise protocol Male Female Total 
Treadmill 4 
Control 5 
9 
9 4 
Total 18 
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3.1.5.1 Growth curves 
Chapter 3 
Weights of CON and TR mice were similar for weeks 1-5; thereafter CON mice were 
heavier (Figure 3.1 a). Control mice were significantly heavier on weeks 9 and II (P - 
0.049 and 0.046, see Table 3.2). Although the mice gained weight throughout the 
study (except for the final week), the amount of weight gained each week decreased 
with time (see Figure 3.1b). Body weight and weight gain both plateaued towards the 
end of the study and then decreased in the last 1-2 weeks. 
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Table 3.2 Mean body weights (g) by week, of mice by exercise group 
Chapter 3 
Week CON TR SEM Probability of 
effect 
1 16.6 16.7 0.59 0.876 
2 18.3 18.9 0.42 0.395 
3 19.7 20.3 0.43 0.366 
4 21.0 21.5 0.51 0.525 
5 22.3 22.4 0.50 0.861 
6 23.5 22.9 0.57 0.461 
7 25.2 23.7 0.65 0.123 
8 26.0 24.3 0.78 0.156 
9 27.3 24.8 0.83 0.049 
10 28.1 25.5 1.02 0.057 
11 28.9 25.7 1.03 0.046 
12 27.7 25.9 1.24 0.313 
The pattern of weight gain was very similar for male CON and TR, but for females 
the rate of body weight gain begin to diverge at week 5, with the body weight of 
female TR mice remaining lower than CON for the remainder of the study. This 
difference in body mass was greatest in week 11, although there was no significant 
interaction between sex and exercise group. 
At the start of the study (week 1), male mice were heavier than female mice (18.3 and 
15.1 g, respectively) and males remained significantly heavier than females throughout 
the study (P < 0.002, Figure 3.2a). Over the 12 weeks of the study, males gained on 
average I 1.4g compared with 7.1 g for the females, an increase in body weight of 62% 
for the male mice and 47% for the female mice. Again, body weight gain decreased 
with time and was negative in the final week (Figure 3.2b). 
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3.1.5.2 Time and amount of running 
Chapter 3 
The mice were given two weeks of training on the treadmill to get them used to this 
form of exercise and to get them up to the proposed speed. When the mice were 
proficient at running on the treadmill, the protocol required the mice to run for a total 
of 60 minutes a day, 5 days a week for 10 further weeks. Unfortunately, the mice were 
averse to this type of activity with many stopping frequently or reffising to run 
altogether (see supporting film on c. d. ). The target speed was initially 18-2 1 m-min-1 
but was reduced to 16m-min-1 after seeing the difficulties the mice were having 
keeping pace with the treadmill. The initial target time of 60 minutes non-stop was 
also altered to 3 periods of 20 minutes with 5 minutes rest in between. Table 3.3 
shows the percentages of possible days of running that were completed by the mice 
and their average fastest speed over the ten weeks of study (data from the two week 
initial training period are not included). 
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Only one mouse (female) ran on every day of the study, reaching the target speed of 
l6m-mid'. The inability/unwillingness of the mice to keep up with the pace led to the 
formation of two running groups - one at 16m-min", the other at 12m-min-1 to 
encourage the mice to do some running and, if possible, to coax them into running 
faster again. Despite these concessions, the average speed of the mice was 14.6 
m-min-I and the average daily time spent running was 43 minutes (see Table 3.3). 
There were no significant differences in running performance between the sexes. 
Table 3.3 Treadmill performance data for individual mice averaged over weeks 3-12 
Mouse number % ofdaysrun 
Average daily time spent Average best speed 
(sex) running (min) (m-min"') 
3 92 48.8 14.8 
4 90 45.3 14.5 
15 78 41.2 13.6 
16 64 29.8 13.9 
17 85 47.2 14.6 
18 (M) 76 37.4 14.4 
1W 84 41.6 13.5 
2 (f) 86 44.8 14.6 
19(o 93 46.9 15.8 
20 (f) 87 37.1 14.7 
21 (f) 100 57.8 16.0 
Mean 85 43.4 14.6 
3.1.5.3 Food intake 
The amount of food eaten each day by individual mice was relatively constant 
throughout the study (Figure 3.3). CON mice ate significantly more than TR mice 
during weeks 5,9 and 10 (P< 0.03 5) whilst the reverse was true during week 12 
(P=0.03 1, Figure 3.4a). 
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When food intake was expressed per I OOg body mass, CON mice ate significantly 
more than TR mice during weeks 3 and 5 (13.0 and 11.0 v. 12.0 and 9.0g/1 OOg body 
mass, respectively), whereas TR mice ate more during weeks 7,11 and 12 (10.0,9.0 
and 9.0 v. 9.0,7.0 and 7.0g/lOOg body mass, Figure 3.4b). 
Males ate significantly more than females for every week except weeks 9,10 and 12 
(P values range from 0.015 to <0.001, Figure 3.5a). The results are somewhat 
different when viewed on a per I OOg body weight basis (Table 3.4). In general, female 
mice ate more food per I OOg of body weight than males and this difference was 
significant during weeks 3 and 6-12 (with females averaging 10.0 g/1 OOg and males 
averaging 9.0g/lOOg body mass across these weeks (Figure 3.5b). 
No results are available for weeks 1 and 2 due to some mice changing exercise 
groups. 
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Table 3.4 Summary of statistical analyses of the effect of exercise protocol and sex on food intake 
Daily food intake Food intake per 100g of body 
weight 
Week of Sex effect Treadmill Sex effect Treadmill 
study exercise exercise effect 
effect 
3 Male* NS Female" Control* 
4 Male** NS NS NS 
5 Male" Control" NS Control" 
6 Male* NS Female" NS 
7 Male" NS Female* Treadmil? 
8 Male* NS Female" NS 
9 NS Control* Female" NS 
10 NS Control* Female" NS 
11 Male* NS Female* Treadmill" 
12 NS Treadmil? Female* Treadmil? 
The table shows the group with the greater food intake and the level of significance. NS, non- 
significant (P:! 0.05); *, (P<0.05); ** , (P-50.001). 
3.1.5.4 Tumours 
Tumour numbers, sizes (estimated as tumour diameter in mm) and location were 
recorded and analysed according to sex and exercise protocol. As anticipated, the 
large majority (over 97%) of tumours were found in the small intestine, with 
approximately equal proportions in the proximal and distal halves (100 and 108 
tumours, respectively). 
The exercise protocol (Table 3.5) did not alter the number of tumours at any location 
at the P<0.05 level. 
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Table 3.5 Tumour multiplicity, tumour burden and distribution of tumours of TR and CON mice 
Variable CON (n=9) TR (n=9) Pooled 
SEM 
Probability of 
exercise effect 
Proximal SI 6.0 5.1 1.02 0.512 
Distal SI 6.5 5.5 1.06 0.502 
Total SI 12.5 10.6 1.64 0.351 
Colon KW 0.0 0.0 - 0.638 
0-1 0-1 
Total tumours 12.9 11.0 1.68 0.401 
Tumour burden 40.2 30.5 4.41 0.135 
(mm diameter) 
Male mice had significantly more turnours in the distal portion of the small intestine 
(P=0.006), a greater total number of turnours (P=0.047) and a greater tumour burden 
(total diameter of tumours in mm, P=0.048) than female mice (Table 3.6). The 
difference in the number of colon tumours was not statistically significant. The total 
number of small intestinal tumours was lower in females compared with males (9.3 v. 
13.8) and this difference approached significance (P = 0.057). 
Table 3.6 Means and SEM of tumour parameters by sex 
Variable Female (n=9) Male (n=9) Pooled 
SEM 
Probability of 
sex effect 
Proximal SI 5.8 5.3 1.02 0.703 
Distal SI 3.6 8.4 1.06 0.006 
Total SI 9.3 13.8 1.64 0.057 
ColonKW 0.0 1.0 0.159 
0-1 0-1 
Total tumours 9.7 14.2 1.68 0.047 
Tumour burden 28.8 41.9 4.41 0.048 
(mm) 
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Table 3.7 shows the tumour data by sex and exercise group. There was no interaction 
between sex and exercise for any of the measured variables, with males generally 
having more turnours than females. 
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Figure 3.6 Distribution of turnours sizes 
Figure 3.6 shows the distribution of tumour sizes in this study with the majority 
(72%) being 1-3mm diameter. There were no significant differences between sexes or 
exercise groups with regards to tumour size. 
There were some negative correlations between treadmill running variables and 
tumour variables, when data from all TR mice were included (Table 3.8, Figure 3.7). 
Decreased tumour numbers and burden occurred with increased speed and % of days 
run. However, when the outlier was removed, so was the significance (P>0.4). 
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Table 3.8 Correlation between treadmill running and tumour variables 
Treadmill variable Tumour variable Pearson's R Probability 
% days run Total number of -0.576 0.064 
tumours 
% days run Tumour burden -0.666 0.025 
Mean best speed Total number of -0.562 0.072 
tumours 
Mean best speed Tumour burden -0.556 0.076 
E2 
25 r -0.562 
P 0.072 
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Figure 3.7 Relationship between treadmill running and tumour variables, with fitted regression 
line 
3.1.6.5 Body organs 
Weights of intestinal organs with their contents, tissues and content weights were not 
different between the two treatment groups (Table 3.9), with the exception of the 
weight of the caecal contents, which was greater for TR mice compared with CON 
mice (0.183 v. 0.134g, P=0.044). 
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Table 3.9 Mean intestinal organ dimensions of treadmill and control mice 
Organ dimension 
CON TR 
Probability of 
Pooled SEM effect 
Slaughter weight 
(9) 25.3 26.5 1.51 0.572 
Length (cm) 
Small intestine 28.3 29.7 1.065 0.354 
ColonKw 5.5 5.0 
4.5-6 4.5-6.5 - 0.546 
Weight (g) 
Stomach (full) 0.42 0.363 0.043 0.334 
Stomach (tissue) 0.153 0.146 0.012 0.609 
Stomach 
(contents) 0.272 0.218 0.037 0.318 
SI (full) 1.097 1.066 0.049 0.665 
SI (tissue) 0.983 0.963 0.043 0.748 
SI (contents) 0.113 0.102 0.024 0.749 
Caecum (full) 0.235 0.280 0.020 0.143 
Caecum (tissue) 0.100 0.098 0.007 0.773 
Caecum 
(contents) 0.134 0.183 0.016 0.044 
Colon (full) 0.262 0.227 0.023 0.308 
Colon (tissue) 0.172 0.158 0.011 0.359 
Colon (contents) 0.090 0.063 0.016 0.253 
When expressed as g/100g final body mass, there were no statistically significant 
effects of exercise regime on organ mass (Table 3.10). 
Table 3.10 Contribution of intestinal organs (without contents) to final body weight in CON and 
TR mice 
Organ (g/100g body 
mass) CON TR 
Pooled 
SEM 
Probability of 
effect 
Stomach 0.71 0.68 0.057 0.650 
S1 4.48 4.46 0.217 0.946 
Caecum 0.45 0.45 0.032 0.955 
Colon 0.78 0.72 0.050 0.431 
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Both absolute weight and proportions (g/100g body mass) of liver and heart were not 
significantly different between CON and TR mice (Table 3.11). Spleen weight in 
CON mice was heavier than in TR mice, and the difference approached significance 
(0.383 v. 0.267g, P=0.073). However, when spleen weight was expressed as g/100g 
final body mass, the effect of exercise was not significant (P = 0.213, Table 3.11). 
Haematocrit was not significantly affected by exercise, 23.1 % and 27.7 % in CON 
and TR mice respectively (pooled SEM = 2.48, P=0.215). 
Table 3.11 Contribution of liver, heart and spleen to final body mass of CON and TR mice 
Organ 
CON TR 
Pooled 
SEM 
Probability 
of effect 
Absolute weight 
(g/mouse) 
Liver 1.109 1.078 0.049 0.663 
Heart 0.171 0.167 0.009 0.750 
Spleen 0.383 0.267 0.042 0.073 
As g/100g body mass 
Liver 5.00 4.96 0.192 0.867 
Heart 0.81 0.77 0.066 0.678 
Spleen 1.72 1.26 0.249 0.213 
Male colons were longer by 14% than those of female mice (5.7 v. 5. Ocm, median 
values, P=0.036, (Table 3.12). ), though there was no significant difference in SI 
length. The weights of the full stomach (0.327 v. 0.461g) and full caecurn (0.211 v. 
0.304g) were significantly lower in females than in males (P = 0.006 and P=0.046 
respectively), whilst the weight of the full SI approached significance (1.011 v. 
1.1 52g in females and males respectively, P=0.063). 
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Table 3.12 Mean intestinal organ dimensions of male and female mice 
Organ Pooled Probability of 
dimension Female Male SEM effect 
Slaughter 
weight (g) 22.1 29.7 1.48 0.003 
Length (cm) 
Small intestine 28.5 29.5 1.065 0.499 
ColonKW 
5.0 5.7 
4.5-6 5-6.5 - 0.036 
Weight (g) 
Stomach (full) 0.327 0.461 0.043 0.046 
Stomach (tissue) 0.145 0.154 0.012 0.708 
Stomach 
(contents) 0.183 0.307 0.037 0.032 
SI (full) 1.011 1.152 0.049 0.063 
SI (tissue) 0.923 1.023 0.043 0.123 
SI (contents) 0.087 0.128 0.024 0.244 
Caecum (full) 0.211 0.304 0.020 0.006 
Caecum (tissue) 0.091 0.107 0.007 0.125 
Caecurn 
(contents) 0.118 0.200 0.016 0.002 
Colon (full) 0.224 0.265 0.023 0.245 
Colon (tissue) 0.154 0.176 0.011 0.169 
Colon (contents) 0.069 0.084 0.016 0.530 
Table 3.13 Contribution of Intestinal organs to final body mass in male and female mice 
Organ (g/100g body Pooled Probability of 
mass) Female Male SEM effect 
Stomach 0.77 0.62 0.057 0.075 
si 4.93 4.01 0.217 0.010 
Caecum 0.49 0.41 0.032 0.117 
Colon 0.81 0.69 0.050 0.108 
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The contents of the organs were heavier in males compared with females, 
significantly so for the stomach (P = 0.032) and caecurn (P = 0.002), but not the SI or 
colon (Table 3.12). 
When the difference in body mass was taken into account and organ dimensions were 
expressed as a proportion of the final body mass, female intestinal organs were 
heavier than those of males (Table 3.13). The empty small intestine was significantly 
heavier in females than in males (4.93 v. 4.01 g/100g, P=0.010), and the difference 
in stomach weight approached significance (0.77 v. 0.62 g/100g, P=0.075). Neither 
the difference in SI weight nor colon weight was statistically significant. 
The weights of the other organs (liver, heart and spleen) were heavier in male mice 
compared with female mice (Table 3.14), with statistically significant differences for 
liver weight (1.179 v. 1.007g, P=0.027) and heart weight (0.186 v. 0.152g, P= 
0.014). When measured as contribution to final body mass, females had significantly 
heavier livers (5.37% v. 4.60%, P=0.013). Heart and spleen weights were not 
significantly different between the sexes (Table 3.14). Haematocrits in female and 
male mice were also not different, 26.6% and 24.2% respectively (pooled SEM 
2.53, P=0.613). 
There were no interactions between exercise and sex on any of the organ proportions 
i. e. mass of organ per 1 OOg body mass (Table 3.15). 
Table 3.14 Liver, heart and spleen weights of male and female mice 
Organ 
Pooled Probability of 
Female Male SEM effect 
Absolute weight 
(g/mouse) 
Liver 1.008 1.179 0.049 0.027 
Heart 0.152 0.186 0.009 0.014 
Spleen 0.291 0.359 0.042 0.273 
As g/100g body 
mass 
Liver 5.37 4.60 0.192 0.013 
Heart 0.83 0.74 0.066 0.375 
Spleen 1.72 1.26 0.249 0.769 
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A positive correlation was observed between spleen weight and the total number of tumours 
present (r = 0.608, P=0.007, Figure 3.8a, and between spleen weight and turnour burden (r 
= 0.448, P=0.062, Figure 3.8b). Linear regression equations were also calculated, as 
follows: 
Spleen weight = 0.12 + 0.0171 (total number of tumours) (R2 = 0.3 3) 
Spleen weight = 0.178 +0.00417(tumour burden) (Rý = 0.15) 
a 
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Figure 3.8 Relationship between spleen weight and (a) the total number of tumours and (b) 
tumour burden, with ritted regression line 
3.1.5.6 Short chain fatty acids (SCFA) 
The data obtained for concentration of SCFA in the large bowel were normally 
distributed only for acetate. Therefore, data for propionate, isobutyrate, butyrate, 
isovalerate and valerate were log-transformed before analysis. When expressed as 
molar proportion of total SCFA, butyrate was the only SCFA requiring log- 
transformation. 
The concentrations of acetate, propionate, isobutyrate, isovalerate and valerate in 
colonic contents were not significantly different betweenr CON and TR mice (Table 
3.16, P>0.05). The concentration of butyrate was significantly higher in colonic 
contents from CON mice compared with colonic contents from TR mice (3.72 v. 1.40 
-89- 
Laura Basterfield Chapter 3 
gmol-g colon contents, P=0.039). When the concentrations of SCFA were converted 
to molar proportions of total SCFA, the effect of exercise on butyrate remained 
significant (P = 0.041, Table 3.17). The isobutyrate proportion was higher in TR 
compared with CON mice (21.5 v. 15.3 mmol/mol, P=0.033). TR mice also had a 
greater proportion of isovalerate compared with CON mice (P = 0.027,18.0 v. 13.3 
mmol/mol total SCFA). There were no significant differences in the proportions of 
acetate, propionate and valerate. 
Table 3.16 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by exercise protocol 
Individual SCFA 
(pmol-g colon Probability of 
contents)* CON TR effect 
Acetate 21.80 21.06 0.834 
16.83-27.27 16.86-25.76 
Propionate 3.18 3.61 0.541 
2.354.31 2.794.68 
Isobutyrate 0.43 0.51 0.403 
0.32-0.58 0.40-0.66 
Butyrate 3.72 1.40 0.039 
1.95-7.08 0.81-2.43 
Isovalerate 0.33 0.42 0.193 
0.26-0.43 0.34-0.52 
Valerate 0.11 0.13 0.558 
0.07-0.17 0.09-0.20 
* data have been log-transformed 
Table 3.17 Molar proportions (mmol/mol total SCFA) of colonic SCFA by exercise group 
SCFA CON SEWCI TR SENVCI 
Probability 
of effect 
Acetate 702 27.7 738 23.6 0.345 
Propionate ill 13.4 141 11.4 0.115 
Isobutyrate 15 2.1 22 1.7 0.033 
Butyrate '09'0 126 73-216 56 35-89 0.041 
Isovalerate 13 1.5 18 1.3 0.027 
Valerate 4 0.9 6 0.8 0.157 
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The concentrations of SCFA were similar in colonic contents from male and female 
mice (Table 3.18). A significant difference existed only in the concentration of acetate 
(P = 0.0 15), with the concentration in samples from females being, on average, 64% 
of that in samples from males (16.7 v. 26.1 gmol-g colon contents). However, when 
expressed as molar proportions of total SCFA, this difference became non-significant 
(P = 0.195, Table 3.19), and values for other SCFA were also not significantly 
different in samples from both males and females. The exception to this was the 
proportion of isovalerate, which was greater in samples from females compared with 
samples from male mice (18.3 v. 14.0 mmol/mol total SCFA, P=0.032). 
Table 3.18 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by sex 
Individual SCFA* 
Female Male 
Probability of 
effect 
Acetate 16.71 26.14 0.015 
11.89-21.45 21.54-30.60 
Propionate 2.90 3.98 0.140 
2.19-3.84 3.05-5.20 
Isobutyrate 0.41 0.55 0.184 
0.31-0.54 0.42-0.71 
Butyrate 1.86 2.38 0.508 
0.94-3.65 1.25-4.51 
Isovalerate 0.33 0.43 0.193 
0.26-0.43 0.34-0.54 
Valerate 0.11 0.14 0.508 
0.07-0.16 0.09-0.20 
*log-transformed data 
Table 3.19 Molar proportions (mmol/mol total SCFA) of colonic SCFA by sex 
SCFA Female SEM/CI Male SEM/CI 
Probability 
of effect 
Acetate 697 26.1 747 24.7 0.195 
Propionate 130 13.3 127 12.6 0.840 
Isobutyrate 20 2.2 18 2.1 0.360 
Butyrate'09'0 85 48-150 72 42-125 0.742 
Isovalerate 18 1.6 14 1.5 0.032 
Valerate 6 0.9 5 0.8 0.495 
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There were no interactions between exercise and sex for the molar proportions of any 
SCFA (P*a 0.224). 
One colonic digesta sample (male control) did not produce discernable peaks on the 
chromatography output and so concentrations of SCFA could not be measured, 
therefore n= 11 for treadmill and 8 for control mice. 
3.1.5.7 Crypt cell proliferation (CCP) 
The numbers of cells in mitosis in each third of the length of the crypts from the 
proximal small intestine were analysed according to sex and exercise protocol. 
Few mitotic cells were detected, and there were no significant differences between 
CON and TR mice in any region of the crypt, nor in crypt dimensions (Table 3.20). 
Table 3.20 Small Intestinal crypt variables by exercise group 
Variable CON SEM TR 
Probability 
SEM of effect 
Mitoses per 
crypt region 
Lower 0.76 0.084 0.88 0.080 0.297 
Middle 1.44 0.128 1.38 0.121 0.719 
Upper KW 0.70 0.90 
0.20-2.60 - 0.70-1.10 - 0.173 
Total 3.02 0.278 3.12 0.264 0.809 
Crypt 
dimensions 
(ttm) 
Length 113.3 3.6 112.9 3.4 0.933 
Width 60.3 2.2 63.1 2.1 0.376 
There were no significant differences between the sexes in either number of mitoses 
per crypt compartment or crypt dimensions (Table 3.21). 
-92- 
Laura Basterfield Chapter 3 
Table 3.21 Small intestinal crypt variables by sex 
Variable Female SEM Male SEM 
Probability 
of effect 
Mitoses per 
crypt region 
Lower 0.83 0.089 0.81 0.076 0.916 
Middle 1.26 0.135 1.51 0.116 0.181 
Upper KW 0.70 0.90 
0.20-1.10 - 0.50-2.60 - 0.226 
Total 2.75 0.295 3.31 0.252 0.172 
Crypt 
dimensions 
(pm) 
Length 114.8 3.8 111.8 3.3 0.561 
Width 63.5 2.3 60.4 2.0 0.327 
3.1.5.8 Body composition 
The body composition data reported below refer to the whole carcass minus the 
intestine, liver, spleen, heart and approximately O. 5mI blood. 
As expected, the major component of the mouse carcasses was water, accounting for 
>55%, with fat making up a further 28-32% by weight (Table 3.22). Other non-fat 
organic matter contributed 11-13% of carcass weight and minerals less than 3%. 
There were no significant (P>0.05) effects of exercise on these aspects of body 
composition (Table 3.22). 
The two treadmill males who did not complete the study were not included in the 
analysis, and two control males were excluded due to experimental error. 
There was no significant difference in body composition between the sexes (Table 
3.23), and no interaction between sex and exercise (P<0.60). 
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Table 3.22 Body composition of mice by exercise protocol 
Chapter 3 
Body Probability 
compartment CON (7) SEM TR (11) SEM of effect 
Water 55.5 2.03 56.9 1.62 0.610 
Fat 31.5 3.76 27.7 3.00 0.441 
Non-fat organic 10.5 1.77 12.5 1.41 0.389 
matter 
Mineral 2.5 0.42 2.9 0.34 0.423 
Table 3.23 Body composition of mice by sex 
Body Probability of 
compartment Female (9) Male (9) Pooled SEM effect 
Water 55.2 57.6 1.75 0.384 
Fat 31.7 26.7 3.27 0.338 
Non-fat organic 10.4 13.0 1.55 0.305 
matter 
Mineral 2.7 2.8 0.37 0.970 
3.1.5.9 Interleukin-6 (IL-6) and Interleukin-10 (IL-10) 
Standard curves for the IL-6 and IL-10 ELI SA are shown in Figure 3.9. 
Figure 3.9 Standard curves for (a) IL-6, R2 = 0.97, and (b) IL-10 = R2 = 0.98 , 
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Plasma levels of both cytokines were close to the limits of the sensitivity of the 
assays, and unaffected by the exercise protocol (Table 3.24). 
Table 3.24 Plasma concentrations (pgIml) of 11,6 and IL-10 by exercise group (n) 
Probability 
Interleukin CON (8) SEM TR (11) SEM of effect 
IL-6 25.1 2.33 22.1 1.98 0.354 
IL-10 83.8 1.57 80.9 1.34 0.181 
Female mice had a tendency towards lower concentrations of IL-6 compared with 
males (P = 0.08 1, Table 3.25), but IL- 10 concentrations were identical. 
Table 3.25 Plasma concentrations (pg/ml) of IL-6 and IL-10 by sex (n) 
Probability 
Interleukin Female (8) SEM Male (11) SEM of effect 
IL-6 19.9 2.32 25.9 1.98 0.081 
IL-10 82.2 1.62 82.0 1.38 0.824 
No plasma was available for mouse 5. 
3.1.5.10 Scanning electron micrograph (SEM) 
Two polypoid colon turnours, both 7mm, diameter, from a female CON and a female 
TR mouse were taken for SEM. Some shrinkage occurred during the dehydration 
stage (Figure 3.10a) but the saddle-shape of the tumour is apparent. The SEM 
revealed surface details of the tissue, such as the microvilli on the normal colonocytes 
(Figure 3.1 Ob) and the lack of such features on the tumour surface (Figure 3.1 Oc). 
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3.1.5.11 Evidence of stress 
Chapter -') 
Figure 3.10 
a) Polypoid colon turnour with surrounding 
normal tissue (folds in the mucosa are just 
visible) 
b) Microvilli on the surface of the nornial 
mucsoa 
c) Surface of the tumour, lacking microvilli and 
other identifiable structures, but possibly 
showing globules of mucus from goblet cells 
(arrows) 
Mice were observed carefully for "normal" behaviour and for any signs of stress. 
Whilst running on the treadmill, mice were still interested in their Surroundings, 
attempting to look over and under the lane dividers or jump over the front barrier. 
During rest periods on the treadmill, mice showed the same behaviours and most 
spent the time grooming. Control mice initially explored their surroundings, attempted 
to escape and then groomed or slept. When returned to their cages, mice again 
displayed "normal" behaviours including climbing on the roof bars. 
-96- 
Laura Basterfield 
3.1.6 Summary of results 
Table 3.26 Summary of pilot study results (P<0.05) 
Effect of treadmill exercise regime 
Variable (compared with Control) 
Body weight gain No difference 
Food intake Increased 
Proximal S1 tumours No difference 
Distal. Sl tumours No difference 
Total S1 tumours No difference 
Colon tumours No difference 
Total number of turnours No difference 
Tumour burden No difference 
Intestinal organ weights No difference 
Non-intestinal organ weights No difference 
SCFA concentration - butyrate Decreased 
Acetate/propionate/isobutyrate/ No difference 
isovalerate/valerate 
SCFA molar proportion 
-butyrate Decreased 
-isobutyrate/ isovalerate Increased 
Acetate/propionate/valerate No difference 
CCP No difference 
Body composition No difference 
IL-6 No difference 
IL-10 No difference 
3.1.7 Specific discussion 
3.1.7.1 Treadmill performance 
Chapter 3 
The average times and speeds run by mice in this study (Figure 3.11) were less than 
those of Colbert et al. (2000). Mice could run at the target speed (18-2 Im-min7l), but 
most would not. This is more surprising when considering the young age (2 1 d) and 
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small size (-I 2g) of mice in the Colbert (2000) study. Without resorting to noxious 
stimuli, such as electric shocks, no way of encouraging the mice to run faster was 
discovered. Whether this was due to the early formation of turnours, individual 
preference, or the "late" age of mice when commencing the exercise treatment 
remains to be elucidated. Naturally, this created heterogeneity in exercise exposure, 
which the use of the treadmill was designed to prevent, and the results should be 
viewed in that light. 
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Figure 3.11 The percentage of days run and the average speed attained by mice over weeks 3-12 
of the study 
3.1.7.2 Organ dimensions 
Weights of non-intestinal organs were unaffected by the treatment, although the 
weight of the spleen tended to be heavier in CON mice compared with TR mice (p 
0.073). This possible splenomegaly may reflect the greater number of turnours in 
CON mice (as shown by the correlation between spleen weight and tumour burden) or 
the greater extent of anaemia shown by the slightly lower haernatocrit of the CON 
mice and which is a characteristic of the Min mouse (Moser et al., 1990). It is also 
possible that the TR mice had reduced levels of systemic inflammation, a condition 
that causes spleen enlargement as lymphocytes are generated (Mehl et al., 2005b). 
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3.1.7.3 IL-6 and IL-10 
Chapter 3 
IL-6 and IL-10 levels were measured to assess the involvement of the pro- and anti- 
inflammatory systems on tumour development. IL-6 is often elevated in colon cancer 
patients (Chung & Chang, 2003) and acute exercise is known to increase IL-6 
concentrations (Petersen & Pedersen, 2005). However, the effects of chronic, non- 
endurance exercise on IL-6 concentration are so far unknown. Reduction of this pro- 
inflammatory cytokine may be particularly useful in patients with colitis, where 
inflammation of the bowel leads to tumour formation. 
IL-6 should normally be undetectable unless the mice are suffering from trauma, 
stress or infection (Mehl et al., 2005b) and the concentrations in plasma in this study 
were low, and not altered by exercise. Using a more sensitive assay, Mehl and 
colleagues (2005b) detected IL-6 concentrations of 1.2 pg/ml in treadmill-running 
mice, a reduction of 96% compared with their control animals at 27.9pg/ml. The 
control value is in accord with that from this study (25. lpg/ml), and the lack of 
reduction of IL-6 in the plasma of TR mice may simply reflect the need for a more 
sensitive test. Alternatively, it is possible that the treadmill treatment caused stress to 
the animals, which may have negated any reduction in IL-6 due to the exercise. 
However, urinary corticosterone was measured by Colbert et al. (2003) as a marker of 
stress and no difference was observed between treadmill-running and control mice. A 
2001 study by Colbert at al. used C57BIJ6 mice and found that in mice given a 
fatiguing exercise bout, IL-6 plasma concentration was significantly higher than that 
of control mice. However, IL-6 was undetectable in mice given a moderate amount of 
exercise (Colbert et al., 2001). As the authors killed the animals in that study 0,1.5 
and 3h following exercise, the lack of detection is probably not due to a rapid half-life 
of the cytokine. However, these results demonstrate the acute effects of exercise, 
which may be very different from its chronic effects. 
IL-10 is an anti-inflammatory cytokine that is released during exercise (Petersen & 
Pedersen, 2005) and although levels in this study were measurable, there was no 
increase due to the treadmill protocol. No other animal study has investigated effects 
on this cytokine so direct comparisons are not possible at this stage. 
A small sex difference existed for IL-6, with female mice having lower concentrations 
than males. The difference tended towards significance (P = 0.08 1) and may reflect 
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the lesser tumour burden of the female mice. Mehl et al., (2005b) did not report a sex 
difference in IL-6 concentrations, although female control mice and those with access 
to a running wheel had lower IL-6 concentrations than their male counterparts, whilst 
female treadmill mice had slightly greater IL-6 concentrations than male treadmill 
runners. Other researchers report decreased concentrations of IL-6 in females, a 
phenomenon that is believed to be linked to oestrogen levels, with physiological 
levels of oestrogen suppressing IL-6 production (Kovacs et al., 2002). 
3.1.7.4 NK cell assay 
As exercise is known to modulate immune function (Nieman, 1997) it was 
hypothesised that beneficial effects of the treadmill regime on tumour number could 
have been due to improved immune defence (Armstrong & Mathers, 2000). The 
spleen provides a good supply of immune cells, but in this study insufficient NK cells 
were harvested for the assay. A recent paper has discovered that Min mice produce 
progressively fewer NK cells as they age, with losses of 5 8% at I 10 d old and 72% at 
120 d old (Coletta et al., 2004), approximately the age of mice when killed in this 
study. In addition to NK cell depletion, the authors observed a general 
lymphodepletion after 80d of age and speculate that the stress of the turnour burden 
may contribute to this change (Nieman, 1997; Coletta et aL, 2004). 
3.1.8 Conclusions from pilot study 
This study was undertaken to develop protocols for treadmill running by Min mice 
and focussed on attempts to follow published treadmill protocols (Colbert et al., 
2000). Reasons for any reduction in tumour number were investigated. There was no 
effect of exercise on any of the measured tumour variables, though there was evidence 
of reduced tumour burden with increased treadmill performance. Some differences in 
food intake, organ dimension and SCFA concentration were observed which deserve 
further investigation. 
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3.2 Treadmill exercise study 2 (ES2) 
3.2.1 Introduction 
The exercise protocol for this study was modified after reviewing the results of the 
pilot study, and also the publication of a study on the effect of treadmill running on 
older Min mice (Colbert et al., 2003). The length of the study was shortened to 10 
weeks to prevent the loss of mice before the end of the study. The target speed, time 
and gradient remained the same. A possible reason for the mice not running on the 
treadmill could have been the forced nature of the exercise, so a voluntary option was 
needed. A wheel-running group (WH) was introduced to determine whether the mice 
would run further when they were given free access to a wheel with no compulsion or 
reward for using it. Numbers of mice were increased to give greater statistical power 
to detect effects of the exercise interventions. 
3.2.2 Aims 
* To develop a protocol for enabling and quantifying voluntary exercise in mice 
using the wheel-running paradigm 
* To compare distances run voluntarily and on the treadmill 
* To assess the effects of the exercise regimes on tumour multiplicity and total 
tumour burden 
* To investigate possible mechanisms for differences in turnourigenesis 
3.2.3 ES2 Specific methods 
67 Min mice, 41 females and 26 males, started the study and were randomised to one 
of the three groups: Treadmill-running (TR), Wheel-running (WH) or Control (CON). 
3.2.3.1 Treadmill regime 
17 Min mice started the treadmill protocol (10 females, 7 males). Those that did not 
drop out were run on the treadmill for a total of 10 weeks. In the first two weeks the 
speed and time were gradually increased, as described in the General Methods and 
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Materials (2.2.3). The target was the same as in the pilot study (ES1) i. e. for the mice 
to run at 18-21mmin-1 on a 5% gradient for 60 min. Mice ran for four 15 minute 
sessions with 5 minutes rest between each session. 
3.2.3.2 Wheel mice 
29 Min mice (17 female, 12 male) randomised to the wheel group were singly housed 
for the first 5 weeks with a small wheel (I Ocm intemal diameter). For the last 5 
weeks, WH mice were singly housed with a larger wheel (1 3cm internal diameter). 
3.2.3.3 Control mice 
21 Min mice were initially assigned to the control group (14 female, 7 male), with 
conditions as stated in General Methods and Materials (2.2.5). 
3.2.3.4 Necropsy 
Mice were killed after 10 weeks of study, (see General Methods and Materials 2.3 for 
details). The same tissues were sampled as in the pilot study (ES I), but this time the 
spleen was removed to record its weight only and the blood was used only for the 
haematocrit measurement. 
3.2.3.5 Mitochondrial mutation analysis 
Two cm of tumour-free tissue from the end of the distal small intestine and the 
beginning of the colon were removed. Each sample was then cut into two and 
mounted on filter paper using OCT cryo-embedding medium (BDH). One sample was 
mounted directly onto the OCT to allow transverse sections through the crypts/villi, 
whilst the other was sandwiched between pieces of agarose gel containing OCT and 
mounted to allow longitudinal sections through the crypts. 
The samples were then frozen using an iso-pentane freezing bath and stored at -80'C. 
Samples were sectioned using a cryostat (Microm HM5060). Briefly, a sample was 
frozen to a metal chuck and fixed to the cryostat. 8ptm sections of the frozen tissue 
were placed onto a microscope slide. Sections were then stained using a Cytochrome 
c oxidase/succinate dehydrogenase (COX/SDH) stain to determine the presence or 
absence of cytochrome C oxidase -deficient cells (see Appendix 6.11 for details). 
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Deficient cells stained blue, normal cells stained brown. The number of deficient cells 
was counted in at least five samples and the mean was calculated. 
3.2.3.6 Statistical analysis 
Data were analysed by the General Linear Model of ANOVA, with sex included as a 
covariate, and comparisons between treatment groups investigated using Dunnett's 
test. This allowed both WH mice and TR mice to be compared with CON separately. 
3.2.4 ES2 Results 
Sixty two Min mice completed the study and were distributed among the exercise 
protocols as shown in Table 3.27. 
Table 3.27 Numbers of mice completing the second study according to sex and exercise protocol 
Exercise Protocol Male Female Total 
Treadmill 369 
Wheel 11 14 25 
Control 10 18 28 
Total 24 38 62 
Five further mice were killed before the end of the study because of deteriorating 
health. Two females had 74 and 100 tumours respectively, I male had 57 tumours, I 
female had 2 polypoid colon tumours of over 9min and 1 male was hydrocephalic. 
The data from these mice were not included in the analysis. The average time between 
finishing the exercise protocol and being killed was 3 days (range 1-7days, CON and 
TR 4 days, WH 3 days, P=0.194). 
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3.2.4.1 Body weight 
Chapter 3 
Most mice continued to increase in weight throughout the study, but some lost weight 
in the later stages. There were no significant differences between exercise protocols in 
body mass at death (P = 0.733, Figure 3.12) though TR mice were the heaviest at 
27.6g, followed by WH mice (26.7g) and CON were the lightest at 26.4g. 
40- 
35- 
30- 
2S- 
20- 
Sex Fenýale Male Fenýale Male Fenýale Male 
Protocol Treadmill Wheel Control 
Figure 3.12 Final (slaughter) body weights by exercise group and sex, 95% CI for the mean 
Weekly weights of mice by treatment group were similar, with no significant 
differences between them at any week, though CON mice were slightly heavier on 
weeks 7,8 and 9 (Figure 3.13). 
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Figure 3.13 Weekly weights of mice by exercise protocol 
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Figure 3.14 Weekly weights of female and male mice 
Chapter 3 
Females were significantly (P < 0.001) lighter at every stage of the study (Figure 
3.14) and also at death (Figure 3.12). 
Figure 3.15 shows the weekly weights by sex and treatment group. The pattern of 
weight gain was very similar for the mice of the different exercise groups. In contrast, 
TR males were the lightest male group from week 2-9 and CON males were the 
heaviest, particularly increasing in weight at week 5 before reaching a plateau. 
Weights of male WH mice were similar to those of CON until week 6, when a 
decrease in weight occurred, followed by an increase at week7 and body masses 
thereafter tracked the growth of male TR mice. 
A sex*exercise interaction existed at week 7 (P = 0.033, Figure 3.16) and at week 8 
the interaction approached significance (P = 0.054). On both of these weeks, male 
-105- 
Laura Basterfield Chapter 3 
CON mice weighed more than the other groups, and the heaviest females were in the 
TR group (Figure 3.16). At all other weeks there was no statistically significant 
interaction (P>0.30). 
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Figure 3.15 Weekly weight by sex and exercise group 
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Figure 3.16 Interaction between sex and exercise on weight at week 7 (P = 0.033) 
Examination of weekly weight gain reveals more variation between the groups (Table 
3.28). There were no significant differences between treatment groups in total weight 
gain over the study, JR 9.2g v. VY'H 8.3g v. CON 8.1 g, P=0.734). However, there 
were significant differences in weekly weight gain between exercise groups on weeks 
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4,6 and 7, with WH gaining more weight on week 4 compared with CON, but CON 
gaining more weight on week 6 and again at week 7 (Table 3.28). 
Male mice gained significantly more weight than female mice over the length of the 
study (10.3g v. 7.4g, P=0.008). VVhile males were consistently heavier than females, 
they gained significantly more weight on only weeks 2-6 (Table 3.29). 
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An interaction existed between sex and exercise on week 6 (P = 0.030), week 7 
(P<0.001) and week 8 (P = 0.021) (Figure 3.17). 
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Week 8 Figure 3.17 Interaction between sex and 
exercise protocol on weight gain in week 6,7 
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In week 6 male mice gained 2-3 times more weight than females with the exception of 
male TR, which gained a similar amount to female TR (0.87g and 0.82g respectively, 
Figure 3.17, Table 3.30). In week 7 females gained more weight than males, except 
for male CON which gained on average 1.9g compared with 0.7g for female CON 
(Figure 3.17). In week 8, male TR gained more weight than female TR (2.5 v. 0.6g), 
while both sexes in CON and WH groups gained similar amounts (Figure 3.17 and 
Table 3.30). 
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Table 3.30 Mean body weight gain (g) of mice by sex and exercise group at weeks 6,7 and 8 
Treadmill 
Week Female Male 
6 0.82 0.87 
7 1.28 1.03 
8 0.60 2.47 
Wheel 
Female Male 
0.48 1.56 
0.54 -0.45 
0.59 0.77 
Control 
Female Male 
1.02 2.77 
0.72 1.94 
0.99 1.01 
p 
0.030 
<0.001 
0.024 
There was no interaction between sex and exercise protocol on total weight gain over 
the study (Figure 3.18). 
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Figure 3.18 Total weight gain between the groups (slaughter weight minus initial weight) 
3.2.4.2 Time and amount of running - treadmill 
The treadmill protocol was altered slightly from the first study (ES I), including more 
breaks and running for shorter times. This resulted in a greater number of animals 
running on every day of the study, a faster average speed and longer daily time spent 
running. There was still a problem with drop-outs -7 males and 10 females started on 
the treadmill. The study ended with 3 males and 6 females. All dropouts but I were 
transferred to the CON group, the other was added to the wheel group but killed early 
due to a large burden of turnours. 
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Data analysed were means of the total time run daily by each mouse, the percentage 
of days on which the mice ran and the fastest speed achieved each day. Individual 
mouse data for the running parameters are summarised in Table 3.3 1. There was no 
significant difference between males and females in the average fastest speed run 
daily (15.6 m-min-1 v. 15.9 m-min"), but differences occurred in the percentage of 
days run throughout the study (80% v. 99%, P=0.003) and the average time spent 
running daily (37 min v. 56 min, P=0.001), with females running on more days and 
also running for longer. No male mice ran on every day of the study. 
Table 3.31 Time and speed data for individual mice on the treadmill 
Mouse 
number Sex 
Average daily time 
spent running 
(minutes) 
Average best speed 
(m-min") % of days run 
26 Male 44.7 15.6 91.7 
24 Male 39.1 15.7 79.2 
25 Male 28.4 15.4 68.8 
33 Female 60.0 16.1 100.0 
28 Female 60.0 16.1 100.0 
30 Female 56.4 16.0 100.0 
47 Female 55.6 15.8 100.0 
49 Female 55.2 15.8 100.0 
50 Female 51.3 15.4 95.8 
Mean 50.1 15.8 92.8 
Mean daily running time was positively correlated with running speed (r = 0.75, 
Figure 3.19), indicating that mice choosing to run for longer also ran faster. The 
regression equation connecting mean daily fastest running speed and mean daily 
running time is: 
best speed = 14.8 + 0.0191 *running time (Rý = 0.49, P=0.02 1). 
N. B. "best speed" represents the fastest speed run by each mouse in each session, as 
the speed was changed if mice could not keep up/dropped out. Therefore different 
mice may have different maximum speeds depending on how long they ran for. 
Figure 3.20 shows that six of the nine mice ran for shorter periods towards the end of 
the study. 
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Figure 3.19 Plot of maximum daily running speed against mean daily running time for individual 
treadmill mice with fitted regression line 
70 - 
ýale 
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Figure 3.20 Average daily running time for each mouse during the final 8 weeks of the study (3 
female mice ran for 60min-d and therefore appear as one line) 
3.2.4.3 Wheel running 
The response of the mice to the running wheels was highly individual. Some ran on 
the first day and continued to run for the length of the study (Figure 3.23), others ran 
considerable distances at the beginning of the study and much less towards the end, or 
ran very little at the beginning of the study and more towards the end (Figure 3.2 1) 
and the distance covered varied widely between mice (e. g. Figure 3.22 and Figure 
3.24). There was a marked difference between males and females, with females 
running significantly (P = 0.004) further after 10 weeks, an average of 314.4 v. 147.0 
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Ian (Figure 3.26). Most mice continued to run throughout the study (Figure 3.25). 
Running speeds were estimated by filming the mice running and counting the number 
of revolutions in a set time period. This method revealed running speeds of 30- 
40m-min" in a female mouse. 
Many females also demonstrated a 3-5 day cyclical pattern in their running (Figure 
3.21 and Figure 3.22). 
Daily distance run by female mouse In running wheel - example I 
20000 
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E 
W 12000 
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C14 04 (n m IT 
Day of study 
Figure 3.21 Daily distance run by a mouse that ran more in the larger wheel (day 36 onwards) 
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Daily distance run by female mouse In running wheel - example 2 
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Figure 3.22 Daily distance run by a female mouse which ran more in the small wheel (up to day 
35) than in the larger wheel. Days of zero distance correspond with the time period Immediately 
after the wheel change 
Daily distance run by male mouse In running w heel example 1 
12000- 
10000- 
8000- 
r 6000- 
An 4000- 
2000 - 
0 ................. .............. 
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Figure 3.23 Typical example of the daily distance run by a male mouse - daily distances varied 
less than in females. The large increase in distance follows access to the larger wheel, although 
distances returned to levels similar to those run In the small wheel 
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Daily distance run by male mouse in running wheel - example 2 
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Figure 3.24 Daily distance run by a mouse that ran relatively little in the small wheel 
(<400m/day), but regularly ran over 2km a day when given access to a larger wheel, showing that 
individual animals varied in their response to wheels 
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Figure 3.25 Cumulative distances run by individual mice in wheels 
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Figure 3.26 Total distances run in 10 weeks by male and female mice 
Chapter 3 
Females ran further than males in weeks 1-5 (134 v. 58km, P=0.001) and again in 
weeks 6-10 (180v. 88km, P=0.036 and Figure 3.27). On a week-by-week basis, 
females ran significantly further on weeks 2,3,4,5,7,8,9 and 10 (see Table 3.32 for 
details). The greater distance run by female mice in week I approached significance. 
The difference in distance run between sexes in week 6 was non-signifi cant. This was 
the week that the wheels were changed to those of larger diameter. 
When changed to the exercise wheels of larger diameter, the mice ran further (Figure 
3.27). However, it appeared that the female mice took longer to adapt to the change 
since their distance run in week 6 (immediately after the change) was only 642m 
further than in week 5, compared with 997m further by the male mice (Table 3.32). 
During weeks 6- 10, males ran 52% further in the bigger wheels than in the smaller 
wheels (88 v. 58km), compared with a 35% increase by the females (180 v. 134km), 
and this difference was significant (P = 0.041) for both sexes (Figure 3.27 and Figure 
3.28). 
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Figure 3.29 Relationship between weight gain in 8 weeks and distance run In 8 weeks with fitted 
regression line 
Over weeks 1-8, the distance run in wheels was negatively correlated with body mass 
gain, with the longer distance runners having a lower body mass than those covering 
shorter distances (r = -0.71, P<0.001, Figure 3.29). Data up to week 8 were chosen 
for this analysis as in the following weeks some mice lost weight (presumably due to 
tumour manifestation). The regression equation was: 
Gain in 8 weeks = 9.91 - 0.0173*distance afler 8 weeks (R2 = 0.50, P <0.001). 
The weekly weight of mice correlated with the average distance run that week in all 
except the first and 6th weeks (the first week with the wheel and the week the wheels 
were changed to those with a larger diameter). Keen runners had a lower body mass 
(P <0.025) than mice running shorter distances. 
3.2.4.4 Food intake 
Food intake and intake/I OOg body mass were significantly different between 
treatment groups during all but two and three weeks respectively. VM mice 
consistently ate more food and TR mice tended to eat less than CON mice (Figure 
3.3 0 and Figure 3.3 1). 
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Figure 3.30 Daily food intake per week for each treatment group (* represent values significantly 
different from Control) 
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Figure 3.31 Daily food intake per week per 100 grams body mass for each exercise protocol 
significantly different from Control) 
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WH ate significantly more during weeks 2 (P<0.00 1), 5 (P = 0.004), 8 (P<0.00 1), 9 (P 
= 0.007) and 10 (P<0.001). TR ate significantly less during weeks 2 (P 0.008), 4 
(P<0.00 1) and 7 (P = 0.027) and significantly more during week 10 (P 0.0 11). 
Intake was relatively stable throughout the study, so as body weight increased, intake 
per 100g body mass decreased correspondingly (Figure 3.3 1). 
Sex differences in food intake are displayed in Figure 3.32. When intake data were 
expressed in g1mouse, males ate more during weeks 1-5 and females ate more during 
weeks 6-10 and these differences were significant during weeks 4,6,8,9 and 10 
(P: 50.025). This changeover in relative food intake from week 6 onwards was due 
both to a decreased intake by male mice and an increase in consumption by female 
mice. However, when expressed per 100g body weight females ate significantly more 
during all weeks except week 4, (P between <0.001 and 0.004, details in Table 3.33 
and Figure 3.33). 
Table 3.33 Mean food intake (g per 100g body mass) of males and females 
Week Female SEM Male SEM Probability 
1 12.8 0.32 11.4 0.38 0.004 
2 10.7 0.26 9.5 0.26 <0.001 
3 12.0 0.36 9.7 0.39 <0.001 
4 9.4 0.32 9.0 0.41 0.161 
5 10.1 0.34 8.4 0.34 <0.001 
6 10.8 0.31 7.6 0.34 <0.001 
7 9.8 0.29 7.8 0.38 <0.001 
8 10.3 0.27 7.2 0.33 <0.001 
9 9.6 0.41 6.8 0.44 <0.001 
10 8.8 0.23 6.2 0.31 <0.001 
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Figure 3.32 Mean daily food intake per week of male and female mice (* denote significant 
differences) 
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Figure 3.33 Mean food intake per 100g body mass for male and female mice (* denote significant 
(P<0.05) differences) 
Variability in intake within separate sex-exercise groups (female TR, male TR etc) 
was quite pronounced (Figure 3.34), especially for female TR and male and female 
CON. When displayed as intake per I OOg body mass, the pattern became more stable, 
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with intake decreasing gradually as the study progressed. The exceptions to this were 
the female TR mice where food intake remained relatively constant throughout the 
study (Figure 3.35). 
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Figure 3.34 Daily food intake during each week of the study by sex and exercise group 
16 
7 14 
E 12 
M 0 10 
Co CD 8 
6 
4 
ig 
2 
0 
23456789 10 
Week of study 
Female Treadmill 
Female Wheel 
Female Control 
Male Treadmill 
Male Wheel 
Male Control 
Figure 3.35 Daily food intake per 100g body mass for each sex and exercise group 
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There were significant interactions between intake/ I OOg body mass and sex during 
week 7 (P = 0.001, Figure 3.36 and Table 3.34) with females eating more than their 
male counterparts, with the exception of male TR who ate more than female TR. 
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Figure 3.36 Interaction between sex and exercise protocol at week 7 
Table 3.34 Mean food intake (g/lOOg body mass) by sex and exercise group at week 7 
Week 7 Treadmill Wheel Control P (interaction) 
Female 7.6 10.7 11.0 
Male 8.2 8.3 6.8 0.001 
3.2.4.5 Tumours 
The 62 mice produced 10 19 turnours; with a total tumour burden of 2587mm. The 
distribution of turnours is displayed in Figure 3.37, which shows that 97% of turnours 
were found in the small intestine (987 out of 1019). The distal portion of the small 
intestine had 1.6 times the number of turnours as were found in the proximal portion 
(608 v. 379). 
- 125- 
Laura Basterfield 
Distal 
609/c 
Iroximal Sl 
37% 
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There were no statistically (P<0.05) significant effects of the exercise protocols on 
tumour variables, although several approached significance (Table 3.35). The mean 
number of distal tumours was reduced in WH mice compared with CON (6.9 v. 10.9, 
P=0.053), and TR mice had fewer turnours of 1-3mm diameter (7.9 v. 13.3, P= 
0.056) as well as fewer turnours in total (10.6 v. 15.8 P=0.068). For both of these 
variables, WH mice had mean values between those of CON and TR mice (data in 
Table 3.35). WH mice had slightly fewer 4-6mm diameter turriours than CON (P = 
0.067). For all the measured variables, CON mice suffered greater tumourigenesis 
than either WH or TR mice, even though the effects were not statistically significant. 
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Table 3.35 Details of turnour variables by exercise protocol (n) 
Tumour variable 
Treadmill 
(9) 
Wheel 
(25) 
Control 
(28) 
Probability of effect 
TR v VM V 
CON CON 
Proximal SSqrt 3.4 5.9 6.0 0.081 0.996 
1.83-5.47 4.55-7.43 4.69-7.42 
Distal S, Sqrt 6.9 6.9 10.9 0.189 0.053 
3.68-11.04 4.87-9.31 8.42-13.68 
Total S, LogI0 10.3 12.5 15.8 0.102 0.247 
7.10-14.95 10.00-15.64 12.80-19.53 
Colon KW 0.0 0.0 0.5 0.190 0.089 
0.0-2.0 0.0-3.0 0.0-2.0 
Total number 
LogI0 10.6 13.0 15.8 0.068 0.204 
7.41-15.14 10.47-16.22 12.88-19.50 
Burden 29.8 33.8 42.7 0.124 0.181 
(mmdiameter)LoglO 21.38-41.69 27.54-40.74 35.48-51.29 
1-3mm LogI0 7.9 11.1 13.3 0.056 0.477 
5.37-1.75 8.71-14.13 10.72-16.60 
4-6mm Kw 2.0 2.0 2.0 0.900 0.067 
0.0-6.0 0.0-4.0 0.0-7.0 
7+mm Kw 0.0 0.0 0.0 0.136 0.860 
0.0-0.0 0.0-2.0 0.0-2.0 
There was no effect of sex on tumour variable (see Table 3.36), with the exception of 
colon turnours, with males having more than female mice (0 v. 1, median values, P= 
0.012). 
There were no significant interactions between exercise and sex on any of the 
measured turnour variables. 
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Tumour variable Female Male 
(38) (24) Probability of effect 
Proximal SISqrt 5.9 5.0 0.212 
4.73-7.10 3.75-6.51 
Distal S, Sqrt 9.3 7.5 0.271 
7.30-11.61 5.24-10.10 
Total S1 LogIO 14.6 11.9 0.193 
12.15-17.59 9.46-15.07 
ColonKw 0.0 1.0 0.012 
0.0-2.0 0.0-3.0 
Total numberLo&10 15.0 12.8 0.300 
12.59-17.78 10.12-16.22 
Tumour burden 39.2 33.5 0.270 
(mm diameterfogIO 33.1145.71 27.54-40.74 
1.3MMLoglO 12.1 10.6 0.425 
10.00-14.79 8.32-13.80 
4-6mmKw 2.0 2.0 0.352 
0.0-7.0 0.0-5.0 
7+mmKw 0.0 0.0 0.736 
0.0-2.0 0.0-1.0 
3.2.4.6 Body organs 
Organs were removed and analysed as described in ES1. The weights of most 
intestinal organs were not different between exercise groups, however VM mice had a 
heavier full small intestine and also a heavier proximal section of small intestine than 
did CON mice (P= 0.007 and 0.005 respectively, Table 3.37). The colon of TR mice 
was significantly longer than that of CON mice (5.5 v. 5.0 cm, P= 0.026). 
When the weights of organs were expressed as a percentage of the final body mass 
there were no significant differences between the treatment groups (Table 3.38) 
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Table 3.37 Intestinal organ dimensions of exercise groups 
Probability of 
effect Treadmill SEM Wheel SEM Control SEM 
Organ dimension TR v. V*IH v. 
CON CON 
Slaughter weight (g) 27.6 1.36 26.7 0.82 26.4 0.77 0.664 0.940 
Length SIKW 29.0 - 30.0 - 29.0 - 0.681 0.383 
(cm) 24.0-31.0 23.0-34.0 23.0-32.0 
Colon KW 5.5 5.0 5.0 - 0.026 0.728 
5.0-6.0 4.0-6.0 4.0-6.0 
Weight Full 0.365 0.373 
(g) stomach 
Lo&10 0.294-0.452 0.328-0.425 
0.356 0.979 0.844 
0.315-0.403 
Stomach 0.185 0.012 0.174 0.007 0.186 0.007 0.996 0.413 
tissue 
Stomach 0.185 0.039 0.223 0.023 0.196 0.022 0.962 0.622 
contents 
Full SI 1.063 0.046 1.098 0.027 0.982 0.026 0.232 0.007 
Proximal 0.638 0.029 0.717 0.018 0.639 0.017 0.998 0.005 
SI 
Distal SI 0.356 0.029 0.361 0.018 0.362 0.016 0.978 0.999 
Full 0.256 0.022 0.275 0.013 0.244 0.012 0.873 0.166 
caecum 
Caecal 0.127 0.010 0.128 0.006 0.121 0.006 0.848 0.588 
tissue 
Caecal 0.129 0.017 0.147 0.010 0.123 0.010 0.948 0.194 
contents 
Full colon 0.257 0.018 0.227 0.011 0.232 0.020 0.394 0.905 
Colon 0.197 0.014 0.184 0.009 0.188 0.008 0.817 0.939 
tissue 
Colon 0.060 0.012 0.043 0.007 0.045 0.007 0.409 0.976 
contents 
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Table 3.38 Intestinal organs (tissue) as % final body mass by treatment group (mean and 95% 
CI) 
Organ as 
%final body 
mass 
Treadmill Wheel Control 
Probability of effect 
TR v. CON WH v. CON 
Stomach 0.674 0.661 0.721 0.618 0.247 
0.579-0.768 0.604-0.718 0.668-0.775 
Proximal Sl 2.335 2.745 2.498 0.565 0.107 
2.038-2.632 2.563-2.927 2.329-2.667 
Distal Sl 1.283 1.324 1.359 0.745 0.891 
LoglO 
1.107-1.487 1.209-1.450 1.250-1.478 
CaeCUMLoglO 0.455 0.476 0.454 0.999 0.716 
0.387-0.534 0.432-0.524 0.414-0.497 
Colon Lo&10 0.718 0.679 0.703 0.958 0.791 
0.626-0.823 0.625-0.739 0.651-0.760 
Several statistically significant differences in organ dimensions existed between the 
sexes, with males having heavier full stomach, stomach tissue, full colon, colon 
contents, full caecum and caecal contents compared with females (Table 3.39). Males 
also tended to have a slightly longer small intestine. However, when these data were 
re-expressed as a percentage of final body weight the differences between male and 
female mice altered somewhat. Females had a heavier proximal Sl (2.50 v. 2.30%, P 
< 0.001) than males and also a heavier distal portion (1.41 v. 1.23%, P=0.028). 
Female mice also had heavier stomach, caecum and colon tissue than males, and these 
differences approached significance (P=0.062,0.070 and 0.071 respectively, Table 
3.40). 
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Table 3.39 Organ dimensions of male and female mice 
Probability of Organ dimension Female SEM Male SEM 
effect 
Slaughter weight 20.5 0.65 30.2 0.82 <0.001 
(9) 
Length (cm) 
siKW 28.5 - 30.0 - 0.074 
23.0-32.0 25.0-34.0 
Colon KW 5.0 5.0 0.160 
4.0-6.0 4.0-6.0 
Weight (g) 
Full stomach LoglU 0.336 - 0.414 - 0.022 
0.303-0.373 0.363-0.471 
Stomach tissue 0.173 0.006 0.193 0.007 0.036 
Stomach contents 0.183 0.019 0.239 0.024 0.085 
Full SI 1.013 0.024 1.085 0.030 0.077 
Proximal SI tissue 0.661 0.016 0.684 0.019 0.534 
Distal SI tissue 0.349 0.014 0.378 0.017 0.207 
Full caecurn 0.236 0.011 0.294 0.013 0.002 
Caecal tissue 0.120 0.005 0.132 0.006 0.146 
Caecal contents 0.116 0.009 0.162 0.011 0.002 
Full colon 0.218 0.009 0.259 0.011 0.004 
Colon tissue 0.180 0.007 0.199 0.009 0.092 
Colon contents 0.038 0.006 0.060 0.007 0.015 
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Table 3.40 Intestinal organs (tissue) of male and female mice as % final body mass (mean and 
95% CI) 
Organ as % final Female Male Probability of effect body mass 
Stomach 0.72 0.64 0.062 
0.673-0.766 0.585-0.701 
Proximal SI 2.75 2.30 <0.001 
2.596-2.900 2.109-2.487 
Distal S, LogIO 1.41 1.23 0.028 
1.309-1.511 1.124-1.344 
CaecuMLogIO 0.48 0.43 0.070 
0.448-0.523 0.391-0.475 
Colon LogIO 0.73 0.65 0.071 
0.679-0.775 0.601-0.709 
The weights of extra-intestinal organs are displayed in Table 3.41 and show that, 
compared with CON mice, WH had significantly heavier livers (1.163 v. 1.098g) and 
both WH and TR mice had lighter spleens than CON mice (0.173,0.121 and 0.246g 
respectively). These differences persisted when the organs were expressed as % final 
body mass (Table 3.41). 
The weights of liver, spleen and heart were all heavier in males compared with female 
mice, and were significantly so for liver and heart (Table 3.42), but this sex difference 
was reversed when the organs were expressed as % final body mass, although 
significantly so for the liver only (4.52 v. 4.12%, P<0.001). 
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Table 3A2 Liver, heart and spleen weights of mice by sex (mean and 95% CI) 
Probability of Organ weight (g) Female Male effect 
Liver 1.102 1.245 0.002 
1.049-1.155 1.178-1.312 
Heart 0.194 0.218 0.004 
0.184-0.204 0.206-0.230 
Spleen LogIO 0.181 0.213 0.172 
0.153-0.214 0.172-0.263 
As % final body mass 
Liver LogIO 4.516 4.122 <0.00 1 
4.386-4.651 3.9724.277 
Spleen L'910 0.747 0.711 0.770 
0.620-0.900 0.563-0.899 
Heart 0.811 0.740 0.128 
0.755-0.866 0.682-0.798 
3.2.4.7 SCFA 
Short chain fatty acids in the colon contents were measured as described in ESI. 
Several of the variables were not normally distributed and these are indicated in the 
text. 
Table 3.43 displays the concentrations of SCFA in colon contents by exercise group, 
with acetate present in the greatest concentration. There were no statistically 
significant differences between the groups. However, when the concentrations were 
converted to molar proportions (Table 3.44), TR mice had a significantly (P = 0.006) 
smaller proportion of isovalerate than CON mice, with 18 compared with 
25mmol/mol (Table 3.44). 
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Table 3.43 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by exercise protocol 
Individual SCFA 
(pmol-g colon 
contents)* 
TR 
(n = 9) 
WH 
(n = 22) 
CON 
(n = 26) 
Probability of effects 
TRvCON WHvCON 
Acetate 25.47 21.73 22.54 0.544 0.898 
20.60-31.50 18.96-24.90 19.90-25.54 
Propionate 3.15 3.15 3.33 0.895 0.824 
2.50-3.96 2.72-3.65 2.91-3.80 
Isobutyrate 6.53 7.00 7.47 0.669 0.846 
4.60-8.72 5.82-8.42 6.30-8.85 
Butyrate 2.00 1.17 1.11 0.099 0.974 
1.21-3.31 0.85-1.60 0.83-1.50 
Isovalerate 0.565 0.573 0.649 0.385 0.679 
0.40-0.83 0.41-1.23 0.32-2.27 
Valerate 0.51 0.55 0.49 0.983 0.741 
0.36-0.73 0.44-0.69 0.40-0.61 
Total 32.60 27.61 28.91 0.588 0.864 
concentration 26.15-40.04 24.08-31.65 25.51-32.76 
* all SCFA Logl. 0-trasnformed, exce pt isovalerate which was tested using Kruskal-Wallis 
Table 3.44 Molar proportions (mmol/mol total SCFA) of colonic SCFA by exercise group, mean 
and SEM/95% CI 
Molar 
proportion 
TR WH CON Probability of effects 
TRvCON VM v CON 
Acetate 789 788 783 0.961 0.952 
18.5 11.8 10.9 
Propionate 100 117 118 0.126 0.992 
8.4 5.4 4.9 
Isobutyrate KW 14 13 14 0.070 0.273 
7.4-14.5 8.8-23.0 0.0-28.7 
Butyrate 66 42 44 0.161 0.972 
10.7 6.9 6.3 
Isovalerate 18 24 25 0.006 0.782 Lagio 
15.5-21.7 21.4-26.5 22.6-27.5 
Valerate 16 15 14 0.775 0.869 
2.6 1.6 1.5 
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Table 3.45 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by sex 
Individual SCFA Female Male Probability 
(pmol-g colon contents)* (n = 33) (24) 
Acetate 21.88 23.88 0.261 
19.55-24.37 20.98-27.17 
Propionate 3.16 3.33 0.543 
2.81-3.55 2.90-3.82 
Isobutyrate 7.00 7.33 0.699 
6.03-8.12 6.15-8.72 
Butyrate 1.19 1.32 0.528 
0.91-1.55 0.97-1.81 
Isovalerate 0.606 0.576 0.974 
0.404-1.857 0.320-2.271 
Valerate 0.48 0.58 0.218 
0.40-0.57 0.47-0.72 
Total concentration 28.05 30.13 0.352 
25.12-31.33 26.47-34.30 
*all SCFA LogIO-trasnformed, except isovalerate which was tested usin g Kruskal-Wallis 
Table 3.46 Molar proportions (mmol/mol total SCFA) of colonic SCFA by sex 
Molar proportion Female Male Probability 
Acetate 780 794 0.377 
9.5 11.1 
Propionate 115 113 0.649 
4.4 5.2 
Isobutyrate 14 13 0.639 
0.0-23.0 7.4-28.7 
Butyrate 50 43 0.538 
5.7 6.6 
Isovalerate LogIO 24 22 0.219 
22.0-26.5 20.1-25.0 
Valerate 16 13 0.155 
1.3 1.5 
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Both concentrations and molar proportions of SCFA in samples from male and female 
mice were not statistically significantly different (P>0.05) as shown in Table 3.45 and 
Table 3.46. 
There was no interaction between sex and exercise protocol for any of the measured 
variables (P>0.05). 
3.2.4.8 CCP 
Of the three variables used in the assessment of proximal SI crypt cell proliferation, 
one was significantly different with regards to exercise protocol. VM mice had 
significantly more mitoses in the upper third of the crypt compared w4h CON (0.79 v. 
0.53, P=0.024, see Table 3.47). Crypt width was almost significantly greater in TR 
mice compared with CON (63.5gm v. 55.7gm, P=0.052, see Table 3.48). 
Table 3.47 Mean mitotic cells per crypt section by exercise group 
Region P 
ofcrypt Treadmill SEM Wheel SEM Control SEM TR WH 
Upper 0.53 0.12 0.79 0.07 0.53 0.07 0.998 0.024 
Middle 0.65 0.13 0.85 0.08 0.83 0.07 0.391 0.985 
Lower 0.50 0.08 0.55 0.05 0.57 0.04 0.731 0.971 
Total 1.68 0.25 2.19 0.16 1.93 0.14 0.613 0.398 
Table 3.48 Mean crypt dimensions between exercise groups 
Dimension p 
(Ftm) Treadmill SEM Wheel SEM Control SEM TR WH 
Length 128.6 5.22 131.5 3.20 130.3 2.96 0.942 0.956 
Width 63.5 3.00 52.9 1.84 55.7 1.70 0.052 0.451 
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Table 3.49 Mean crypt mitoses and dimension of male and female mice 
Mitoses Female SEM Male SEM P 
Lower 0.53 0.04 0.59 0.05 0.312 
Middle 0.77 0.06 0.87 0.08 0.388 
Upper 0.58 0.06 0.71 0.08 0.233 
Total 1.88 0.124 2.17 0.16 0.191 
Dimension (pm) 
Length 131.8 2.50 128.4 3.22 0.388 
Width 56.4 1.54 54.7 1.98 0.586 
Mitoses and crypt dimensions were not significantly different between the sexes 
(P>0.05, Table 3.49). 
3.2.4.9 Body composition 
Body composition was measured on the carcass of the animal after the intestinal and 
related organs had been removed for analysis. 
The proportion of non-fat organic matter (principally carbohydrate and protein) was 
significantly different between treatment groups (Table 3.50), with TR mice having a 
smaller proportion of non-fat organic matter than CON mice (P = 0.050). There was 
no significant difference between the proportion of organic matter in CON and WH 
mice. There was no significant difference for any of the other variables. Further details 
are displayed in Table 3.50. 
Table 3.50 Body composition (g/IOOg carcass) of mice in each exercise groups 
Component 
(%) Treadmill SEM Wheel SEM Control SEM 
Probability 
TR WH 
Water 49.6 1.98 55.0 1.31 51.8 1.17 0.545 0.152 
Fat 31.2 2.84 21.6 1.87 25.2 1.7 0.138 0.276 
Non-fat 16.4 19.0 17.8 0.050 0.467 
organic 
matterKw 
6.04-20.03 15.18-28.25 14.68-33.98 
MineralLo&10 3.3 4.0 3.9 0.161 0.807 
2.79-3.84 3.62-4.47 3.51-4.24 
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Table 3.51 Body composition (g/100g carcass) of male and female mice 
Component (%) Female SEM Male SEM P 
Water 53.8 1.06 50.8 1.31 0.036 
Fat 23.6 1.54 26.5 1.91 0.130 
Non-fat organic 18.0 17.8 0.987 
matterKw 6.04-33.58 15.18-28.25 
MineralLogtO 4.0 3.5 0.023 
3.72-4.40 3.15-3.88 
Sex differences in body composition existed for percentage of water and for mineral 
content (Table 3.5 1). Females had a greater proportion of mineral than males (4.0 v. 
3.5%, P=0.023) and also a higher water content (53.8 v. 50.8%, P=0.036). The 
proportion of non-fat organic matter was not different between the sexes (17.8% in 
females and 18.3% in males, p=0.987). 
3.2.4.10 Caecal transit time 
The difference in caecal transit time between exercise groups were not statistically 
significant (P=0.414 for TR v. CON and 0.531 for WH v. CON, data in Table 3.52). 
The difference between males and females was significant (P = 0.008), with males 
having a caecal transit time 30% slower than females (3.10 v. 4.50 hours). There was 
no interaction between sex and exercise protocol. 
Samples from 7 mice were excluded from the analysis due to experimental problems 
(broken tubes, balance errors). 
Table 3.52 Caecal transit times of treatment groups (h) (median and range) 
Variable Treadmill Wheel Control Probability 
TR v CON WH v CON 
Transit time KW 3.10 4.12 4.28 0.414 0.531 
1.36-5.29 1.83-34.87 0.08-21.93 
N=9 (Treadmill), 23 (Wheel), 23 (Control) 
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Table 3.53 Caecal transit time of male and female mice (h) (median and range) 
Variable Female Male Probability 
Transit time KW 3.10 4.50 0.008 
0.08-21.93 1.91-34.87 
3.2.4.11 Mitochondrial mutation analysis 
Tissue samples from the distal end of the small intestine and the proximal colon were 
processed as outlined in the Specific Methods section of this chapter (3.2.3.5). 
Example of samples are shown in Figure 3.38. 
10 random samples from each treatment group were selected and examined for the 
presence of blue-stained cells which indicate cytochrome c oxidase (COX) deficiency. 
After 38 slides had been examined only I blue cell had been found, so tissue samples 
from two older mice (from another study) were examined as the lack of COX- 
deficient cells could be due to the young age of the mice. Neither the 26 nor the 18 
month-old mouse had any blue-stained cells, so it was decided that the remainder of 
the samples were unlikely to yield any greater numbers and were not examined. 
Tissue samples from both sites were not available from all study mice due to the 
fragility of the tissues, particularly the distal small intestine. 
Figure 3.38 (a) Longitudinal section through colon (b) Transverse section through colon crypts from 
crypts from a 26 month-old mouse an 18 month old mouse 
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3.2.5 Summary of results 
Table 3.54 Summary of results from second experiment (p<0.05) 
Effect of exercise regime (compared with 
Control) 
Variable Treadmill Wheel 
Body weight gain 
Food intake 
Proximal SI tumours 
Distal SI tumours 
Total SI tumours 
Colon tumours 
Total number of tumours 
Tumour burden 
Intestinal organ tissue weights 
Non-intestinal organ weights 
-liver 
-spleen 
-heart 
SCFA concentration 
SCFA molar proportion 
-Isovalerate 
-Acetate/Proplonate/Isobutyrate/ 
butyrate/valerate 
CCP mitoses 
No difference 
Decreased 
Decreased (0.081) 
No difference 
No difference 
No difference 
Decreased (0.068) 
No difference 
No difference 
No difference 
Decreased 
No difference 
No difference 
Decreased 
No difference 
No difference 
Increased 
No difference 
Decreased (0.053) 
No difference 
No difference 
No difference 
No difference 
No difference 
Increased 
Decreased 
No difference 
No difference 
No difference 
No difference 
-upper No difference Increased 
-other regions No difference No difference 
CCP dimensions 
-length No difference No difference 
-width Increased No difference 
Body composition 
-non-fat organic matter Decreased (0.050) No difference 
-other components No difference No difference 
Caecal transit time No difference No difference 
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3.2.6 ES2-specific discussion 
3.2.6.1 Treadmill performance 
The desired number of TR in mice ES2 was 12, i. e. 6 of each sex. This number was 
not higher due to the time taken to run the mice and the extra disturbance this would 
have caused. The treadmill only allowed 6 mice to be run simultaneously. 
Nine mice finished the study, as in ESI, but compliance with the protocol was much 
improved, with the percentage of days when the mice ran increasing from 85 to 93%, 
and daily time run increasing from 43 to 50 min, and the fastest speed increasing from 
14.6 to 15.8m-min7l. The decrease in time spent running towards the end of the study 
reflects the declining health status of the Min mice and an increased unwillingness to 
run. 
The lack of difference between the sexes with regards best speed was probably due to 
the best speed being run first. As running performance/inclination declined, so did the 
speed. For example, the speed ran by all the mice at the beginning of each session was 
the target speed of around 16m-min", but as the session continued and the mice 
struggled to keep up with the treadmill the speed was decreased accordingly. 
Therefore, a mouse that ran forjust 20 minutes will have run as fast as one that ran for 
the whole hour. For this reason, time and % days run are better indicators of 
performance (endurance), both of which were significantly better in females. 
3.2.6.2 Wheel-running 
The wheel running treatment was added to this study design in response to the mixed 
reaction to the treadmill in ES 1. The idea was that a voluntary running option may be 
more attractive than forced treadmill running. Female mice initially took to the wheels 
more readily than males, although the performance of the males increased when the 
wheels were changed to those with the larger diameter. This difference could have 
been due to the male mice being slightly larger than the females, and the larger wheel 
gave them more comfort. The larger wheel also revolved slightly more freely than the 
small wheel, which may also have been a factor. The halted response of the females to 
the larger wheels suggests that either they did not like change, or were experiencing 
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the "hotel effect' 'in their new cage (i. e. the excitement of being in a new 
environment, with new smells), and were simply exploring the new cage and ignoring 
the wheel. 
Whatever the reason, the distances ran in the wheels were generally far in excess of 
those run on the treadmill. The TR mice ran a maximum of 930m/day (and on most 
days ran less), corresponding to a 10-week maximum of 46.5km (ignoring the fact 
that the first two weeks were for training). This is in stark contrast to the average 
distance run in wheels after 10 weeks of 314km by female mice and 1471an by the 
males. 
The speed of running also far exceeded that on the treadmill (approximately 30- 
40m-min" v. 16m-min"), and the pattern of running was also different. Wheel running 
was characterized by frequent short bursts of fast running by many mice, an 
observation also reported by De Bono et al., (2006), although other mice would run 
steadily for longer periods. 
The average daily distances of 4.53km for females and 2.10km for male mice 
compare with those obtained by Colbert (2003) of 3.59krn and 3.071an run by the 
mice during three weeks of quarantine. Results from other groups (Koteja et al., 1999) 
have shown that female mice run further than males, a combination of both increased 
speed and time on the wheel (De Bono et al., 2006). 
Although there was a lack of difference in body mass gain between treatment groups, 
a negative correlation between body mass gain and increased running was observed. 
Other studies have not reported this type of analysis. 
From this perspective, the wheels achieved the objective of increased running. 
3.2.6.3 Crypt cell proliferation 
Intestinal neoplasia, is caused by uncontrolled crypt cell proliferation. Mitosis usually 
occurs in the bottom of the crypt, and cells migrate upwards towards the lumen. 
Mitotic cells in the upper part of the crypt may provide evidence of abnormal cell 
proliferation. Few mitotic cells were observed in this study, where vincristine was not 
used. Vincristine halts cells in mitosis so more cells would have been visibly mitotic 
than observed in this study, where only cells that were mitotic at death are stained. 
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The effect of exercise on CCP has not been examined previously. There was no 
increase or decrease in CCP with exercise detected by this study, with the exception 
of the upper third of the crypt, where WH mice had more mitotic cells, as analysed by 
non-parametric methods. The tissue that was examined for CCP came from the 
proximal intestine, and WH mice had slightly more proximal tumours than CON mice 
(6.7 v. 6.0), which may be connected to the increase in mitosis. 
TR mice had wider crypts than CON or WH though the significance of this is unclear. 
Male mice had more upper mitoses and tended to have more mitotic cells in total. 
These discoveries deserve further exploration. 
3.2.6.4 Mitochondrial mutation analysis 
The observation of only one COX-deficient cell in mucosa from the mice in this 
study, and the absence of deficient cells in older mice suggests than either the exercise 
was not sufficient to produce a response or that deficiencies do not occur in the 
intestinal tissue. Navarro et al. (2004), treadmill-exercised CD-1 mice from 28wk to 
78wk of age and measured the activity of various mitochondrial enzymes and found 
that whilst cytochrome oxidase activity decreased with aging this effect could be 
modulated by moderate exercise. Cytochrome oxidase activity was measured by 
isolating n-ýitochondrial membranes from homogenized samples of brain, heart, liver 
and kidney. This suggests that a different method and organ may have produced 
different results in this study, or that deficiencies in the electron transport chain are 
not responsible for tumourigenesis in Min mice. 
3.2.7 Conclusions 
The wheel-running paradigm proved to be successful and deserves further 
exploration. Although there was no significant effect of the exercise treatments on 
tumourigenesis, there was a suggestion of reduced proximal tumours, in TR mice, 
which may be uncovered if numbers of mice are increased. 
-144- 
Laura Basterfield Chapter 3 
3.3 Treadmill exercise study 3 (ES3) 
3.3.1 Introduction 
The results from the previous study (ES2) suggested that the voluntary aspect of 
wheel running was worth pursuing further. In addition, the effects of a treadmill 
exercise protocol may become clearer with greater numbers of mice undertaking the 
treadmill protocol. In essence, more mice were needed, with the aim being to achieve 
approximately equal numbers of animals in each exercise group. It is possible that the 
current protocols were confounded by the amount of activity undertaken by mice in 
their home cage, i. e. CON may make up for being confined for 60 minutes by 
increasing their activity levels in the cage, while TR may decrease the amount of 
activity they undertake in their cage after being forced to run for an hour. This non- 
exercise physical activity (NEPA) has not been measured in any previously published 
study and should be measured to understand how an exercise regime influences the 
total activity patterns of mice and to address any issues of possible confounding. 
3.3.2 Alms 
9 To increase the number of mice completing the treadmill protocol 
9 To examine NEPA in TR and CON mice 
e To further investigate the effects of the voluntary wheel-running protocol on 
tumourigenesis 
* To examine tissues for evidence of stress 
3.3.3 ES3 Specific methods 
78 Min mice, 41 females and 37 males were randomised to Treadmill, Wheel or 
Control groups. Conditions were as stated in General Methods and Materials (Chapter 
2). 
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3.3.3.1 Treadmill mice 
Chapter 3 
31 mice (14 female, 17 male) started the treadmill protocol. The length of the study 
was kept at 10 weeks, which included 2 weeks of initial training. The target speed was 
18-2 1 m-min-1, and to help achieve this, the duration of running each day was reduced 
to 30 minutes (3xlO minutes sessions with 3 minutes rest between bouts of running). 
Any mice that dropped out during the training period were placed in the wheel- 
running (WH) group if a wheel was available, or the control (CON) group if not. 
3.3.3.2 Wheel mice 
20 mice (13 female, 7 male) were randomised to WH, and singly housed with the 
smaller wheels (1 Ocm internal diameter) for the first 5 weeks and the larger wheels 
(13cm. internal diameter) for the second 5 weeks. 
3.3.3.3 Control mice 
27 mice (14 female, 13 male) were initially assigned to CON, with conditions as 
stated in General Methods and Materials. Time in the control lanes was reduced to 30 
minutes daily, in line with the altered treadmill protocol. 
3.3.3.4 Non-exercise physical activity (NEPA) 
Non-exercise physical activity (NEPA) by singly housed TR and CON mice was 
recorded as often as was possible using the Inframot device (see General Methods and 
Materials, 2.6). Some WH mice were also recorded although it was recognised from 
the outset that it would not be possible to distinguish wheel-running from other 
activities using this device. 
3.3.3.5 Necropsy 
After 10 weeks of study mice were killed as described in General Methods and 
Materials. The tissues collected were: small intestine, caecum and contents, colon and 
contents, liver, adrenal glands, heart (weight only), thymus gland (weight only), brain 
and blood. 
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3.3.3.6 Storage of new tissue 
The brain was used for in situ hybridisation of anti-diuretic ho ' rmone 
(ADH) mRNA 
in the hypothalamic paraventricular nucleus (work performed by Dr J. M. H. M Reul, 
Bristol University). The brain was removed within 2 minutes of death in a manner 
that protected the hypothalamic area as follows. The head was cut from the body and 
the ears and any excess skin and fur removed. An incision was made through the eye 
socket and cut through to the other socket. The skull was carefully cut from the base 
along the midline to the incision between the eyes to split the skull in two. A small cut 
was made from the base of the skull to each auditory opening and the skull peeled 
away from the brain using fine forceps. The brain was then gently loosened from the 
front of the skull and optic nerves and dropped into a freezing bath of iso-pentane in 
dry ice. When frozen, the brain was wrapped in foil, weighed and buried in dry ice 
until storage at -80'C. The adrenal glands were placed into separate eppendorfs and 
weighed. They were placed on ice until storage at -20'C. 
3.3.4 ES3 Results 
75 mice finished the study and provided data that were suitable for statistical analysis. 
These mice were distributed between exercise groups as shown in Table 3.55. 
Table 3.55 Distribution of mice completing the study 
Exercise protocol Male Female Total 
Treadmill 10 13 23 
Wheel 12 12 24 
Control 13 15 28 
Total 35 40 75 
2 mice were killed before the end of the study, a female WH with 3 polypoid tumours 
in the colon and many small turnours throughout the small intestine, and a male WH 
with hydrocephaly. One male treadmill mouse finished the study but was excluded 
from analyses as he lost a large amount of weight in the last 2 weeks of the study but 
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appeared to have only one small tumour, suggesting that he had other health 
complications which were not identified. The data from these three mice were not 
included in the statistical analyses. 
3.3.4.1 Body weight 
The exercise protocol did not have a significant effect on body weights at any week, 
although the difference at week 7 approached statistical significance (P = 0.052 for 
TR, the lightest group at 22.76 v. 23.18 (WH) v. 24.07g (CON), Figure 3.39). Weight 
gain between exercise groups was significantly different at weeks 2,7 and 8 of study 
(Table 3.56). At week 2, TR and WH gained significantly less weight compared with 
CON mice (P = 0.038 and 0.024 respectively). At week 7, WH mice gained 
significantly less weight than CON (P= 0.006), and at week 8, TR and WH gained 
more weight than CON mice (P = 0.0 19 for TR and 0.025 for WH). There was no 
significant effect of exercise on total weight gain (P = 0.544 for TR v. CON, 7.2g v. 
8.1g, and p=0.439 for WH v. CON, 7. lg v. 8.1g). 
Males were again significantly heavier than females at every stage of the study 
including death (p <0.001, Figure 3.40). When comparing weekly weight gain, males 
gained significantly more on weeks 2-6 and females gained significantly more on 
week 10 (Table 3.57). There was no significant difference in total weight gain of 
males and females over the length of the study, with means of 6.9g for females and 
8.2g for male mice (P = 0.104). 
An interaction between sex and protocol occurred for weight gain on week 7 of the 
study, (P = 0.009, Figure 3.42). No interaction occurred between sex and exercise on 
total wcight gain (P = 0.294, Figurc 3.43). 
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Figure 3.39 Mean weekly body weights, by treatment group 
28.0 
- 26.0 CD I 
Z' 24.0 - 
22.0 
20.0 
M 18.0 - --, . 
11 
1: 1 
Ar 
Feý 16.0 - -ale 
14.0 
123456789 10 
Week of study 
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Figure 3.41 Mean weekly weight gain of mice by sex and exercise protocol 
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Figure 3.42 Interaction between sex and exercise on weight gain at week 7 
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Figure 3.43 Weight gain of mice by sex and treatment group (% increase from 
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3.3.4.2 Treadmill running 
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The treadmill protocol was altered from the previous studies to aid compliance and to 
reduce the likelihood of mice dropping out of the study. The duration was reduced by 
half to 30 minutes, though the target speed of 18-21m-min-I and the 5% gradient 
remained the same. The altered running protocol seems to have suited the mice. Many 
more mice kept up with the regime with a marked improvement especially for the 
males compared with previous studies. The males who dropped out early were added 
to the Wheel group (n = 6), the female who dropped out became a Control mouse as a 
wheel was not available. Most mice ran every day and also achieved the target speeds 
and times (displayed in Figure 3.44 and Table 3.58). There were no significant 
(P>0.05) differences in perfonnance between the sexes and the drop-off in 
performance demonstrated in the previous study (ES2) was not observed. 
Table 3.58 Treadmill-running data for females and males 
Mean daily time spent Mean best speed (m-min- Sex 
running (minutes) 1) % of days run 
Target 
30 18-21 100 
Female 
28.4 20.5 98 
Male 28.6 20.6 96.9 
Mean 28.5 20.5 97.5 
30 0 25 0 . 
25.0 
. 
20.0 
20 0 r c . 15.0 E E 
15.0 E 
4) E 10.0 
10.0 
Time co 
5.0 1 50 -0-Bestspeed ,, 
0.0 
11111 
0.0 Sex Females Males 
Figure 3.44 Daily average running time and best running speed by individual mice 
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3.3.4.3 Wheel running 
The wheel protocol was the same as the previous study, with a smaller wheel being 
used for the first five weeks and a larger wheel for the final five weeks. Switching 
mice that would not run on the treadmill to wheels worked well, with the 6 males who 
were moved using their wheels and running between 33km and 3321an over the 
remainder of the study. 
Females ran further at all stages of the study, and the difference in distance after 10 
week of study approached significance (231.8 v. 129.9km, P=0.060, Figure 3.45). 
On a weekly basis, the difference in running distance was statistically significant only 
at week 8 (P = 0.046, Figure 3.46 and Table 3.59). A large inter-animal variation in 
distances run by the mice was observed, displayed in Figure 3.48. 
The maximum daily distance run was highly significantly different between the sexes, 
with females having a greater average maximum compared with males (9.78 v. 
5.15km, P=0.009). The maximum daily distance run by an individual mouse was 
18.35km for a female, whilst the corresponding maximum distance by a male mouse 
was 11.76km. 
Table 3.59 Mean weekly distances run In wheels by each sex (km) 
Week of study 
Sex 123456789 10 
Female 0.722 1.617 2.192 2.328 2.034 5.048 5.703 5.500 4.515 3.868 
Male 0.424 1.099 1.253 1.273 1.128 2.787 3.013 2.635 2.546 2.463 
SEM 0.243 0.445 0.425 0.436 0.429 0.998 1.063 0.956 0.949 0.915 
p 0.395 0.420 0.133 0.101 0.149 0.123 0.087 0.046 0.156 0.289 
n= 12 for both sexes 
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Figure 3.46 Mean daily running distance for each week of the study by male and female mice 
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Figure 3.47 Total distances run in each type of wheel by male and female mice 
As in the previous study, mice ran further in the larger wheels than the smaller wheels 
49.05 v. 131.75 km average (P = 0.001, Figure 3.48). The total distance run in each 
size of wheel is displayed in Figure 3.47, although there was no significant difference 
in distance run between males and females in either type of wheel. In the small wheels 
300 
Female I 
-11--Male 
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(weeks 1-5), female mice ran on average a total of 62.3km, compared with 35.9km by 
males (P = 0.144). In the larger wheels (weeks 6-10) females ran on average a total of' 
169.5krn compared with 94.0krn by the male mice (P= 0.092). 
400 
350 
300 
250 
r 
.9 200 A 
1 
«a 
150 
100 
50 
0 
Sex 
Figure 3.48 Total distances run by individual female and male mice in both small and larger 
wheels 
There was no significant (P>0.05) correlation between distance run on any weck and 
the body weight or weight gain during that week, or between total distance run and 
final body mass or total weight gain. 
3.3.4.4 Food intake 
Food intake was measured daily and also calculated on a per I 00gram body weight 
basis. Measurement of food intake was not always possible for all mice because of the 
problems of food scattering, where mice would chew the food into small balls and 
spread it through the sawdust 
- 155 - 
Laura Basterfield Chapter 3 
There was a significant effect of exercise protocol on food intake during weeks 3,5,7 
and 9, with WH eating more than CON on all weeks and TR eating more than CON 
during weeks 3 and 7. Figure 3.49 shows absolute food intake (g/d), whilst Table 3.60 
shows relative food intake (g/ I OOg body mass) for each exercise group. Overall, CON 
mice ate less than the other groups. WH mice ate significantly more than CON during 
weeks 3,5,7 and 9, whilst TR mice ate significantly more than CON during weeks 3 
and 7. Data are displayed in Table 3.60. 
Figure 3.49 Food intake(g/d) by treatment group 
- 156- 
u 1.0 C) C) V) o rn (D rn --4 rn CD rn CD v) CD r- (D r- -4 a-, > vý (=) v <D 0 CD (Z CD (D 
0 (Ci cý cý c; cý cý cý cý v v 
cc 
Z 
r- 
oo 
0 
v C) 
ýe 
.' 
e 
"0 
oo 
V 
rq 
q 
c7, 
1 
e 
i C> - ) 0 r 0 CN 
> C, 9 vý rn -4 
C) 
CD 00 0 0 c> C) c> 0 CD Z; c; c; cý 
r- 'gt 00 r- rl t- VI 
vi r- (1q kA Xt N kn 00 t- 
w ri vý ei v-, rn e (N rq ci c9 
CD CD c> c; c5 c; cý (:: 5 c; cý 
Mw 
Z 
W 
4. d ýe, 3 ý:: ý 
vi "0 m cý 
0. 0 i 
0 M 0 m N r- cý 00 
k. u 0 
r".. 
q -d cý cý cý, oJ OJ od rz rz 
>ý :ý N 00 00 o M N M 10 V) 00 rn ýt r- 0, % 0 
2 w M le rn le en le (N N clý m 
49 In c; c; c; cý c; cý cý c5 cý cý 
oj (: r- \c c\ 0 ý cý w 
40. rý -ý -ý c; cý 
e v) Z 
cý 
r- 
Cd 
00 ell tý (D 't CN 
CD IM tn 1,0 C> V) 0 e 0 oo cý 
ri vý r! v-i cn -e (N rA C-1 ci 
c> CD c> cý c; cý c; cý c; cý 
b 
E 
0 rn m fn t- -0 "t m M rn 
00 IZ 
l 
vl, cý C> 
. .A m ri ; ý ; 
C> r- V b cý t- t- 
t - - cc cý 0; cý c2 C. J cJ 
9 
iz cu 9--ý rq m " in ýc t, = c> CD 
N 
Laura Basterfield 
2.4- 
2.3- 
2.2- 
2.1 - 
2- 
1.7 - Rble 
1.6- 
... 13.. Female 
1.5 
123456789 10 
Week of study 
Figure 3.50 Mean daily food intake (g/d) for male and female mice 
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Table 3.61 Mean daily food intake (g/100g) for each week of study for male and female mice 
Probability 
Week Female SEM Male SEM Sex Sex*Exercise 
1 13.60 0.280 12.98 0.284 0.125 0.002 
2 11.60 0.417 11.40 0.439 0.771 0.014 
3 11.12 0.359 10.66 0.346 0.066 0.006 
4 10.77 0.418 9.80 0.412 0.102 0.178 
5 10.37 0.303 9.35 0.308 0.025 0.205 
6 10.19 0.395 8.45 0.366 0.003 0.078 
7 10.25 0.224 8.11 0.237 <0.001 0.005 
8 10.17 0.213 8.73 0.225 <0.001 0.001 
9 9.72 0.245 7.44 0.248 <0.001 0.050 
10 9.56 0.235 7.08 0.252 <0.001 0.118 
In terms of absolute intake (g food/d), male mice ate more than females during weeks 
1-5 (P<0.003). Female mice ate significantly more during week 10 only (P = 0.0 11, 
Figure 3.50). Male mice consumed less food in the second half of the study compared 
with the first half. 
When food intake was analysed on a g/lOOg body weight basis, female mice ate more 
food compared with males during weeks 5-10 (P from 0.025 to <0.001, Table 3.61). 
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Figure 3.5 1a and Figure 3.5 1b display food intake (g/d) and intake per I OOg body 
mass by sex and treatment groups. 
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Figure 3.51 a) Comparing food intake by sex and protocol, b) food intake per 100g of body mass, 
by sex and treatment group 
- 159- 
3456789 10 
Week of study 
Laura Basterfield 
Week 1 #Treadmill 
s Meel 
A Co ntrol 15 
14 
co 
(D 13 
x 12 
11 
0 o 10 U- 
Female Male 
Week 2 
14 
CD C), 13 Z: N 
2 12 
I 
. 2c 
li 
.S 10 -0 0 9 0 U. 8 
Female Nble 
Week 3 
13 
12 
11 
lo 
9 
S8 
M7 0 06 
LL 
Female Nble 
Figure 3.51 Interaction between sex and exercise on food intake in weeks 1-3 
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Figure 3.51 shows the interaction between sex and exercise on food intake during 
weeks 1-3. Female WH mice ate more food than all other groups during week I and 3, 
and more than the other female groups during week 2. During weeks I and 2 female 
WH and CON mice ate more than male WH and CON but female TR ate less than 
male TR mice (P = 0.002 and 0.014 for weeks I and 2, respectively). During week 3, 
female WH and TR ate more than male WH and TR mice, but male CON ate more 
food than female CON mice (P = 0.006). 
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Figure 3.52 Interaction between sex and exercise on food intake in weeks 7-9 
Figure 3.52 displays the interaction between sex and treatment group for food intake 
(g/I OOg body mass) in weeks 7,8 and 9. As in weeks 1-3, female WH mice ate more 
food per I OOg body mass than any other group. Male mice ate less food than female 
mice during all three weeks, in the order (greatest first): TR > WH > CON. The 
difference in the amount of food eaten was greater between male and female WH and 
CON mice than between male and female TR mice. During week 7 the difference 
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mice. During week 7 the difference between sexes for TR mice was 1.15g compared 
with differences of 3.32g for " and 1.96g for CON mice (P = 0.005). During week 
8 the differences between the sexes were 0.71 g for TR mice, 3.29g for WH and 2.97g 
for CON mice (P = 0.001). The differences during week 9 were 1.1 Ig for TR mice, 
2.57g for WH mice and 2.98g for CON mice (P = 0.050). 
3.3.4.5 Tumours 
The 75 mice produced 1 352 turnours (Figure 3.54), with the majority in the small 
intestine (96%). These turnours were present in approximately equal numbers in the 
proximal and distal sections of the SI. 
4% 
13 Proximal S1 
13 Distal Sl 
0 Colon 
539Y 43% 
Figure 3.54 Anatomical distribution of tumours in ES3 
Tumour data for treatment groups are displayed in Table 3.62. In general, WH mice 
suffered more and bigger turnours than either TR or CON, although none of these 
differences were statistically significant. Numbers of small intestinal tumours were 
similar in all treatment groups. There were fewer colon turnours in TR mice compared 
with CON mice, and this difference approached significance (median values 0.0 v. 
1.0, P=0.061). In contrast, TR mice had significantly more 4mm diameter tumours 
than CON mice, with median values of 1.0 compared with 0.0 (P = 0.042). 
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Table 3.62 Mean tumour data by exercise protocol 
Tumour 
variable 
Treadmill 
(n = 23) 
Wheel 
(n = 24) 
Control 
(n = 28) 
Probability of effect 
TR v. CON WH v. CON 
Proximal SI 6.8 7.9 6.2 0.763 0.190 
natLog 
5.46-8.42 6.35-9.80 5.08-7.52 
Distal SI natLog 5.9 8.8 7.9 0.280 0.808 
4.38-7.95 6.62-11.70 6.02-10.30 
Total SjLogI0 12.8 16.9 14.5 0.648 0.535 
10.16-16.12 13.48-21.19 11.78-17.90 
Colon KW 0.0 0.5 1.0 0.061 0.589 
0.0-3.0 0.0-5.0 0.0-4.0 
Total number 13.1 17.6 15.4 0.505 0.607 
LogI0 
10.32-16.53 13.99-22.19 12.43-19.04 
Tumour 31.6 38.6 35.3 0.692 0.787 
burden (mm 25.38-39.41 31.0747.82 28.94-43.11 
diameter) Log10 
1 MmKW 1.0 2.5 1.0 0.771 0.141 
0.0-32.0 0.0-31.0 0.0-17.0 
2mmýw 7.0 7.0 8.0 0.177 0.811 
1.0-16.0 3.0-30.0 1.0-22.0 
3mmýw 3.0 3.0 3.5 0.298 0.504 
0.0-9.0 0.0-9.0 0.0-20.0 
4mmKw 1.0 1.0 0.0 0.042 0.445 
0.0-13.0 0.0-4.0 0.0-4.0 
No sex differences were observed in this study (Table 3.63), where numbers of mice 
were more closely matched than before, and all tumour variables produced similar 
values for both sexes. In addition, there were no significant sex*exercise interactions. 
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Table 3.63 Mean tumour data for male and female mice 
Tumour variable Female 
(n = 40) 
Male 
(n = 35) 
Probability of 
effect 
Proximal S, natLog 7.2 6.5 0.440 
6.07-8.44 5.45-7.80 
Distal SI natLog 7.0 8.0 0.471 
5.59-8.84 6.32-10.19 
Total SjLog1O 14.5 14.6 0.908 
12.15-17.28 12.31-17.94 
Colon KW 0.0 1.0 0.246 
0.0-5.0 0.0-4.0 
Total number 
LogIO 15.0 15.6 0.851 
12.53-17.94 12.87-18.90 
Tumour burden 33.7 36.8 0.516 
(mm diameter) LogIO 28.49-39.74 30.82-43.98 
jMmKW 2.0 1.0 0.623 
0.0-32.0 0.0-17.0 
2mmýw 7.0 8.0 0.315 
1.0-30.0 1.0-22.0 
3mmKw 3.0 4.0 0.577 
0.0-9.0 0.0-20.0 
4mmKw 1.0 1.0 0.739 
0.0-13.0 0.0-4.0 
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Figure 3.55 shows the distribution Of tUMOUr sizes in this study, which was positively 
skewed, with most turnours having a diameter of between I and 3mm. The largest 
turnours were 7mm diameter. 
3.3.4.6 Relationship between fathers and number of turnours in their 
offspring 
The great variation in tuniour number between mice prompted an assessment of the 
relationship fathers played in the number of turnours produced by their offspring. 
Table 3.64 shows some of the tumour data from Table 3.62 categorised according to 
father. Some mice sired more offspring than others, some produced more Mins than 
wild types, and some were used only once, if they were old or the number of mice 
required for the study had been reached. As a consequence, the number of mice in the 
study sired by each father ranged from I to 19. Table 3.64 shows that the fathers had a 
significant effect on both the tumour number and tumour burden of their offspring (P 
= 0.046 and 0.0 12 respectively), with the worst affected mice having 3.5 times the 
tumour burden of the least affected mice. 
A highly significant positive correlation was observed between tumour burden and 
tumour multiplicity (r = 0.95, P <0.001, Figure 3.56). 
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Table 3.64Tumour data (mean and 95% CI)according to father 
Father code Number of Tumour burden (mm Total number of turnours 
offspring in diameter) of offspring'-09'0 of offspring 1-0' 10 
study 
1 
-1 
70.0 27.7 
40.07-122.22 15.15-50.59 
2 11 28.8 12.7 
21.51-38.67 9.22-17.39 
3 9 49.5 21.2 
35.92-68.33 14.95-29.96 
4 19 42.9 18.7 
34.12-53.83 14.62-23.94 
5 1 39.8 15.6 
15.09-105.04 5.47-44.53 
6 12 26.9 11.9 
20.37-35.56 8.82-16.11 
7 7 31.5 14.5 
21.86-45.33 9.75-21.44 
8 2 20.8 7.91 
10.5141.23 3.79-16.54 
9 12 30.4 13.9 
23.0240.18 10.27-18.75 
Probability - 0.012 0.046 
80 13Tumour multiplicity 
70 STumoL; r buiden 
60 
U 50 
a 
4) 
= 40 
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Figure 3.56 Relationship between total number of tumours and tumour burden in study mice, by 
father 
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3.3.4.7 Organs 
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Table 3.65 shows data for the intestinal organs of mice by exercise treatment group.. 
TR mice had colons that were significantly shorter than those of CON mice (4 v. 5cm, 
P=0.0 10). No other weights were significantly different between the treatment 
groups. 
Table 3.65 Intestinal organ measurements of each treatment group (mean and SEM) 
Organ 
dimension 
Treadmill 
(n = 23) 
Wheel 
(n = 24) 
Control 
(n = 28) 
Probability of effect 
TR v. WH v. 
CON CON 
Slaughter 23.0 23.5 24.0 
weight (g) 0.71 0.70 0.65 0.488 0.810 
Length (cm) 
S1 29.0 27.6 27.5 0.101 0.983 
0.550 0.538 0.498 
Colon KW 4.0 4.5 5.0 0.010 0.106 
3.5-6.0 3.5-5.0 3.5-6.0 
Weight (g) 
Full SI 1.024 1.005 0.974 0.239 0.540 
0.025 0.024 0.022 
Proximal SI 0.626 0.627 0.607 0.600 0.574 
0.017 0.016 0.015 
Distal SI 0.348 0.364 0.376 0.280 0.764 
0.015 0.014 0.013 
Full Caecum 0.250 0.247 0.233 0.453 0.581 
0.012 0.012 0.011 
Caecal tissue 0.098 0.095 0.104 0.559 0.245 
0.004 0.004 0.004 
Caecal contents 0.152 0.152 0.129 0.146 0.146 
0.010 0.009 0.009 
Full colon 0.233 0.229 0.227 0.899 0.982 
0.011 0.011 0.011 
Colonic tissue 0.160 0.169 0.159 0.985 0.358 
0.006 0.006 0.006 
Colon contents 0.072 0.060 0.068 0.888 0.715 
0.009 0.008 0.008 
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When the weights of these organs are expressed as % final body mass, there were no 
statistically significant differences (Table 3.66). 
Table 3.66 Intestinal organs of exercise groups as % final body mass (mean and SEM) 
Organ (% 
final body 
mass) 
Treadmill 
(n = 23) 
Wheel 
(n = 24) 
Control 
(n = 28) 
Probability of effect 
TR v. CON WH v. CON 
Proximal SI 2.77 2.76 2.56 0.237 0.263 
0.105 0.100 0.093 
Distal SI 1.52 1.59 1.59 0.655 0.996 
0.067 0.064 0.059 
Caecum! '09'0 0.42 0.40 0.43 0.936 0.453 
0.388-0.456 0.372-0.436 0.398-0.461 
Colon KW 0.70 0.69 0.65 0.325 0.180 
0.461-1.190 0.501-1.320 0.500-0.961 
The weights of other organs taken at nccropsy are displayed in Table 3.67. WH mice 
had hearts 10% heavier than those of CON mice (0.229 v. 0.204g, P=0.02 1). The 
weights of thymus and adrenal glands were very similar between groups, although lcft 
adrenals were consistently heavier than right (P = 0.027). 
When the weights of these non-intestinal organs were expressed as % final body mass 
(Table 3.68), the weight of hearts in WH mice remained significantly heavier than 
those of CON mice (1.0% v. 0.9%, P=0.033), and the difference in the weight of the 
liver between these two treatment groups also became significant, at 4.5% for WH 
mice and 4.2% for CON mice (P = 0.004). Weights of hearts and livers of TR mice 
were between those of WH and CON groups. There were no significant differences 
between exercise groups for any of the other organs. 
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Table 3.67 Non-intestinal organ measurements of each treatment group (mean and SEM) 
Probability of effect 
Organ weight 
Treadmill Wheel Control 
(9) (n = 23) (n = 24) (n = 28) TR v. CON WH v. CON 
Liver 0.987 1.049 1.004 0.861 0.388 
0.028 0.027 0.025 
Heart 0.219 0.229 0.204 0.219 0.021 
0.007 0.007 0.006 
BralnKw 0.478 0.473 0.472 0.072 0.594 
0.439-0.520 0.446-0.591 0.447-0.513 
Thymus 0.061 0.059 0.061 1.000 0.922 
0.003 0.003 0.003 
Left adrenal 0.0074 0.0072 0.0069 0.789 0.955 
gland 0.00058 0.00057 0.00053 
Right adrenal 0.0060 0.0052 0.0058 0.944 0.578 
gland 
LoglO 
0.0050-0.0072 0.0043-0.0062 0.0049-0.0068 
Haematocrit 26.2 26.8 24.1 0.663 0.498 
(%) 2.00 1.92 1.77 
Table 3.68 Nonwintestinal organs as % final body mass of exercise groups (mean and SEM) 
Organ 
Treadmill 
(n = 23) 
Wheel 
(n = 24) 
Control 
(n = 28) 
Probability of effect 
TR v. CON WH v. CON 
Liver 4.31 4.49 4.20 0.367 0.004 
0.066 0.06 0.06 
Heart 0.96 1.008 0.863 0.190 0.033 
0.045 0.044 0.040 
Brain 2.13 2.10 2.01 0.223 0.419 
0.059 0.057 0.053 
Thymus 0.26 0.25 0.26 0.994 0.777 
0.014 0.013 0.012 
Left adrenal 0.032 0.031 0.028 0.314 0.642 
0.002 0.002 0.002 
Ri ht adrenal 
Lo 
iO 1' 0.026 0.022 0.024 0.669 0.612 
g 
0.023-0.030 0.019-0.026 0.021-0.028 
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Male mice tended to have longer and heavier intestinal organs than females (Table 
3.69). The weight of the full caecum and caecal contents were heavier in males (P = 
0.019 and 0.001 respectively) and also the full colon, colon contents and colon tissue 
(P = 0.004,0.023 and 0.030 respectively). 
Table 3.69 Intestinal organ measurements of males and female mice (mean and SEM) 
Organ Female Male 
dimension (n = 40) (n = 35) Probability 
Slaughter 21.7 25.8 
weight (g) 0.54 0.58 <0.001 
Length (cm) 
sl 27.6 28.5 0.130 
0.424 0.453 
CojonKW 4.5 4.5 0.148 
3.5-6.0 4.0-6.0 
Weight (g) 
Full SI 0.989 1.011 0.407 
0.019 0.020 
Proximal SI 0.621 0.616 0.768 
0.013 0.013 
Distal SI 0.367 0.360 0.618 
0.011 0.012 
Full Caecurn 0.228 0.260 0.019 
0.009 0.010 
Caecal tissue 0.102 0.096 0.278 
0.003 0.003 
Caecal 0.126 0.164 0.001 
contents 0.007 0.008 
Full colon 0.212 0.249 0.004 
0.009 0.009 
Colonic tissue 0.155 0.171 0.030 
0.005 0.005 
Colon 0.056 0.078 0.023 
contents 0.007 0.007 
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When the intestinal organs were expressed as % final body mass, the direction of 
significance was reversed (Table 3.70). Female mice had heavier proximal and distal 
SI, heavier caecal tissue and heavier colonic tissue compared with males. These 
differences were highly significant for proximal SI, distal SI and caecum (all 
P<0.001). The difference in weight of colon tissue approached significance (P 
0.069). 
Table 3.70 Male and female intestinal organs as % final body mass 
Organ 
Female 
(n = 40) 
Male 
(n = 35) Probability 
Proximal SI 2.91 2.44 <0.001 
0.079 0.084 
Distal SIKw 1.70 1.42 <0.001 
0.050 0.053 
CaecuM LogIO 0.46 0.372 <0.001 
0.435-0.492 0.348-0.397 
Colon 0.70 0.63 0.069 
0.502-1.320 0.461-1.224 
The weights of liver and heart were significantly heavier in males compared with 
females (Table 3.7 1), although females had a slightly heavier brain and a significantly 
heavier thymus gland. 
When these data were expressed as % final body weight, female mice had 
significantly heavier liver, brain, thymus and left adrenal gland (Table 3.72). 
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Table 3.71 Non-intestinal organ weights of male and female mice 
Chapter 3 
Organ weight 
Female Male 
(g) (n = 40) (n = 35) Probability 
Liver 0.949 1.087 <0.001 
0.006 0.022 
Heart 0.196 0.240 <0.001 
0.006 0.006 
BrainKw 0.477 0.472 0.301 
0.439-0.520 0.447-0.591 
Thymus 0.067 0.053 <0.001 
0.002 0.003 
Left adrenal 0.0073 0.0069 0.520 
0.00044 0.00047 
Right 0.0055 0.0057 0.716 
adrenalý'9" 0.0048-0.0064 0.0049-0.0066 
Haematocrit 28.3 22.5 0.009 
(%) 1.49 1.58 
Table 3.72 Non-intestinal organs as % final body mass 
Female Male 
Organ (n = 40) (n = 35) Probability 
Liver 4.40 4.25 0.034 
0.053 0.056 
Heart 0.92 0.96 0.497 
0.035 0.037 
Brain 2.24 1.89 <0.001 
0.045 0.047 
Thymus 0.30 0.21 <0.001 
0.010 0.011 
Left adrenal 0.034 0.026 0.001 
0.001 0.002 
Right 0.03 0.02 0.122 
adrenalL, gIO 0.023-0.029 0.020-0.025 
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3.3.4.8 SCFA 
Chapter 3 
The concentrations of SCFA present in the colon contents of mice of each exercise 
group are shown in Table 3.73. The concentration of acetate was significantly greater 
in CON samples compared with both TR and WH mice samples(P = 0.021 and 0.009, 
respectively), but concentrations of other SCFA were similar between the groups and 
not statistically (P>0.05) different. However, the total concentration of colonic SCFA 
was greater in CON samples compared with both TR (P = 0.044) and WH (P = 0.034) 
mice samples. 
Table 3.73 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by exercise protocol 
Individual 
SCFA (pmol-g 
colon 
contents)* 
TR 
(n = 17) 
VVII 
(n = 19) 
CON 
(n = 22) 
Probability of effects 
TRvCON WHvCON 
Acetate 17.70 17.18 25.06 0.021 0.009 
14.59-21.48 14.30-20.63 21.15-29.70 
Propionate 2.66 2.90 2.83 0.853 0.970 
2.21-3.21 2.43-3.47 2.40-3.34 
Isobutyrate 0.33 0.34 0.36 0.747 0.852 
0.26-0.41 0.27-0.42 0.30-0.44 
Butyrate 0.84 0.87 0.77 0.918 0.851 
0.57-1.24 0.60-1.25 0.54-1.08 
Isovalerate 0.60 0.57 0.53 0.496 0.714 
0.50-0.71 0.49-0.67 0.46-0.61 
Valerate 0.35 0.42 0.42 0.658 0.999 
0.26-0.48 0.31-0.56 0.32-0.55 
Total 22.91 22.80 30.27 0.044 0.034 
concentration 20.93-27.34 20.94-26.96 27.97-35.35 
*all LoglO transformed, data shown are mean and 95% CI 
When expressed as molar proportions, there were several differences in SCFA 
between the exercise groups (Table 3.74). Acetate proportion was again greater in 
CON compared with TR and WH mice (829 v. 777 and 759 mmol/mol respectively). 
For all other SCFA proportion, the inverse association was observed, with CON mice 
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having a smaller proportion of these SCFA than both TR and WH mice, significantly 
(P<0.05) so for propionate, isobutyrate and isovalerate (Table 3.74). 
Table 3.74 Molar proportions (mmol/mol total SCFA) of colonic SCFA by exercise group, mean 
and SEAV95% Cl 
Molar 
proportion TR WH CON 
Probability of effects 
TR v CON WH v CON 
Acetate 777 759 829 0.034 0.002 
15.8 15.0 13.9 
Propionate'09" 116 127 93 0.059 0.004 
100.5-134.8 110.8-146.3 82.1-106.1 
Isobutyrate KW 15 15 9 0.004 <0.001 
6.5-36.2 5.9-33.3 0.0-17.8 
Butyrate KW 43 46 37 0213 0.158 
14.1-87.6 11.6-83.7 0.0-84.7 
Isovalerate 26 26 18 0.0006 0.001 
LoglO 
22.7-30.8 22.1-29.5 15.5-20.2 
Valerate 16 16 12 0.334 0.231 
2.3 2.2 2.0 
Data shown are: acetate and valerate - mean and SEM, proplonate and isovalerate - mean and 
95% CI, isobutyrate and butyrate - median and range 
Table 3.75 shows the concentrations of colonic SCFA in samples from male and 
female mice, which were significantly different for acetate (P = 0.0 18) and butyrate (P 
= 0.049). Male samples had a greater concentration of acetate (23.01 v. 17.54 [Lmol-g 
colon contents) but a lower concentration of butyrate (0.62 compared with 1.06 
Itmol-g colon contents). When expressed as molar proportions, sample from male 
mice again had more acetate and females a greater proportion of butyrate (Table 
3.76). In addition, samples from female mice had a significantly greater proportion of 
isovalerate than did males (25 v. 20, P=0.041). 
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Table 3.75 SCFA concentrations (mean and 95% CI) (pmol-g colon contents) by sex 
Chapter 3 
Individual SCFA 
(pmol-g colon 
contents)* 
Female 
(n = 30) 
Male 
(n = 28) 
Probability 
Acetate 17.54 23.01 0.018 
15.00-20.51 19.57-27.06 
Propionate 2.73 2.88 0.573 
2.38-3.14 2.50-3.33 
Isobutyrate 0.35 0.33 0.642 
0.30-0.41 0.28-0.40 
Butyrate 1.06 0.62 0.049 
0.79-1.41 0.46-0.84 
Isovalerate 0.56 0.57 0.775 
0.49-0.63 0.50-0.65 
Valerate 0.46 0.34 0.126 
0.36-0.57 0.27-0.44 
Total concentration 23.01 28.31 0.046 
21.43-26.46 26.30-32.72 
*all LoglO transformed, data shown are mean and 95% CI 
Table 3.76 Molar proportions (mmol/mol total SCFA) of colonic SCFA by sex 
Molar proportion Female Male Probability 
Acetate 767 816 0.011 
13.0 13.5 
Propionate'09" 119 102 0.088 
105.5-133.8 90.1-115.2 
Isobutyrate Kw 14 12 0.367 
0.0-36.2 5.9-21.1 
ButyrateKw 59 27 0.012 
0.0-87.6 2.8-83.7 
Isovalerate uglo 25 20 0.041 
21.5-28.0 17.8-23.3 
Valerate 17 12 0.118 
1.75 1.81 
Data shown are: acetate and valerate - mean and SEM, propionate and Isovalerate - mean and 
95% Cl, isobutyrate and butyrate - median and range 
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Figure 3.57 Interaction between sex and exercise on propionate molar proportion (mmol/mol 
total SCFA) 
There was an interaction between sex and exercise protocol for the proportion of 
propionatc only (P = 0.028), with samples from female YV'H and CON mice having a 
greater proportion of propionate than their male counterparts, whilst female TR mice 
had a smaller proportion than male TR (Figure 3.57). 
3.3.4.9 Transit time (TT) 
There was no significant difference in caecal transit time between exercise groups, 
with the median values at around 3.5 hours (Table 3.77). = 
Table 3.77 Caecal transit time of treatment groups (h) 
Group (n) Median transit Range P (v. CON) 
time KW 
Treadmill (22) 3.17 0.79-10.84 0.533 
Wheel (24) 3.89 0.50-23.40 0.584 
Control (27) 3.48 0.39-13.67 - 
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Despite considerable inter-animal variation in caecal transit time for both sexes, on 
average, males had TT which was significantly slower than that of female mice (P = 
0.004, Table 3.78). 
Table 3.78 Caecal transit time of male and female mice (h) 
Group (n) Median transit Range Probability 
time KW 
Female (39) 3.18 0.39-23.40 
0.004 
Male (34) 4.07 1.25-20.14 
3.3.4.10 Non-exercise physical activity (NEPA) 
Activity of singly-housed mice was monitored continuously using the InfraMot device 
for 23h periods. For CON and TR mice, the other hour in the 24h period was spent in 
the imposed exercise regime and associated activities. The numbers of animals 
studied and the total number of recordings for each exercise group are summarised in 
Table 3.79, and varied between one and 23 recordings per animal. Inter- and intra- 
animal variation over the recording period was great, as shown by Figure 3.58. 
Table 3.79 Summary of NEPA recordings for each exercise group 
Exercise group Number of animals studied Total number of recordings 
(female, male) 
CON 6(3,3) 77 
TR 
WH 
9(2,7) 85 
12(8,4) 54 
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Figure 3.58 Inter- and Intra-animal variation in cage activity 
Chapter 3 
The NEPA variables analysed were total activity in 23 hours ("total 23h activity"); 
time spent sleeping (classed as zero activity); activity in the dark period (I 2h) and 
activity in the light (I I h). 
Analysis of activity - Treadmill v. Control mice 
The difference in total activity in 23h was highly significant (P = 0.001) between the 
treatment groups, with TR mice recording 32% more activity during the recording 
period than CON mice (Table 3.80). The bulk of this activity appears to have been 
during the dark phase, where TR mice were 40% more active (P <0.001) than CON 
mice. There was no difference in activity during the light phase (P = 0.687) or in time 
spent sleeping (P = 0.327, Table 3.80). 
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Table 3.80 Activity measurements (arbitrary units X103 ) by treatment group (mean and 95% CI) 
Activity variable Treadmill Control Probability 
Total 23h 984 671 0.001 
activityL0910 849-1 141 575-785 
Light phase 
LoglO 140 151 0.687 
110-180 117-195 
Dark phase 
LogIO 752 454 <0.001 
646-874 388-532 
Sleep (min) 649.0 672.3 0.327 
616.9 - 681.1 639.7 - 704.9 
For all aspects of the activity recording, female mice were more active than males 
(Table 3.8 1). Male mice recorded just 38% of the activity in 23h as females (P<0.001) 
and the female mice were significantly more active in both light and dark periods (P 
0.006 and <0.001, respectively). This increased activity by female mice was 
associated with a significantly shorter time spent sleeping than for male mice (579 v. 
722 min, P<0.00 I Table 3.8 1). 
Table 3.81 Activity measurements by sex (arbitrary units X103) (mean and 95% CI) 
Activity variable Female Male Probability 
Total 23h activity 1442 552 <0.001 LogIO 
1223-1700 477-640 
Dark phase 
LogIO 1 148 366 <0.001 
963-1368 316-425 
Light phase 
LogIO 199 116 0.006 
152-260 92-146 
Sleep (min) 578.5 722.4 <0.001 
544.1-612.9 692.6-752.3 
There were interactions between sex and exercise protocol for total activity (Figure 
3.59a), dark activity and time spent sleeping (P = 0.016,0.020 and 0.044 
respectively). On all occasions female mice were more active than males, and 
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treadmill mice were more active than controls, but the difference in 23h activity was 
greater between male CON and TR mice than their female counterparts. Male CON 
mice slept more than male TR mice (762 v. 698min), whereas female CON slept less 
than female TR mice (567 v. 599min, Figure 3.59b). 
Figure 3.59a) Interaction between sex and exercise b) Interaction between sex and exercise on sleep 
on total activity in 23h (geometric means) times 
Analysis of activity - Wheel v. Control mice 
Total activity was significantly greater in CON compared with WH mice (803 X103 V. 
256 X103Counts, P <0.001), as was activity in both the light and the dark phases 
(P<0.001 for both, Table 3.82). WH mice slept for less time than CON and the 
difference approached statistical significance (609 v. 655 min, P=0.065). 
Table 3.82 Activity measurements of WH v. CON (arbitrary units x103) (medians and range) 
Activity variable Wheel Control Probability 
Total 23h activity" 257 803 <0.001 
10-884 35-4091 
Light phase 
Kw 33 178 <0.001 
20-661 1-227 
Dark phase 
Kw 215 605 <0.00 1 
15-3719 8-795 
Sleep (min) 609 655 0.065 
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The direction of significance for activity when measured according to sex did not alter 
from the TR v CON measurements, with females more active (P<0.001) at all periods 
except the light (P = 0.238) and sleeping for a shorter amount of time (P<0.001). 
There was a slight interaction between sex and exercise on sleep time (P = 0.08 1), 
where sleep times were similar in females of both treatment groups, but male CON 
mice spent more time asleep than male WH. 
3.3.4.11 Stress marker (ADH mRNA expression) 
Only 9 intact brains, all from male mice, were available for analysis. There was no 
difference between the exercise groups (Table 3.83), although TR mice had the lowest 
optical density, and therefore the lowest amount of expression. 
Table 3.83 ADH mRNA expression in male mouse hypothalamus (mean and SEM) 
Variable (nett Treadmill Wheel Control Probability 
optical density) (n = 2) (n = 3) (n = 4) TR v CON WH v CON 
ADH 209.5 213.7 214.0 0.576 0.996 
3.8 3.1 2.7 
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3.3.5 Summary 
Table 3.84 Summary of results from the third experiment (P<0.05) 
Variable 
Effect of exercise regime (compared with 
Control) 
Treadmill Wheel 
Body weight gain No difference No difference 
Food intake Increased Increased 
Tumours 
-colon Decreased (0.061) No difference 
-other sites No difference No difference 
Total number of tumours No difference No difference 
Tumour burden No difference No difference 
Intestinal organ weights No difference No difference 
Non-intestinal organ weights 
-liver 
-heart No difference Increased 
-other organs No difference Increased 
No difference No difference 
SCFA total concentration Decreased Decreased 
-Acetate Decreased Decreased 
No difference No difference 
Propionate/Isobutyrate/butyrate/ 
Isovalerate/valerate 
SCFA molar proportion 
-Acetate Decreased Decreased 
-Propionate Increased (0.059) Increased 
-Isobutyrate/isovalerate Increased Increased 
-Butyrate/valerate No difference No difference 
Transit time No difference No difference 
NEPA 
-total Increased Decreased 
-dark phase Increased Decreased 
-light phase No difference Decreased 
-sleep time No difference Decreased 
Stress markers - ADH No difference No difference 
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3.3.6 ES3-specific discussion 
3.3.6.1 Treadmill performance 
The altered treadmill protocol saw "jusf '7 of 31 mice dropping out, with most then 
running every day. This is a vast improvement on the previous studies and could be 
due to either the speed being increased more quickly in this study (though previous 
performances suggest that is not always a factor) or the reduced duration of daily 
running sessions. The performance of the male mice was particularly surprising, given 
their previous form. There is evidence to suggest that strain may play a part in this, as 
Lerman et al. (2002) reported that male C57BL/6 mice, out of six strains of mice, ran 
slowest and stopped most often during a treadmill performance test. Conversely, the 
C57BL/6 mice ran further and faster in running wheels than the other strains (Lerman 
et al., 2002). The next challenge will be to have mice running quickly and for a 
longer time. The time may continue to be a problem, as observations of the wheel- 
running mice in this study showed that they tended to run in short bursts, a behaviour 
also reported by De Bono et al., (2006) and found to last -150s at an average speed of 
3km/h, considerably faster than most treadmill protocols, which rarely go beyond 
1.2km/h. These combined observations offer an explanation for the poor treadmill 
performance of some mice. 
3.3.6.2 Wheel-running 
Unlike the previous study (ES2), female mice did not perform significantly better than 
male mice on the wheels, although females consistently ran further. The daily average 
distance was less than in ES2 (2.63kin v. 3.46km), with most of the decrease due to 
less running by the females mice (down from 4.53km in ES2 to 3.32km in ES3, 
whereas male mice ran 2.1 km in ES2 and 1.951an in ES3). The increases in running 
distance observed in ES2 when the large wheels were present also occurred in this 
study. Large variation between animals was also present, which results in 
heterogeneous exercise exposure. This could possibly be avoided by selecting male 
mice that run well and successively breeding from them, as running performance can 
be selected (Swallow et al., 1998a). Mice selected for high running ability were found 
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to have greater V02rrux than sedentary controls (Swallow et al., 1998b), indicating 
improved cardiorespiratory responses. The genes responsible for high running ability 
in a comparable rat model were investigated using a microarray approach, with 
samples from the left ventricle (Lee et al., 2005). The authors found several potential 
candidates to be upregulated, including those in energy pathways and glucose uptake, 
which may produce more efficient glucose utilisation and muscle contractions, 
increasing cardiac performance (Lee et al., 2005). Animals with this phenotype might 
produce a less varied response to the running wheel, and might permit a dose- 
response analysis of tumourigenesis. 
3.3.6.3 Organs 
Adrenal and thymus glands were measured as a marker of activity of the 
hypothalamic-pituitary-adrenocorticaI (HPA) axis. The left adrenal gland is known to 
be larger than the right, a finding bome out by this study. Other researchers have 
found that exercise abolishes this difference due to an increase in size of the right 
adrenal gland (Droste et al., 2003). This indicates an increase in HPA axis activity 
(though should not be confused with the stress-like changes caused by forced or 
endurance exercise), and is due to the increase in glucocorticoid levels at the start of 
the dark phase, when most wheel running activity took place (Droste et al., 2003). A 
decrease in thymus weight was also observed by this group, again due to the increase 
in glucocorticoid secretion. 
However, no such changes in right adrenal size or reduction in thymus weight were 
observed in this study and it might be useful to measure glucocorticoid levels in future 
studies, to see if they are comparable with studies where an alteration in adrenal size 
was observed. 
3.3.6.4 Parental influence on offspring turnours 
The observation of 3 siblings each with an unusually large number of tumours 
prompted the investigation of the variation in turnourigenesis between offspring of 
different sires. The finding that the father had a huge influence on the tumour number 
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and burden of its offspring is perhaps not too surprising given the fully penetrant 
autosomal dominant nature of Min inheritance. The finding may have an effect on 
studies where the mean number of tuniours produced is quite low, as results could be 
skewed by a few mice bearing many more tumours than the rest of the study 
population. Knowing how many tuniours the fathers had could be vital information 
for controlling the variability inherent in studies such as this. The offspring of sires 
with similar numbers of tuniours could be used to maintain the colony, and perhaps 
generate a colony where the numbers of turnours produced by each mouse were more 
similar. The effect of mothers was not examined, but they may pass on modifier genes 
(such as Mom] or Mom2, discussed in Chapter 1.7.8) to their offspring, a hypothesis 
that could be tested by genotyping. 
3.3.6.5 Transit time 
Transit time has not been measured in animal exercise studies before, though it has 
been mooted as a possible reason for decreased incidence of colon cancer in the 
physically active, as potential carcinogens are in contact with the mucosa for shorter 
periods of time (Quadrilatero & Hoffman-Goetz, 2003). The human studies are not all 
directly comparable as some measured colon transit (Liu et al., 1993), others measure 
mouth-to caecurn transit (Scott & Scott, 1994) and others measure total transit 
(Robertson et al., 1993). 
In this study, median caecal transit time was unaffected by the exercise protocol, 
though the range was smaller for TR compared with WH and CON. It may be more 
valuable to measure total transit in these mice, as most tumours were generated in the 
small intestine, and none in the caecum. Another potential problem comes from the 
small amounts of caecal matter available and another method may be more suitable, 
such as the use of indigestible markers. 
3.3.6.6 NE PA 
As NEPA has not been measured before on exercising animals, the results of this 
experiment were particularly exciting, and could be interpreted in several ways. 
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Treadmill mice were significantly more active than Control mice, and this was in 
some ways surprising, as it was thought that after being made to ran for 30 minutes 
the mice would perhaps decrease the amount of activity in their home cage. Such a 
compensatory change in NEPA could have accounted for the lack of difference in 
tumour number in response to treadmill running. If the Control mice had been more 
active, it could have been due to having been confined to a control lane for 30 
minutes. 
The use of a computerised tracking system allowed de Visser et al., (2005) to separate 
time spent running in a wheel from time spent on the cage floor or sheltering. Mice 
with access to a running wheel spent significantly less time on the cage floor than 
non-running counterparts, but had a greater total cage activity (including wheel 
running). The InfraMot system used in this study was not able to distinguish between 
wheel-running and other activity, and may even have been unable to monitor wheel 
activity if the infrared sensor was blocked by the wheel. The observation of increased 
activity by CON compared with WH compares favourably with those of de Visser et 
al (2005). Unfortunately, a literature search has not yielded similar evidence regarding 
treadmill-running and cage activity. 
People who undertake physical activity in their leisure time are known to have a 
healthier lifestyle in general (Schroder et al., 2003), and those who take exercise may 
be more active generally, though studies do not distinguish between these types of 
"leisure" activity. A year-long exercise intervention in post-menopausal women found 
that adherence to the protocol was increased in women who were already intending to 
start exercising, or who had undertaken physical activity in the 3 months prior to 
randomisation (Irwin et al., 2004). 
Female mice were more active than males in all categories, and the shorter sleep time 
may reflect this. Whether this was due to increased time spent nest building or on 
general cage activity cannot be determined by this experiment, and others measuring 
voluntary activity (de Visser et al., 2005) have used only female mice, although De 
Bono ct al., (2006) reported that the increased wheel running of female mice 
compared with male mice happened in the second half of the dark period, and may 
suggest that males were sleeping at this time. 
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3.3.6.7 Stress markers 
Chapter 3 
The number of mice in this analysis was smaller than intended, however the technique 
worked well and can be used in future studies. Despite the small number of samples, 
the lack of difference in ADH expression between exercising and control mice 
suggests that neither the treadmill nor the wheel running produced a stress response in 
the mice. Stress activates ADH neurons in the paraventricular nucleus of the 
hypothalamus, increasing circulating concentrations of ADH (Genuth, 1998). This 
ultimately causes an increase in plasma cortisol concentrations, resulting in increased 
blood pressure, cardiac output and increased glucose utilisation by the central nervous 
system (Genuth, 1998). The lack of stress response suggests that treadmill-running 
should not produce any adverse effects in this group of mice. 
3.4 Combined results 
Data from the three studies involving the treadmill were pooled to give greater 
statistical power and re-analysed. To assess the effect of the particular study on the 
outcome, "study" was included as a fixed factor in the analysis, as each study varied 
slightly from the others. Where a variable category contains transformed data, mean 
and 95%CI are given; where data from a category were all normally distributed, mean 
and SEM. Data measured by non-parametric methods are presented as the median and 
the range. 
The main outcome criteria of tumour load, food intake, body weight, organ weight, 
body composition and SCFA are discussed in detail. 
3.4.1 Comparison of studies 
3.4.1.1 Tumour data 
The tumour data for all three studies are shown in Table 3.85. The number of tumours 
generated by each study was relatively stable, with the exception of the increase in 
proximal SI turnours observed in study 3 (P=0.007). The was a slight increase in the 
total number of turnours generated (P = 0.063), with mice in the first study having 
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fewer tumours than mice in the second study, and mice in the third study having more 
tumours still (10.9,13.5 and 15.2 tumours, respectively). 
Table 3.85 Combined turnour data, by study 
Variable 
Study group 
Study 1 Study 2 Study 3 
Probability of 
difference 
between studies 
Tumours n= 18 n= 62 n=75 
ProximalSqrt 5.5 5.5 7.4 
4.1-7.2 4.7-6.4 6.5-8.3 0.007 
Distal SILogIO 5.1 7.1 7.5 
3.6-7.3 5.9-8.6 6.3-8.9 0.160 
TotalLogIO 10.6 12.9 14.7 
8.1-13.8 11.2-15.0 12.9-16.6 0.073 
ColonKw 0.0 0.0 0.0 
0-1 0-3 0-5 0.258 
Total number 
LoglO 10.9 13.5 15.2 
8.4-14.2 11.7-15.5 13.4-17.3 0.063 
Burden (mm 32.1 35.5 34.8 
diameterfogio 
25.141.2 31.040.6 31.0-39.2 0.791 
Data shown are mean and 95% CI except for colon, which are the medians and ranges 
3.4.1.2 Weight gain, food intake and body composition 
The amount of weight gained by the mice in each study remained constant, with the 
slight increase shown by mice in study I reflecting the longer study (12 weeks as 
opposed to 10). However, the average food intake decreased with each study, even 
though the mice were fed the same diet (Table 3.86). 
With respect to body composition, there was a significant effect of study on water, 
mineral and non-fat organic matter proportions, with body water higher in study 1 
mice and mineral and non-fat organic matter greater in study 2 mice (Table 3.87, body 
composition was not analysed in study 3 mice). However, the proportion of fat in the 
mice was of most interest, and this variable was unaltered between studies. 
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Table 3.86 Combined weight and food intake data, by study 
Study group 
Probability of 
difference 
Variable Study 1 Study 2 Study 3 between studies 
n= 18 n= 62 n=75 
Total weight 8.4 7.9 7.2 
gain 
Sqrt (g)* 6.73-10.29 6.98-8.85 6.42-8.00 0.203 
Food intake over 2.39 2.18 2.09 
study (g/d) 0.05 0.02 0.02 <0.00 I 
* Initial weight included as a covariate 
Table 3.87 Body composition of mice by study 
Study group 
Probability of difference 
Variable Study 1 Study 2 between studies 
Body composition 
n= 18 n=56 
Water 55.9 52.3 
1.49 0.85 0.045 
Fat 29.6 25.7 
2.26 1.29 0.155 
Mineral 2.8 3.8 
0.26 0.15 0.001 
Non-fat organic 11.6 17.8 
matter Kw 3.05-19.12 6.04-33.98 <0.00 I 
3.4.1.3 Organ weights 
When expressed as % final body mass, liver weights for all studies were consistent, 
but mice in the third study had heavier hearts, which may reflect the increased number 
of mice running (Table 3.88). The spleens of mice from study I were significantly 
heavier than those of mice from study 2 (1.13 % v. 0.67%, P=0.001). When spleen 
data was analysed with that of turnour burden and haernatocrit, a heavier spleen was 
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associated with a reduced haematocrit (Figure 3.60c), and both spleen weight and 
haematocrit were predictive of tumour burden, with decreased haematocrits and 
increased spleen weights associated with a greater tumour burden (Figure 3.60a and b, 
P<0.001 and P=0.001 respectively). 
The regression equation is turnour burden = 73.6 - 1.25 *haematocrit. (Rý = 0.27, P 
<0.001). 
Table 3.88 Extra-intestinal organ weight data, by study (mean and 95% CI) 
Variable Study 1 
Study group 
Study 2 Study 3 
Probability of 
difference 
between studies 
Organ (% final 
body mass) n= 18 n= 62 n= 75 
Liver 4.42 4.36 4.34 
4.25-4.59 4.27-4.45 4.26-4.42 0.704 
Heart 0.69 0.78 0.94 
0.60-0.79 0.73-0.83 0.90-0.99 <0.00 I 
Spleen LogIO 1.13 0.67 
0.87-1.46 0.58-0.77 - 0.001 
Haematocrit 26.3 29.1 26.0 
22.4-30.2 27.0-31.2 24.1-27.9 0.086 
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Figure 3.60 Relationships between (a) haematocrit and (b) spleen weight and tumour burden, 
and (c) between spleen weight and haematocrit, with fitted regression lines. N Is less for (b) and 
(c) as spleen weights were not measured in ES3 
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3.4.2 Comparison of sexes 
Chapter 3 
Sex differences occurred for several variables, some of which are presented here. 
3.4.2.1 Tumour data 
In general, tuniour data for the sexes was similar (Table 3.89), and the only 
statistically significant sex effect was on colon turnours, where female mice had fewer 
than males (median 0.0 v. 1.0, P=0.004), but the range was greater in females. The 
higher number of proximal SI tuniours in females compared with males approached 
significance (6.8 v. 5.9, P=0.072). All other variables were not different. 
Table 3.89 Effect of sex on tumour variables 
Sex 
Variable Female Male 
Tumours n=87 
n= 68 Probability of sex 
effect 
Proximal Sqrt 6.8 5.9 
6.1-7.6 5.1-6.7 0.072 
DistalLogIO 7.1 7.3 
6.1-8.4 6.1-8.7 0.772 
Total SILogIO 13.7 13.6 
12.2-15.5 11.8-15.5 0.832 
Colon KW 0.0 1.0 
0-5 0-4 0.004 
Total number 
LoglO 14.2 14.3 
12.6-16.0 12.5-16.4 0.945 
Burden (mm 34.9 36.0 
diameterfogIO 31.3-39.0 31.8-40.7 0.718 
Data shown are mean and 95% CI except for colon, which are the medians and ranges 
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3.4.2.2 Weight gain, food intake and body composition 
Male mice were heavier than females during each study and also gained more weight 
(Table 3.90), although the food intake of the sexes was not significantly different, and 
neither was the composition of the carcasses. 
Table 3.90 Total weight gain and average food intake, by sex 
Sex 
Female 
Variable n=87 
Male 
n= 68 Probability of sex 
effect 
Total weight 6.8 8.9 
gainSqrt (g)* 6.1-7.5 8.0-9.8 0.001 
Food intake (g/d) n variable but all 3 studies used 
Average intake 2.13 2.18 
over study 0.02 0.03 0.151 
Body composition n= 43 n= 31 
Water 54.1 52.8 
0.95 1.12 0.151 
Fat 25.3 26.6 
1.43 1.69 0.484 
Mineral 3.9 3.4 
0.18 0.21 0.065 
Non-fat organic 17.5 17.8 
matter 
Kw 
3.05-19.12 6.04-34.00 0.814 
Initial weight included as a covariate 
3.4.2.3 Organ weights 
In general, male mice had heavier organs than females, but when expressed as % final 
body mass, female mice had heavier organs than males (both intestinal and extra- 
intestinal). Liver weight was heavier in female mice compared with males, but there 
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were no differences in heart or spleen weight (Table 3.91), and haematocrit was 
significantly lower in male mice compared with females (P <0.001). 
Table 3.91 Extra-intestinal organ weights of male and female mice (mean and 95% CI) 
Sex 
Variable Female Male 
Organ (% final 
n=87 n=68 
Probability of sex 
body weight)* effect 
Liver 4.48 4.18 
4.40-4.56 4.09-4.27 <0.00 I 
Heart 0.85 0.84 
0.81-0.90 0.79-0.89 0.553 
SpIeen 0.80 0.81 
0.68-0.95 0.66-1.00 0.791 
Haematocrit 29.3 23.7 
27.5-31.1 21.6-25.7 <0.00 1 
* all LogIO transformed 
3.4.2.4 SCFA 
Colonic SCFA concentrations were mostly not different between the sexes, with 
acetate concentration the only statistically significant difference between the two (P 
0.001), with a greater concentration observed in male mice samples compared with 
females (23.01 v. 17.54 gmol-g colon contents). Male samples also had a greater 
concentration of total SCFA (28.31 v. 23.01 gmol-g colon contents, P=0.007). 
Several differences in molar proportion of colonic SCFA existed, with male mice 
having a greater proportion of acetate than female mice (P = 0.03 1), and a 
corresponding decrease in the other SCFA, significantly so for butyrate, isovalerate 
and valerate (Table 3.92). 
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Table 3.92 Colonic SCFA (mmol/mol total SCFA) of male and female mice 
Variable 
Sex 
Female Male 
n= 72 n= 
62 
Chapter 3 
Probability of sex 
effect 
SCFA* (molar 
proportion) 
Acetate 773 802 
490.5-891.5 658.6-918.0 0.031 
Propionate 120 ill 
40.4-372.4 40.6-213.2 0.223 
Isobutyrate 14 14 
0.0-36.2 5.9-28.7 0.288 
Butyrate 54 34 
0.0453.9 0.0-172.1 0.038 
Isovalerate 23 20 
21.5-25.2 18.2-21.6 0.008 
Valerate 15 11 
1.0 1.1 0.023 
* all Kruskal Wallis test except Isovalerate - LogIO transformed, and valerate - normally 
distributed, therefore median and range displayed for acetate, proplonate, Isobutyrate nad 
butyrate, mean and 95% Cl for isovalerate, and mean and SEM for valerate 
3.4.3 Effects of treadmill- and wheel-running exercise 
3.4.3.1 Tu mourd ata 
The treadmill protocol affected many of the turnour variables (Table 3.93), with 
decreases in distal SI, total SI, colon and total number of turnours and also turnour 
burden (P values of 0.03 - 0.062) compared with control mice. There was no 
significant (P>0.05) effect of wheel running on any of the measured variables. 
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Table 3.93 Effect of exercise protocol on turnourigenesis 
Treatment group 
Variable 
Tumours 
Treadmill 
n=41 
Wheel 
n=49 
Control 
n=65 
Probability of effect 
TR v CON WH v CON 
Proxima, Sqrt 5.6 6.7 6.0 
4.6-6.7 5.6-8.0 5.2-6.9 0.814 0.469 
Distal"910 5.6 6.3 7.7 
4.4-7.1 4.9-8.0 6.4-9.4 0.062 0.587 
Total SILogIO 10.8 13.2 14.0 
9.1-12.9 9.6-18.2 12.1-16.2 0.052 0.837 
ColonKW 0.0 0.0 1.0 
0.0-3.0 0.0-5.0 0.04.0 0.049 0.213 
Total 11.1 13.7 14.6 
numberLo&10 9.3-13.2 11.4-16.5 12.6-16.9 0.030 0.798 
Burden (mm 29.9 34.8 38.1 
diameter)LO2'0 
25.3-35.2 29.441.3 33.243.7 0.041 0.587 
Data shown are mean and 95% CI except for colon, which are the medians and ranges 
3.4.3.2 Weight gain, food intake and body composition 
Wheel mice were on average 0.8g heavier than control mice at the start of the project 
(P = 0.036), but CON mice gained more weight overall than either TR or WH mice 
although there was no significant (P>0.05) effect of exercise regime on total weight 
gain when using initial weight as a covariate (Table 3.94). 
Food intake when averaged over the whole study was not significantly different 
between TR and CON, but VM mice ate significantly more than CON mice 
(P<0.0001, Table 3.94). 
Body composition was similar in all treatment groups, although the proportion of non- 
fat organic matter was less in TR mice compared with CON (P<0.001, Table 3.94). 
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Table 3.94 Weight gain, food intake and body composition of mice by exercise group 
Treatment group 
Treadmill Wheel Control Probability of effect 
Variable n=41 n=49 n=65 TR v CON WF[ v CON 
Total weight 7.57 7.65 8.27 
gain 
Sqrt (gr 6.49-8.73 6.51-8.87 7.32-9.26 0.618 0.597 
Average food 2.15 2.37 2.14 intake over 
study (g/d) 0.03 0.03 0.03 0.869 <0.0001 
Body 
composition 
(%) n= 16 n=32 n=26 
Water 52.4 56.2 53.7 
1.48 1.09 1.46 0.748 0.235 
Fat 31.7 24.3 27.1 
2.25 1.65 2.21 0.234 0.447 
Mineral 2.9 2.5 3.4 
0.26 0.19 0.26 0.277 0.916 
Non-fat 15.3 17.6 17.8 
0 OU anic matter K 3.05-20.03 3.65-28.25 14.68-33.98 <0.001 0.274 
* Initial weight was Included as a covariate 
3.4.3.3 Organ weights 
There was no effect of the treadmill protocol on any of the organs measured, with the 
exception of the spleen, which was lighter than in CON mice (P = 0.0003, Table 
3.95). Wheel mice had heavier proximal Sl portions, heavier livers and lighter spleens 
than CON mice (P values from <0.001 to 0.035). 
Both WH and TR mice had a greater haematocrit than CON mice (P = 0.0 13 and 
0.004, respectively, Table 3.95). 
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Table 3.95 Extra-intestinal organ weights by exercise protocol (mean and 95% CI) 
Variable 
Organ (% final 
body mass) 
Treadmill 
n=41 
Treatment group 
Wheel 
n=49 
Control 
n=65 
Probability of effect 
TR v CON WH v CON 
Liver 4.32 4.57 4.23 
4.21-4.43 4.46-4.68 4.14-4.32 0.361 <0.001 
Heart 0.80 0.84 0.79 
7.32-0.86 0.77-0.90 0.73-0.84 0.951 0.300 
Spleen 'A910 0.64 0.85 1.20 
0.50-0.81 0.66-1.10 0.99-1.44 0.0003 0.035 
Haematocrit 29.2 28.2 23.9 
M 
26.6-31.8 25.5-30.9 21.8-26.0 0.004 0.013 
3.4.3.4 SCFA 
Significant differences in individual SCFA concentration between exercise groups 
occurred only for acetate, with samples from CON mice having a greater 
concentration than those from WH mice (23.6 v. 19.2 pinol-g colon contents, P 
0.016). CON mice also had the greatest total concentration of SCFA in their samples, 
significantly greater than VM mice only (P = 0.046). 
There were differences between exercise groups for the molar proportions of all the 
colonic SCFA measured except valerate Table 3.96). Acetate proportion was greater 
in CON samples compared with both TR and WH mice (P = 0.020 and 0.006 
respectively). For propionate, isobutyrate and isovalerate, CON samples had 
significantly smaller proportions than WH samples, whilst TR samples had a greater 
proportion of butyrate than CON mice (P = 0.002) and VM mice samples (Table 
3.96). 
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Table 3.96 Colonic SCFA (mmollmol total SCFA) of mice by exercise group 
Treatment group 
Variable 
SCFA* (molar Treadmill Wheel Control 
proportion) n=34 n=52 n=48 
Probability of effect 
TR v CON WH v CON 
Acetate 782 773 809 
490.5-848.6 506.4-918.0 658.6-908.3 0.020 0.006 
Proplonate 111 125 106 
40.3-211.9 40.6-372.4 56.6-168.7 0.424 0.001 
Isobutyrate 14 15 12 
6.5-36.2 5.9-33.3 0.0-28.7 0.194 0.002 
Butyrate 61 47 36 
14.1453.9 0.0-186.3 0.0-110.8 0.002 0.192 
Isovalerate 19 22 18 
17.3-21.5 19.9-23.7 16.5-20.3 0.668 0.018 
Valerate 12 12 10 
1.4 1.1 1.4 0.286 0.153 
* all Kruskal Wallis test except isovalerate - LogI 0 transformed, and valerate - normally 
distributed, therefore median and range displayed for acetate, propionate, isobutyrate nad 
butyrate, mean and 95% Cl for isovalerate, and mean and SEM for valerate 
3.4.3.5 Wheel running 
When the second and third studies were combined, female mice ran, on average, more 
than males, as shown in Table 3.97. 
Table 3.97 Combined wheel-running data 
Distance Females 
SEM 
Males 
SEM Probability variable (km) n=26 n= 23 
Daily distance 3.94 0.37 2.03 0.39 0.001 
Total (10weeks) 274.3 25.23 139.2 26.79 0.001 
Small wheel 99.04 9.24 47.76 9.81 <0.001 
Large wheel 175.26 20.20 91.42 21.45 0.007 
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Mice from the third study ran further than those in the second study, though the 
difference was statistically significant only for the distance run in the small wheel, 
with mice in the second study running 98km and those in the third study running 
49km (P = 0.001). 
There was no correlation between total running distance and tumour number (r =- 
0.070) or with distance and tumour burden (r = -0.088). 
3.5 Discussion - Investigations into treadmill- and wheel- 
running exercise 
3.5.1 Comparison of studies 
Although differences between studies existed for some variables, in general the main 
variables of interest were constant (turnours, body weight gain, body fatness, SCFA). 
3.5.1.1 Growth, body composition and food intake 
There were small differences between individual studies in the amount of weight 
gained, as displayed in Table 3.98. At first glance it is perhaps surprising that there 
were no significant differences in body weight between the groups, given the extra 
energy expenditure of the TR and WH mice.. In both ES2 and ES3, WH mice gained 
slightly less weight in week 6 than in the weeks before or after. This corresponds with 
the week that the wheels were changed, and the distances covered increased, 
indicating that perhaps the mice had not altered their energy intake accordingly. 
Table 3.98 Total weight gained (g) by each treatment group in each study 
Study Treadmill Wheel Control 
ES1 9.2 - 11.1 
ES2 9.2 8.3 8.1 
ES3 7.2 7.1 8.1 
N. B. ES1 was a 12 week study, ES2 & ES3 were 10 weeks 
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The weight of 37/155 mice decreased in the final 1-3 weeks of the study and was 
associated with an increased total number of tumours (mean 18.8 compared with 13.1 
for mice that had not lost weight, P=0.00 1), a decreased haernatocrit (19.7 v. 29.0, P 
<0.001), and an increased spleen weight (0.325 v. 0.23 Ig, P=0.044, ES 1 and ES2 
only). Taken together, these observations suggest that the weight loss is indicative of 
tumour formation. As with many human cancer patients, Min mice develop cachexia, 
where both fat and muscle tissue is lost (Mehl et al., 2005a). The presence of tumours 
is thought to cause cachexia by a variety of mechanisms, including physical 
obstruction, metabolic disturbances of various organs, an increase in resting energy 
expenditure and decreased appetite (Van Cutsern & Arends, 2005), the last of which 
was often observed concurrently in the mice that lost weight. 
For reasons unknown, mice in ES 1 ate more than those in ES2 or ES3. The diet was 
the same so should not have been more "palatable" and the environmental conditions 
were identical. 
3.5.1.2 Treadmill-running 
Treadmill performances increased dramatically from ES I to ES3, with many more 
mice adhering to the protocol for the length of the study and running at greatly 
increased speeds, probably helped by the shorter duration of running in ES3. The 
number of male mice completing the treadmill protocol in ES3 was especially 
pleasing, given their previous poor performances. Initially (ES I and ES2), mice were 
run quite slowly in the training periods, as due to their small size it was thought that to 
force strenuous exercise on them might cause injury, and indeed, several damaged 
toenails were suffered. However, reports from others of fatalities on the treadmill 
(Colbert et al., 2003), were thankfully not experienced. Given the improved 
performance in ES3, it would seem acceptable to ran the mice at faster speeds when 
they are young, provided the time is increased steadily and the mice observed for 
injuries. 
The mice were all run during the light, although they are nocturnal. This may have 
accounted for some of the poor performances, but as they were run at the time when 
normal cleaning and feeding routines were being carried out, they would have been 
disturbed at this time anyway. In the studies by Mehl et al., (2005b) and Colbert et al. 
(2003), mice were run under red lights in the dark cycle, but both studies produced 
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mice that could not finish the protocol, suggesting that running with the lights on is 
not a significant factor in poor ninning performance. 
As mentioned in the Discussion to ES3, mouse strain may affect treadmill-running 
performance, with C57BL/6 mice performing badly in a treadmill test but Performing 
well in running wheels, compared with six other strains of mice (Lerman et al., 2002). 
The differences in treadmill performance between male and female C57BL/6 mice 
have also been reported by Konhilas et al., (2004), with females reaching greater 
maximum speeds and stopping less frequently than male mice. This may influence 
future studies with respect to selection of sex/strain, or expectation of homogeneous 
exercise exposure. 
3.5.1.3 Wheel running 
Wheel-running performances, though varied, exceeded expectations and are 
comparable with those of other studies of C57BU6JMin mice (Table 3.99). 
Most mice responded well to the presence of the wheel, though some ran very little. 
However, as part of the purpose of the wheel was to offer a voluntary, non-stressful 
alternative to the treadmill, this inter-animal variation has to be accepted. 
Table 3.99 Comparison of wheel-running distances (km/d) by male and female mice 
Study Female Male 
ES2 4.5 2.1 
ES3 3.3 1.9 
Colbert et al. (2003)* 3.1 2.6 
Mehl at al. (2005b) 3.5 4.7 
*2-3wk quarantine period only 
The larger wheels seem to have suited the male mice better, and the female mice did 
not respond to the change to the larger wheels as well as the males, a consideration for 
future studies. Although the distance run by female mice decreased in ES3, combined 
distances were still greater for females compared with males. The reason for this is 
unknown, and while it is the converse of that observed by Mehl et al. (2005b), is in 
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accord with the findings of Colbert et al (2003) and Koteja, Swallow et al. (1999). In 
tests of voluntary wheel performance, female C57BU6J mice run further and faster 
than males of the same strain (Konhilas et aL, 2004; De Bono et aL, 2006). Evidence 
for wheel-running performance in C57BU6J mice is mixed, with some reporting 
almost 81an run per night by male mice (Lerman et al., 2002), significantly more than 
six other strains of mice, whilst others (Lightfoot et al., 2004) report approximately 
half that distance, placing C57BI16J mice tenth out of 13 strains. 
3.5.2 Comparison of sexes 
3.5.2.1 Growth and food intake 
As expected, male mice gained more weight than females, both overall and in each 
study, although as a% increase, both sexes gained the same amount of weight in ES3 
(Table 3.100). 
Table 3.100 Total weight gained (g) by male and female mice in each study 
Study Female Male 
ES1 7.1(47%) 11.4(62%) 
ES2 7.5(43%) 11.3(51%) 
ES3 6.9(68%) 8.2(68%) 
N. B. ESI was a 12 week study, ES2 & ES3 were 10 weeks 
With respect to food intake, although male mice ate more than females in absolute 
terms, as a percentage of their body weight, females consumed 20% more food than 
males (10.3 v. 8.4 g/I 00g, P<0.001). This may reflect the increased NEPA in the 
home cage compared with males (with males recording just 3 8% of the activity of 
females). 
3.5.2.2 Tumours 
The only difference between the sexes in the combined analysis was in the number of 
colon turnours, as measured by non-parametric methods, with female mice suffering 
fewer colon turnours. However, colon tumours made up less than 4% of the total 
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turnours in this analysis, suggesting that the use of both sexes in the experiment 
should not have distorted the data. 
3.5.3 Comparison of treadmill- and wheel-running groups 
3.5.3.1 Growth, body composition and food intake 
This investigation found no effect of either treadmill or wheel running exercise on 
body weight, both weekly and at death. This is in accord with Colbert et al. (2000) 
and Mehl et al. (2005b). In contrast, Colbert et al. (2003) found that treadmill-running 
mice were significantly lighter than non-running controls on weeks 5-8 of their 8 
week study, and also at death. 
Given the lack of difference in body weight between exercise groups, it is perhaps not 
surprising that there were no significant differences in body composition, although 
analysis in the study by Colbert et al. (2003) found that treadmill exercise decreased 
body fat and increased bone mineral density. Other studies in mice have reported 
decreased body fat with voluntary wheel-running (Swallow et aL, 2001; Droste et aL, 
2003), decreased body fat mass with treadmill running (Bhattacharya et al., 2005), but 
others have reported no difference in carcass energy content after 6 weeks of wheel 
access (Bell & McGill, 1991). A complication in drawing conclusions from body 
composition analysis in Min mice was the weight loss experienced by many mice 
towards the end of the study. This cachexia (as mentioned previously) will decrease 
both fat stores and muscle tissue and may explain the difference between this study 
and the shorter study of Colbert et al. (2003). 
The exercise protocol influenced food consumption. In accord with the findings of 
other groups (Cohen et aL, 1988; Reddy et aL, 1988; Koteja et aL, 1999) wheel- 
runners consumed more food than either TR or CON mice. When considering the 
distances run each day by the WH mice, this is perhaps not surprising. In the week 
that the wheels were changed (week 6), the consumption of male WH mice dropped, 
which in addition to the increased distance run that week would account for the 
decrease in weight that week. The reason for the decreased intake could be due to the 
novel object in the cage causing stress, or the preference for running over eating that 
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week, as food intake increased again the following week, though this conjecture was 
not tested. 
Given the increased energy expenditure of the TR mice, one might assume they would 
therefore consume more food. As they did not consistently eat more than the CON 
mice in ES I or ES2, this suggests that either the energy content of the high fat diet 
was providing sufficient energy for their needs or that the mice did not expend more 
energy than the controls may have used on voluntary activity in the home cage. TR 
mice in ES3 consumed more food than CON, and this may be a reflection of the 
increased speeds, although the time spent running was much less than in ES I and 
ES2. However, overall, TR mice did not consume more food than CON mice and this 
suggests that the treadmill protocol could be increased. 
Neither study by Colbert and colleagues (2000 and 2003) reported food intake of the 
animals. However, the second study (Colbert et al., 2003) measured intake of control 
mice and pair-matched exercising animals in the following week to that amount "to 
prevent over-consumption" by the exercising mice. However, Reddy (1988) and 
Thorling (1993; 1994) found that exercising rats (both forced and voluntary) ate more 
food than their sedentary counterparts. Increases of 13,22 and 25% more, 
respectively, were reported. Mehl and colleagues (2005b) reproduced the findings of 
this study with wheel running mice eating more than controls and treadmill runners 
eating a similar amount as controls (exact amounts were not reported), supporting the 
theory that wheel-running mice and rats undertake more activity compared with their 
treadmill-running counterparts. 
An interaction between sex and exercise protocol existed for both food intake (g/d, P 
= 0.009)) and intake per 100g body mass (P = 0.016), with slightly different outcomes 
for the two measurements (Figure 3.61). Mean daily food intake was greater for TR 
males than females, and similar for CON and WH mice of both sexes, with WH mice 
eating more than the other groups. However, when expressed as g/100g mouse, 
female mice ate more than their male counterparts, with female WH eating more than 
the other groups (Figure 3.61), reflecting the differences in body mass between the 
sexes. 
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Figure 3.60 Interaction between sex and exercise protocol on mean daily food intake (a) Wd and (b) 
g/100g mouse 
3.5.3.2 Tumours 
The combined data for these studies found a slight reduction in tuniour numbers for 
treadmill mice compared with controls, with TR mice having on average 11.1 
tumours, compared with 14.6 for controls and 13.7 for wheel-runners. This was a 
surprising finding, as it might have been expected that given the variability in 
responses to the treadmill a decrease in tumour would not have been observed. More 
surprising was the lack of effect of the wheel-running protocol, as the increased 
distances run in wheels compared with those run on the treadmill might have been 
expected to be beneficial. 
Table 3.101 compares the total number of tumours in the published studies of Min 
mice and exercise. Mehl et al. (2005b) found an effect of treadmill exercise on tumour 
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number in male mice, but not wheel-running. Treadmill runners suffered 29% fewer 
polyps than controls and had 38% fewer large polyps (classed as >I mm). The tumour 
numbers differed considerably both from those in our studies and those of the Colbert 
et al. studies (2000; 2003). Mehl et al., (2005b) reported that male treadmill runners 
had an average of 66 ±9 polyps compared with 13 seen in this study, and male 
controls had 93 ±7 tumours compared with 15 in this study. This contrasts with the 
numbers of tumours in the first study by Colbert et al. (2000), where the mean number 
of turnours for different treatment groups was between 25 and 41. The 2003 study 
generated 6-9 tumours/mouse. Mice from the 2000 study were bred in-house after 
purchase of sires from the Jackson Laboratories, the mice from the 2003 study were 
purchased from the Jackson laboratory. This disparity in tumour number reflects the 
slight genetic diversity that occurs with separation of breeding colonies, differing 
diets and exposure to various environmental challenges (Dove el al., 1997, Newman 
et al., 200 1; Corpet & Pierre, 2003) and creates a problem when attempting to 
compare studies. The presence or absence of modifier genes (which can affect the 
severity of the Min phenotype (Dietrich et al., 1993) was not examined in this thesis. 
The large inter-animal variation may also disguise any true effects of the treatment. 
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Figure 3.61 Distribution of turnour sizes reported by Mehl et al., (2005b) 
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This disparity in tumour number may be due to genetic variation, as mentioned 
earlier, but may also be a consequence of staining the tissue (Mehl et al., 2005b) and 
examining it with a microscope to identify tumours. Using this method, 
approximately 10-20 tumours/group were identified as <Imm, which greatly 
increases the number of tumours that can be identified (Figure 3.62). This does, 
however, still leave the majority of tumours sized ý: I mm (49 ±6 in treadmill-runners 
and 79 ±6 in controls). The lower limit for sizing of tumours in our studies is Imm, 
but staining may reveal smaller tumours. The treatments may be having an effect at 
the microscopic level, and staining would allow us to identify a greater number of 
tumours and perhaps show a treatment effect at an earlier stage of tumourigenesis. 
There was a difference in anatomical site of turnours between the published studies 
and our results. Mehl et al., (2005b) reported that 95% of tumours were in the small 
intestine, of which 25% were in the proximal and 75% in the distal portion. 
Anatomical distribution was unaffected by exercise. 96% of the turnours generated 
per animal in this thesis were in the small intestine. 46% of these were in the 
proximal section, 54% in the distal. This approximately 50-50 split was maintained by 
TR and WH mice, but CON mice showed a tendency towards increased distal 
tumours (P = 0.062, Table 3.93). 
The only significant interaction between sex and exercise group was on proximal SI 
turnours. Female TR and VM mice suffered from more proximal turnours than their 
male counterparts, but female CON mice had fewer proximal SI turnours than male 
CON (P = 0.037). 
3.5.3.3 Organ dimensions 
VM mice had the heaviest livers, perhaps indicative of the greater food intake leading 
to an increased storage of glycogen or fat. 
The weight of the spleen was heavier in CON mice compared with TR and WH mice 
(P = 0.0003 and 0.035 respectively for organ as % body mass). This splenomegaly 
may reflect either the greater number of tumours in CON mice or the anaemia that all 
the mice suffered from, shown by the significantly lower haematocrit of the CON 
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mice (Moser et al., 1990). It is also possible that the TR and V; H mice had reduced 
levels of systemic inflammation, a condition that causes spleen enlargement as 
lymphocytes are generated (Mehl et al., 2005b). However, a significant positive 
correlation was found between spleen weight and tumour burden in this study (r 
0.36, Figure 3.60), suggesting that the heavier spleen was in fact caused by tumour 
load. This is reinforced by data from the study by Mehl et al. (2005b), which 
measured heart and spleen weight and found that spleen weight of male treadmill- 
running Min mice was decreased by 35% and the spleen of male wheel-running mice 
decreased by 47% compared with non-running controls. This would correspond with 
the difference in tumours between exercising and control male animals. No 
differences in spleen weight were detected in female mice, and no differences in 
tumour number were found. Spleen weights from that study were much lighter than 
those in this study (TR 91mg, WH 75mg and CON 141mg, compared with TR 
165mg, WH 218mg and CON 304mg), which is surprising given the increased tumour 
burden of the animals in the Mehl (2005b) study. The correlation between haematocrit 
and tumour burden suggests a use for the haernatocrit as a useful surrogate for tumour 
burden in mice before they are killed, as only a small amount of blood is required. It 
could provide an estimate of turnour burden half-way through a study, or to confirm 
the necessary killing of a mouse before the end of a study due to morbidity. 
An unexpected result was that TR and WH mice did not have a heavier heart mass 
than CON mice, although VvIH mice had the heaviest hearts. Heart weight of 
treadmill-running mice was not significantly different from control mice in the study 
of Mehl et al. (2005b), which supports the findings of this study, though female 
wheel-runners had increased heart weight (Mehl et al., 2005b). This is in accord of the 
findings of Konhilas et al, (2004), who reported that female wheel-runners 
significantly increased cardiac mass compared with males, though wheel-running 
produced a significant increase in mass-adjusted heart weight in males also. 
3.5.3.4 SCFA 
Resistant polysaccharides are fermented in the large intestine by the resident 
anaerobic bacterial flora. The products of this fermentation include short chain fatty 
acids, which are monocarboxylic hydrocarbons. SCFA are absorbed by the intestinal 
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lumen both passively and actively, along with an increase in Na' and Cl- absorption 
(Kles & Chang, 2006). Absorbed SCFA are then oxidised by the epithelial cells and 
used as fuel. Acetate, propionate and butyrate occur in the greatest concentrations, 
and butyrate has been shown to display dual properties. In nomial cells it is the 
preferred energy source and induces proliferation, although both low and high 
concentrations inhibit proliferation (Csordas, 1995), but in colon cancer cell lines 
butyrate increases apoptosis and induces differentiation (Csordas, 1995). 
The colon contents of TR mice in this study contained a greater proportion of butyrate 
than those of CON mice (P = 0.002, Figure 3.63). TR mice also suffered fewer distal 
tUMOUrs (P = 0.062) and colon turnours (P= 0.049). 
E3Treadmill 
MWheel 
0 Control 
C=: Elm= 
Isobutyrate Butyrate Isovalerate Valerate 
Figure 3.63 Molar proportions of SCFA (nitnol/mol total SCFA) for each exercise treatment 
group 
Diet is known to alter SCFA concentrations, particularly polysaccliarjdcs, but no 
infori-nation on the effect of exercise on SCFA has been reported. Exercise may have 
altered the proportions of gut bacteria, promoting growth of the anaerobes that 
produce butyrate, though this proposal has not been tested. The greater proportion of 
butyrate in TR mice might help to explain the reduction in tumour number seen in this 
group of mice. As fen-nentation occurs in the caecum there may be some back flow of 
SCFA into the small intestine, accounting for the decrease in distal SI tUrnours 
observed. It is perhaps more likely that butyrate acts indirectly, by increasing 
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inimunosurveillance (Pierre et aL, 1997; Armstrong & Mathers, 2000) or targeting 
cells from the basal surface and decreasing inflammation or angiogenesis (Williams et 
al., 2003). Butyrate is known to increase with decreased transit time(Lewis & Heaton, 
1997), so a decreased transit time due to exercise (although not observed in this study) 
could have led to an increase in colonic butyrate concentrations. 
3.6 Critique of study and suggestions for further research 
As detailed in the Materials and Methods, some mice in this study changed treatment 
group in the first 2 weeks (the training period). This was to prevent wasting the 
animals, as the mice that were taken off the treadmill would otherwise have been 
destroyed. It was felt that their minimal exposure to exercise would allow them to 
move groups. However, it raises the question of why these particular mice would not 
run e. g. did they dislike the treadmill-running more than the other mice, or were they 
already forming tumours that made this exertion uncomfortable? This question cannot 
be answered without further study, which might require immediately killing and 
dissecting mice that refuse to run. However, the lack of correlation between running 
distance and tumour number/burden observed in wheel-running mice suggests that 
even with a heavy tumour load some exercise is still possible. 
Data were reanalysed with mice placed in one of the following five groups: 1) 
treadmill only (TR), 2) wheel only (WH), 3) control only (CON), 4) was treadmill but 
moved to control (TR-to-CON), 5) was treadmill but moved to wheel (TR-to-WH). 
Using the General Linear Model of ANOVA and Dunnett's test, groups were 
compared with CON. 
There was no difference in turnour number (p = 0.698) or tumour burden (p = 0.149) 
between mice that had changed groups and mice that had not, so broadly speaking, 
mice that had changed groups were not affected differently to the other mice in the 
study. When the turnour variables were re-analYSed compared with the control group 
the significant effect of the treadmill exercise was removed, but the tend towards 
decreased total number of tumours was still present (11.7 v. 15.4, p=0.077). The 
decrease in significance is presumably because the TR-to-CON mice, whilst not being 
significantly different from CON, were more affected (15.5 tumours on average), so 
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removing them from the CON group decreases the overall number of tumours in the 
CON group. However, this does not help to explain why mice that would not run on 
the treadmill but were given a wheel which they used (Figure 3.64), had in general 
fewer turnours than WH or CON (13.7 on average, compared with 15.2 for WH and 
15.4 for CON). 
It should be noted though, that numbers of mice in the "changed" groups were 
considerably less than those in the "unchanged" categories, and this complicated issue 
deserves further exploration, perhaps by increasing the numbers of mice that have a 
short treadmill exercise exposure followed by access to a wheel. 
250.00 13 Distance 15.0 
E 200 00 
Turnour tumber 14.8 
14 6 0 . . E 14.4 3 
150.00 14.2 0 
14.0 
100.00 13.8 E 
13.6 
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0.00 13.0 
WH only TR to WH 
Figure 3.64 Mean total distances run (km) by WH mice (n = 43) and TR-to-WH mice (n = 6), 
with corresponding total tumour number 
3.6.1 Ability of the study to address the hypotheses 
3.6.1.1 Hypothesis I- Treadmill- or wheel-running exercise will reduce 
tumour number compared with controls 
There was no consistent effect of exercise across the studies, with no effect of 
treadmill running in the pilot study, a trend towards decreased total number of 
tumours in ES2, a trend towards decreased colon turnours in ES3 but overall 
decreased tumour number and burden. With respect to wheel running, ES2 showed a 
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trend towards decreased distal turnours, no effects were seen in ES3 (though running 
distances were less), and overall no difference was observed compared with control. 
The reasons for this apparent paradoxical finding that forced exercise should reduce 
tumour number, and conversely, why the exercise involved in voluntary wheel 
running should have no effect on turnourigenesis, have yet to be elucidated. 
3.6.1.2 Hypothesis 2- Exercised mice will have lower body fat than 
controls 
No difference in body fat was discovered in treadmill or wheel running mice 
compared with controls. This suggests that the imposed treadmill exercise regime was 
not sufficient to alter body fat stores. The extra energy expended by the wheel- 
running mice appears to have been compensated for by increased food intake. 
3.6.1.3 Proposed mechanisms of protection 
Caecal transit time, CCP, IL-6 and IL-10 do not appear to be consistently altered with 
exercise in this thesis. The increase in molar proportion of butyrate observed in TR 
mice may present one explanation for the decreased turnour number observed in this 
group. 
3.6.2 Conclusions and suggestions for further research 
This series of experiments was performed to assess the impact of exercise on 
intestinal tuniourigenesis in the Min mouse. Despite a modest reduction in tumour 
number in treadmill-running mice, there was no consistent evidence to suggest that 
exercise affected tumourigenesis to any significant extent, in agreement with previous 
studies (Colbert et aL, 2000; Colbert et aL, 2003). The lack of effect of wheel-running 
suggests that there are other factors at work, such as hormonal or neuroendocrine, that 
deserve further investigation. 
The disparity between rat and Min mouse studies needs to be addressed, and the main 
difference between the two appears to be the lower body weight (and loss of fat mass, 
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where measured) by exercising rats, whereas exercising mice, in general, maintained a 
body weight similar to that of controls. This suggests that imposed exercise regimes 
need to be higher for mice than rats. This difference in energy economy of the mice 
can be further explored using caloric restriction, as reducing the available food energy 
reduced total tumour number in Min mice (Mai et al., 2003) and of tumours >2mm 
(Kakuni et al., 2002). More accurate measurement of food intake is possible through 
the use of metabolic cages, and indirect calorimetry will provide more accurate 
estimates of energy expenditure. Different strains of mice have different resting 
energy expenditures (Funkat et al., 2004), so it is likely that a species difference 
exists, which may explain, in part, the differences between rat and mouse studies. 
Serial body fat measurements can be made using MRI (Tang et al., 2000), to 
counteract any loss of body fat that occurs with increasing illness in Min mice. 
One new technique that may help assessing the impact of exercise regimes in the 
future is the mouse endoscope (Becker et al., 2005). This miniature endoscope, with 
an external diameter of 1.9mm allows the researcher to monitor the progress of ACF 
and turnours in the colon. This endoscope was designed for use with mice developing 
colitis; if it were possible to use this equipment to examine the small intestine (where 
most Min tumours occur), it would be extremely valuable. Another alternative could 
be to use AOM-treated Min mice, which generate more colon tumours than normal 
Min mice (Suzui et al., 2002). Exercise effects which have an impact on humans may 
become more obvious with a greater number of colon turnours, allowing us to find a 
more accurate level of beneficial activity. 
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4 Effects of diet and exercise on body fatness in mice 
4.1 Introduction 
Dietary fat and obesity are closely implicated in the development of colon cancer, as 
discussed in Chapter 1. Obesity is associated with chronic inflammation, which 
generates several measurable biomarkers, such as tumour necrosis factor-alpha (TNF- 
a) and various interleukins, as mentioned in Chapter I (Opal & DePalo, 2000). 
Bell et al., (1997), showed that access to an exercise wheel for 8 weeks caused a 
significant reduction in body fat in female Swiss Albino mice even when fed a high 
fat diet (P<0.001). All exercising mice ran well, averaging 14.5kni/day (n =13/group), 
with no significant difference between low and high fat fed mice. Providing access to 
an exercise wheel for animals fed a high fat diet decreased body fat to values similar 
to those of non-exercised mice fed a low-fat diet (12.6% v. 13.9%). Exercised mice 
fed high fat diets were not significantly heavier than their low fat-fed exercising 
counterparts, but high fat non-running mice were significantly heavier than low fat- 
fed non-running mice (33g v. 28g). 
The following study was undertaken to investigate in more detail the effect of a high 
or low-fat diet on wheel running and on body composition. In particular, attempts 
were made to quantify non-exercise physical activity (NEPA), which has not been 
measured previously in studies of this kind. This is potentially important since 
animals undertaking exercise through wheel running (or treadmill running) may have 
different amounts or patterns of NEPA from mice without access to such exercise 
devices. This may have implications for energy balance and turnourigenesis. Also, a 
previous study (ES2) suggested that (possibly due to the oestrus cycle) female mice 
have a different pattern of running compared with male mice, and this observation 
was examined more closely in the following study. 
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4.2 Aims 
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e To quantify the effects of high and low fat diets on wheel running, body 
composition and NEPA in mice 
9 To investigate the effect of such diets on the inflammatory marker, TNF- a 
9 To test for relationships between running distance and stage of oestrus in 
female mice 
4.3 Hypotheses 
o Mice fed high fat diets will have more body fat than those fed low fat diets 
* Whcel-running mice will have less body fat and heavier hearts than non- 
running counterparts 
* High fat-fed mice will have higher plasma concentrations of TNF- a 
4.4 Specific methods 
4.4.1 Sample size 
The software package nQuery Advisor (Statistical Solutions Ltd, Cork, Ireland) was 
used to determine the required sample size to detect a difference at the P=0.05 level. 
The power calculation was based on the results of Bell et al, (1997) whose paper was 
the basis for this study. Four groups of size 8 were calculated to be required. 
4.4.2 Animals 
32 six-week-old C57BL6/J female mice were purchased from Harlan (Oxon, UK). 
They were housed in groups of 8 mice and fed chow (RM3 pellets, SDS, Essex, UK) 
ad libitum for two weeks to acclimatise them to their new accommodation. Other 
housing conditions were as stated in General Materials and Methods (Chapter 2). 
Mice were weighed twice each week on Monday and Thursday. 
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4.4.3 Diet and exercise groups 
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At 8 weeks old mice were randomised to either high fat (HF) or low fat diets (LF) (n-- 
16 for each group). Mice were then split into wheel (WH) or control (CON) groups (n 
=8 for each) and individually housed in cages. Wheels were 5 V2 " Comfort Wheels 
as used previously (Chapter 3). 
4.4.4 Diet composition 
The formulation of the test diets was based on Bell et al. (1997) as summarised in 
Table 4.1. 
Table 4.1 Composition (g/kg) of high and low fat test diets 
Ingredient High fat (HF) Low fat (LF) Supplier 
g/kg g/Mi g/kg g/MJ 
Cornstarch 253 27.0 500 32.5 Sigma 
Casein 241 13.0 200 13.0 Sigma 
Sugar 181 9.8 150 9.8 Co-op 
Beef fat 145 7.8 0 - Co-op 
Corn oil 60 3.2 50 3.2 Co-op 
Cellulose 60 3.3 50 3.3 MP Biomedicals 
(Alphacel) 
Mineral mix 42 2.3 35 2.3 MP Biomedicals 
AIN-93-G-MX 
Vitamins 12 0.6 10 0.6 MP Biomedicals 
AIN-93-VX 
Methionine 4 0.2 3 0.2 MP Biomedicals 
Choline 2 0.1 2 0.1 MP Biomedicals 
Butylated 0.04 0.0022 0.01 0.0006 Sigma 
hydroxytoluene 
Mice were offered 6g of diet daily. Food refusals were measured over two weeks of 
the study. Water was freely available. 
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4.4.5 Oestrus washes 
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A previous study (ES2) had highlighted the apparently cyclical nature of distances run 
by female mice and it was thought that this might reflect different stages in their 
oestrus cycle (approximately 3-5 days). Stage of oestrus cycle may be determined by 
the type and quantity of cells present in the vagina. To measure this, a fine tip pastette 
(Alpha Laboratories Ltd, Hants, UK) containing sterile saline was placed into the 
vagina. One drop of saline was squirted in and out of the vagina to collect the cells. 
The drop was placed onto a microscope slide and left to air dry before being stained 
with 0.1 % methylene blue. Slides were examined under a microscope and stage of 
oestrus detennined (Figure 4.1) (Short & Woodnott, 1969). 
Slides were categorised as stage 1-4 of oestrus as follows: I- (not in oestrus) mainly 
leucocytes present, possibly a few epithelial cells; 2- (approaching oestrus) mainly 
epithelial cells, few leucocytes; 3- (oestrus) no leucocytes, just cornified cells); 4- 
(post-oestrus) comified cells and leucocytes. 
Depending on when the sample is taken, stages may not always be clear-cut. 
-IL JA 
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Figure 4.1 Oestrus stages: a) stage 1. A few epithelial cells (upper arrow) are present amongst the 
majority leucocytes (lower arrow); b) stage 2 into 3. The leucocytes have disappeared, some 
epithelial cells are still present (upper arrow) but most cells are cornified cells (lower arrow); c) 
stage 3 (oestrus). Only cornified cells are present; d) Stage 4 (post-oestrus). Leucocytes are now 
present again amongst the cornified cells. All x200. 
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Vaginal washes for characterisation of oestrus stage were collected from each mouse 
on 17 consecutive days at the same time each day. Wheel revolutions were recorded 
immediately before the samples were taken. 
4.4.6 NEPA 
Non-exercise physical activity (NEPA) by each mouse was monitored by InfraMot for 
24 hours on two separate occasions. 
4.4.7 Necropsy and sampling 
Mice were killed after 8 weeks of study, using the methods described in General 
Methods and Materials (Chapter 2). Blood was collected into EDTA tubes and stored 
on ice until separation. Whole blood was centrifuged at x5000 for 10 minutes and the 
plasma pippettcd into a fresh cppendorf tube and frozen at -201C until use. Final body 
weight, liver and heart weights were recorded. Livers and hearts were snap frozen in 
liquid nitrogen and stored at -80T. Carcasses were stored at -20T. 
4.4.8 Body fat content 
The amount of fat in the carcass excluding the heart and liver was measured. 
Carcasses were first freeze-dried to remove water and then body fat was extracted 
following the Soxhlet procedure, as detailed in Appendix 6.3. 
4.4.9 TNF-a determination 
Plasma TNF-a was measured by ELISA (Ready-Set-Go!, eBioscience, cat # 88-7324- 
22), method as described in Appendix 6.9. The standard curve ranged from 8pg/ml to 
10OOpg/ml. Sensitivity of the test was 8pg/ml. Plates were read on a Molecular 
Devices Spectramax Plus using Spectramax software. 
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4.5 ES4 Results 
4.5.1 Wheel running data 
All the mice used their running wheels, and most mice ran a similar amount each 
week, with no decrease towards the end of the study. The range of distances varied 
between mice, as shown in Figure 4.2. 
Although HF mice as a group ran further on weeks 1,2,7 and 8 whilst LF mice ran 
further on weeks 3,4,5, and 6 (Table 4.2 and Figure 4.3), none of the between-diet 
differences was statistically significant (P>0.05). The similarity in running distance 
between groups was demonstrated at the end of the study, when after 8 weeks, LF 
mice had run further than HF mice byjust 7km (374km v. 367km, P=0.905, Figure 
4.4). 
Table 4.2 Mean daily distance (km) run each week by HF and LF mice 
Probability of effect 
Week High fat Low fat SEM of diet 
1 4.64 2.46 1.11 0.187 
2 9.28 6.75 1.60 0.282 
3 8.24 10.41 1.49 0.320 
4 7.06 9.10 1.46 0.341 
5 6.69 7.61 1.16 0.583 
6 5.67 6.62 0.81 0.424 
7 5.66 4.91 1.04 0.621 
8 6.08 5.30 0.84 0.525 
Total in 8 367.3 374.0 38.99 0.905 
weeks 
n=8 for each group 
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Figure 4.4 Distances run in 8 weeks by individual mice in each diet group 
Two mice ran so much that their feet started to bleed, so wheels were removed on 3 
and 2 separate days, respectively (Figure 4.5) to give the animal's feet time to 
recover. When the wheels were returned, the mice continued to run as non-nal and no 
further ill effects were observed. 
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Figure 4.5 Daily distance run by 2 individual mice. The yellow shapes at distance zero are the 
days when the wheels had been removed as the mice were making their feet bleed. This was 
followed by a return to normal running distance (green shapes) 
4.5.2 Food intake 
Due to the physical nature of the food, measurement of intake was possible only for 
those mice consuming the HF diet. The LF diet had a fat content that was too low to 
allow the food to be compressed, so the mice were effectively given a powder diet. 
This resulted in the food being spread around the cage, including throughout the 
sawdust, on the cage bars, in the bedding and in the mouse's fur. In preliminary 
studies, attempts were made to prevent this spillage by mixing the LF diet with water 
but it was found that the diet solidified when liquid was added and the diet became 
too hard for the mice to eat. If a mouse urinated into the pot it was not possible to 
remove all of the diet to weigh it. 
Although the HF diet was not solid, it had a more crumbly texture that allowed the 
mice to pick up small lumps to eat. There was a problem with scattering from some 
HF mice, but in general any uneaten diet remained in the food pot. 
To determine the extent of scattering, the indigestible marker chromic oxide was 
added to trial samples of food. The chemical is bright green and stands out well 
against the other cage contents. This showed the LF diet being well scattered. 
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Food intake was measured during weeks 4 and 5, when the mice were accustomed to 
the diet and protocol. There were no significant differences between WH and CON 
during either week, and no difference from week 4 to week 5 within each group 
(Table 4.3). 
Table 4.3 Mean daily food intake (g) for WH and CON fed high fat diets 
Week of 
study Wheel ci Control CI Probability 
Week 4 3.3 2.96-3.68 3.1 2.42-3.84 0.337 
Week 5 3.1 2.85-3.46 3.1 2.81-3.41 0.826 
P 0.152 0.640 
n=8 for each group 
4.5.3 Body weights 
Initial weights ranged from 15.6g to 20.4g and final weights ranged from 17.8g to 
33.2g. Weekly weights and weekly weight gain of all mice are displayed in Figure 
4.6. Due to the large difference in initial weights, these values were used as a 
covariate in the analysis of weekly weights. 
One HF CON mouse gained substantially more weight than any other mouse (see 
Figure 4.6). Analyses were also run with data for this mouse removed in case of bias, 
but values did not alter greatly. For weekly VM v. CON weights, the only difference 
was at week 1, with VM starting heavier than CON (18.27g v. 17.24g, P=0.015). 
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Chapter 4 
Weight differences between diet groups were significantly different on every week 
except the first, with HF mice heavier than LF at every week (Figure 4.7 and Table 
4.4). This did not change even with the heavy mouse removed, although some P- 
values altered slightly, with week 3 showing the only alteration in statistical 
significance (P = 0.043 changed to P=0.057). 
Weight gain was significantly different between the dietary groups on weeks 2 and 7 
(P = 0.036 and 0.005 respectively) only. On both occasions HF mice gained more 
weight (Figure 4.7). 
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Weights were not significantly different between WH and CON on any week (Figure 
4.8) and weight gain was significantly different between exercise groups for the first 
week (P = 0.024) only, during which WH mice lost on average 0.56g compared with a 
gain of 0.23g by the CON mice. 
Weights by exercise and diet group are displayed in Figure 4.9 and Table 4.4. There 
was no interaction between diet and exercise on any week. However, there was a 
Significant interaction between diet and weight gain at week 4 (P = 0.008) only, which 
is displayed in Figure 4.10. In week 4, HF WH mice gained more weight than LF 
WH, but LF CON gained more weight than HF CON. 
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4.5.4 Organ weights 
Chapter 4 
Hearts and livers were removed for weighing and these weights were also calculated 
as percentage of final body mass. There were significant (P<0.05) effects of diet on 
both heart and liver weights (Table 4.5). HF-fed mice had heavier hearts compared 
with LF-fed mice (0.170 v. 0.140g, P=0.040), and also heavier livers (1.039 v. 
0.925g, P=0.025) but when these weights were expressed as % final body mass, 
differences were non-significant (P>0.05, Table 4.6). Wheel-running mice had 
heavier hearts than control mice (0.169 v. 0.13 8g, P=0.023), and this effect persisted 
when expressed as % final body mass (P = 0.009, Table 4.6). There was no 
statistically significant effect of exercise on liver weight. 
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4.5.5 Body composition 
Chapter 4 
Body composition measurements were made on the carcass after the removal of the 
heart and liver. 
Individual body fat values ranged from 7.7% in a LF WH to 37.8% in a HF CON 
mouse but the differences between either diet or exercise groups ) were not 
statistically significant (P>0.05 Figure 4.11, Table 4.7). When exploring diet and 
exercise groups further, mice had body fat in the following order (greatest first): HF 
CON, HF WH, LF CON, LF " with percentages of 14.6,13.7,12.9 and 10.7 
respectively. 
There was no interaction between diet and exercise on body fat. 
Wheel Control 
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12% PF OWater 
0 Fat 
U Fat free mass 
Low fat 
12 '/,, 
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151Y. 
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2% 
Figure 4.11 Body cornposition data by diet and exercise group (arithmetic nicans) 
LF mice had significantly more body water than HF mice (65.4 v. 62.3%, P=0.019) 
but there was no significant difference between CON and WH mice (64.4 v. 64.5%, P 
= 0.880, Figure 4.11 and Table 4.7). 
-231 - 
Laura Basterfield Chapter 4 
Fat-free dry matter (FFM) contributed a similar proportion to total body mass in all 
groups, with no statistically significant differences (Table 4.7 and Figure 4.11). 
The data included the mouse that grew much more than any other (finishing the study 
9g heavier than the next heaviest mouse). This mouse had a carcass constituting 38% 
body fat, 45% water and 17% FFM. As these values were markedly different from the 
other mice (the next greatest percentage of body fat was 21% in a LF CON mouse), 
analyses were performed after excluding this mouse to observe whether this one 
mouse had skewed the results. Table 4.8 shows the data obtained. P-values were 
increased, but the difference in body water between HF and LF remained significant 
(63.1 v. 64.9%, P=0.039). 
On a g/mouse basis, the only statistically significant difference was of dietary group 
on body water, with HF mice containing 0.8g more than LF mice (13.1 v. 12.3g P 
0.004), the converse of the observation when data were expressed as % of carcass. 
The amount of fat in HF mice approached significance compared with LF, 2.8v. 2.3g, 
P=0.08 1. There was no effect of exercise group on any of the variables and no 
interactions were observed (Table 4.9). 
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Table 4.9 Body composition (g/mouse) excluding the heaviest mouse (n) (mean and SEM) 
Variable 
(9) 
WH 
(8) 
HF 
CON 
(7) 
LF 
WH 
(8) 
CON 
(8) 
Diet 
Probability of Effects 
Exercise Diet*exercise 
Water 13.3 12.9 12.4 12.3 0.004 0.344 0.575 
0.25 0.26 0.25 0.25 
Fat 2.9 2.7 2.1 2.5 0.081 0.758 0.248 
0.27 0.29 0.27 0.27 
FFM 1.3 1.1 1.1 1.1 0.160 0.390 0.361 
0.09 0.09 0.09 0.09 
4.5.6 TNF-alpha 
Concentrations of TNF-a were low in all plasma samples. Concentrations of TNF-a 
were lower in WH than CON mice (median values 44.8 v. 49.7pg/ml respectively). 
LF and HF mice had identical median TNF- a concentrations of 48.2pg/ml (Table 
4.10 and Figure 4.12). Neither the difference between WH and CON nor between HF 
and LF mice approached significance (P > 0.05). 
The ELISA required 100ýtl of plasma per sample. Blood samples from four mice did 
not produce enough plasma for duplicate tests and for three mice there was less than 
I 00gl in the duplicate sample. When analyses were re-run including only samples for 
which there was enough plasma for two complete measurements, there were only 
marginal alterations in the median values of TNF-a concentration (Table 4.11). The 
difference between VM and CON mice became even less significant, with the CON 
concentration becoming closer to that of WH mice. The difference between HF and 
LF mice widened, though not statistically (P<0.05) so, with the median LF 
concentration decreasing and the HF concentration remaining the same (44.8 v. 48.2 
pg/ml, Table 4.11 and Figure 4.13). 
-234- 
Laura Basterfield Chapter 4 
Table 4.10 TNF- a concentrations of mice by diet and exercise group (pg/ml) (median and range) 
Exercise (n) Diet (n) Probability of 
effects 
Variable Wheel Control HF LF Exercise Diet 
(16) (16) (16) (16) 
TNF_(XKW 44.8 49.7 48.2 48.2 0.141 0.752 
40.6-57.3 42.2-84.9 43.3-65.4 40.6-84.9 
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Figure 4.12 Concentrations of TNF-a by exercise and diet group 
LF 
Table 4.11 TNF-a concentrations (pg/ml) for samples with complete duplicates only (median and 
range) 
Exercise (n) Diet (n) Probability of 
effects 
Variable Wheel Control HF LF Exercise Diet 
(15) (9) (14) (10) 
44.8 0.355 0.178 
40.6-57.3 42.2-65.4 43.3-65.4 40.6-51.4 
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Figure 4.13 Concentrations of TNF-a for samples with complete duplicates only 
4.5.7 NEPA 
The non-exercise physical activity (NEPA) of each mouse was recorded twice over 
the duration of the study using the InfraMot, for 24 hours on each occasion. One 
mouse from each treatment group (HF CON, HF WH, LF CON, LF WH) was 
recorded each day. Figure 4.14 shows the differences in activity by individual mice in 
the first and second recordings. There were very large between-mouse differences but 
only small differences in activity levels between the two days of recordings, and 
overall the between-day differences were not significant (P = 0.368). 
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Figure 4.14 Differences in total activity by individual mice in each 24h recording 
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Table 4.12 shows the differences in activity of the mice by treatment group. VvUlst there 
was no effect of diet on total 24h activity, HF WH recorded the most activity, followed 
by LF WH and LF CON. HF CON were the least active over the 24h recording period. 
As expected, there was a significant (P<0.001) effect of exercise treatment on 24h 
activity, with both LF and HF WH recording more activity than their sedentary 
counterparts. CON mice recorded 59% of the activity of WH mice (855 X103 V. 1 449 
X103 counts, Figure 4.15). 
The activity recorded during the light phase was affected by both diet and exercise (P = 
0.002 and 0.001 respectively), with LF CON mice the most active group, recording twice 
the activity of the other 3 groups (193 X103 counts). Activity during the dark phase was 
unaffected by diet (P = 0.728) but significantly affected by exercise group (P<0.001), 
with both HF and LF WH more active than HF and LF CON. 
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Figure 4.15 Mean and 95% Cl of 24 h activity for exercise and diet groups (arithmetic means, n- 16) 
Activity during the dark phase was considerably higher than activity during the light for 
all groups, with on average 9.5 times more activity during the dark than the light (1 133 
X103 V. 119 X103 counts, arithmetic means). However, whilst LF mice were more active 
during the light than HF mice (P = 0.002), there was no significant difference in mean 
activity between the two diet groups during the dark phase (Figure 4.16). When averaged 
across both diet groups, WH mice were 1.9x more active than CON during the dark (I 
3 X103 X 103, p,,, 55 v. 701 '0.001). 
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There were significant interactions between diet and exercise on all three NEPA 
variables; total 24h activity (P = 0.002), light-phase activity (P = 0.001), and dark-pliasc 
activity (P = 0.012, Table 4.12 and Figure 4.17). 
Whilst HF WH were more than twice as active as HF CON over 24h, the activity ofl-F 
WH and LF CON was more similar, with LF WH recording 1 239 X103 counts compared 
with 1 014 x 103 of LF CON. 
During the dark phase, WH mice of both diet groups were more active than the CON 
mice of their respective diet group, but LF CON were more active than HF CON and LF 
WH were less active than HF WH. 
HF CON and HF WH had similar, low levels of activity during the light phase, which 
were matched by LF WH. However, LF CON mice recorded very high levels of activity 
during this phase, more than doubling the activity of the other groups (Figure 4.17). 
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Figure 4.17 Interactions between exercise and diet for (a) 24h, (b) dark-phase and (c) light- 
phase activity (arbitrary units) 
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4.5.8 Oestrus cycle 
Chapter 4 
A previous study (ES2) had discovered that some female mice demonstrated a cyclical 
pattern with regard to the daily distance run in wheels, when no such pattern was evident 
in males. 
During the present investigation, the mice were assessed for stage of oestrus at the same 
time on each of 17 consecutive days, as described in the Specific Methods section to this 
chapter (4.4.5). Four main stages were identified, designated 1-4. 
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Figure 4.18 Examples of the variation In 
running distance and pattern In mice during 
the 17d period during which measurement of 
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extreme patterns, while mouse 8527 Is more 
typical of the patterns observed In this study 
-241- 
Laura Basterfield 
Mouse 8534 
12000- 4 
10000-- p0 E0 00 
POO 
Cy- 3 
C 8000-- %0 10 % 0) .0 20 '01 
0 00 6000-- --2 
0 4000-- 
vU 
-10 2000 
0 
16 11 Distance 
Day of measurement ---$-Stage 
Figure 4.19 Relationship between oestrus stage and running distance 
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A cyclical pattem of running was not as obvious in this study as in the previous study 
(ES2), as shown in Figure 4.18. Mice demonstrated varying cycle lengths and time spent 
in each stage. Stage data were unavailable for 38 of 272 samples due to technical 
difficulties including the cells not taking up the stain or too few cells being present in the 
sample. In particular there were few slides of stage 2, either due to lack of staining or 
through mice passing through this stage quickly, before samples were taken. 
The pattern that seemed to emerge was one of decreased running during- and post-oestrus 
(stage 3-4) followed by increased distance pre-oestrus (stages 1-2). Figure 4.19 shows an 
example of this possible link. 
The difference between the distance run during each stage of the oestrus cycle was tested 
using one-way ANOVA with Tukey's 95% simultaneous confidence intervals. This test 
"provides confidence intervals for all pairwise differences between level means" 
(Minitab). An error rate of 5 was chosen to provide the 95% confidence intervals. 
The test showed that the distances run during stages 3 and 4 were significantly difference 
from stage 2 (P = 0.021, Figure 4.20), i. e. the distance run during stage 2 (pre-oestrus) 
was significantly further than that run during and just after oestrus. 
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Oestrus stage 
Figure 4.20 Means and 95%C1 for the distances run during each stage of the oestrus cycle 
4.6 Discussion 
This investigation was carried out to assess the impact of diet and exercise on weight 
gain, body composition and inflammatory status. 
4.6.1 Wheel-running and NEPA 
Previous studies (ES2 and ES3) suggested that the mice would use their wheels, and 
indeed there were few problems with this form of exercise, although the inter-animal 
distances run varied considerably. The average daily distance run by HF mice was 6.6kn-4 
and by LF mice, 6.7krn. Table 4.13 compares some studies of mice given access to 
running wheels and shows that the distances run by the mice in this study are similar to 
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those run by male mice in a comparison of 7 different mouse strains (Lerman et al., 
2002), and almost double those run by the same strain of mice (C57BU6) in the study of 
Lightfoot et al. (2004), although female mice of this strain ran approximately Skm/d. 
The studies using Min mice (which are on a C57BL/6 background) observed distances 
that were also much less than those of this study (Colbert et al., (2003), Mehl et al., 
(2005b) ES2 and ES3). Indeed, the distances in this study compare favourably with 
distances run by female mice selected and bred for their running ability, which covered 
6.5km/day (Bronikowski et al., 200 1). However, Bell et al. (1997) recorded distances of 
14.91an for LF and 14.5km/d for HF-fed mice which, given the maximum average daily 
distance in the inter-strain study of Lightfoot et al. (2004) was 7.95km by C57UJ mice 
(10km for the females), is a high value, though the Swiss Albino mice used by Bell et al. 
were not included in the comparison. 
The InfraMot system does not allow us to distinguish activity that is wheel running from 
any other cage activity. A literature search has not yielded any evidence of increased 
cage activity by mice that also have access to a wheel. For this reason, the difference in 
activity between VVH and CON is not discussed in detail. 
Unlike the small number of WH mice recorded in ES3, this study found a highly 
significant increased in total activity of WH mice compared with CON mice. This had 
been expected, but it is not possible to detennine whether this increase is solely due to the 
running or whether the presence of a wheel in the cage caused the mice to be more 
inquisitive and active in exploring the wheel and the cage in general. 
For each NEPA variable, LF CON mice were more active than HF CON (Table 4.12). 
This is in accord with Funkat et al., (2004) who reported decreased activity in C57BIJ6 
mice fed HF diets compared with those fed control diets, an effect also observed in rats 
(Bartol-Munier et al., 2006). However, Funkat et al. (2004) also reported a decrease in 
wheel-running activity of HF-fed mice, which is the opposite of the observations made in 
this study. No explanation is offered for this finding. The differences in activity may have 
been linked to food intake, but as LF intake was not measurable, further investigation of 
this phenomenon is required. To date, NEPA has not been measured in any other studies 
of exercise in mice. 
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Table 4.13 Summary of distance run (km/d) by mice given free access to exercise wheels 
Mouse strain 
Sex Age Distance Length of study Reference 
(wk) (km) (wk) 
Lightfoot et C57BL/6 Combined 9 3.8 3 al t)nnA't* 
C57BL/6 Male 20-24 
C57BL6/Min Female 5-6 
Male 5-6 
"I., k'&Wwýj 
7.6 2 
Lennan et al. 
(2002)** 
3.6 2-3 (Quarantine 
Colbert et al., 
only) (2003) 
3.1 2-3 (Quarantine if 
only) 
MAI ftql-- 
C57BL6/Min Female 4 3.5 9 -- -1 (2005b) 
Male 4 4.7 9 of 
C57BL6[Min Female 5 4.5 10 ES2 
Male 5 2.1 10 it 
C57BL6/Min Female 5 3.3 10 ES3 
Male 5 1.9 10 it 
Swiss Albino Female 6 14 9 8 
Bell et al., 
low fat diet . (1997) 
Female - 6 14.5 8 of high fat diet 
Outbred 
Hsd: ICR Female 6-8 
3.6 6 days 
Bronikowski 
et al., (2001) 
Outbred 
Male 6-8 2.6 6 days it Hsd: ICR 
Outbred 
Hsd: ICR Female 6-8 6.5 6 days it 
selected*** 
Outbred 
Hsd: ICR Male 6-8 4.3 6 days it 
selected*** 
* 14 strains of mice were analysed In this study, C57BU6 shown here as this Is the Min background 
strain, ** 7 strains of mice were analysed, *** mice have been bred for wheel-running ability 
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4.6.2 Food intake 
Chapter 4 
Food consumption was only measurable on the HF-fed mice, as the LF diet was powder 
and was scattered by the mice. There was no detectable difference in intake between WH 
and CON mice, which was unexpected given the anticipated extra energy expenditure of 
the WH mice. ES2 and ES3, Bell et al. (1997) and others (Koteja et al., 1999; 
Bronikowski et al., 2001; Mehl et al., 2005b) have also reported an increase in food 
consumption among wheel-running mice. Bell et al. (1997) found an increased energy 
intake of HF mice compared with LF for both WH and CON mice, perhaps suggesting 
that the HF food was more palatable, as the WH mice did not need the extra energy for 
running, as they did not run further than the LF mice. Bell et al. (1997) did not note any 
problems in measuring food intake, but also did not give any detail of how it was 
achieved. The inherent problems in measuring food intake (as mentioned in 4.5.2) mean 
that the validity of our results is thrown into doubt. 
4.6.3 Body mass and composition 
The lack of difference in body weights between WH and CON are in accordance with the 
results of ES2 and 3 but, in contrast, Bell et al. (1997) found that exercised mice were 
lighter than controls. The lack of difference in this study could have been due to the 
formation of muscle tissue by the WH mice as opposed to the fat produced by the control 
mice. However, this supposition was not fully supported by the body composition 
analysis, because although CON mice had more body fat and less non-fat dry matter 
(including protein from muscle), the differences between VVH and CON mice were not 
significant. 
The significant effect of diet on weekly body weights was due to the HF mice weighing 
more than the LF mice. The HF mice consisted of more fat and significantly more water 
than the LF mice (when expressed as g1mouse), and agrees with the findings of Bell et 
al., (1997) who used the same formulation diets as in this experiment. 
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Why one mouse grew more than the others, and consisted of 38% fat, is harder to 
explain. C57BL/6 mice have a preference for fat when offered a choice of macronutrients 
and a tendency to obesity (Smith et al., 2000), but the mice did not have a choice of food, 
and this mouse in particular did not eat more than the other mice over the recording 
period. The average intake for the heavy mouse on week 4 was 2-9g compared with a 
group average of 3.1 g, and 3.4g on week 5 compared with 3.1 g for the group. However, 
out of the 64 InfraMot recordings generated by all the mice on study, the heavy mouse 
recorded the least and tenth least amounts of activity for its 2 recordings. If this mouse 
had continued to be inactive and had increased its food consumption the weight gain 
could perhaps be explained. However, there was no correlation between fmal body 
weight and total 24h activity (r = -0.07, P=0.704). 
Organ weights 
This study found an increase in heart weight that had not been detected in previous 
investigations (ES2). This increase is consistent with reports of cardiac hypertrophy in 
response to prolonged exercise exposure (McArdle et aL, 2001; Mehl et aL, 2005b). 
HF-fed mice had heavier livers than their LF-fed counterparts, a finding also seen in 
female Zucker rats (Jen et al., 2003), however, as % body mass there was no difference 
between either the diet or exercise groups in this experiment, the converse of that found 
in ES2 and 3, suggesting that the increased mass was simply a result of the mice being 
larger. Schernmel et al. (1992) found that treadmill exercise in young female rats did not 
change body mass or organ weights compared with controls and Jen et al., (2003) found 
no effect of swimming exercise on liver weight in female Zucker rats. 
4.6.4 TNF-a 
TNF-a was measured in this investigation as a biomarker of inflammatory status, as 
obesity is associated with increased levels of inflammatory proteins such as C-reactive 
protein and TNF-a (Panagiotakos et al., 2005b). Feeding HF diets led to a non-significant 
increase in TNF- a concentration compared with LF-fed mice, perhaps suggesting that 
the higher fat diet was causing some increase in inflammatory status, which would tie in 
with the increased body fat of the HF-fed mice. Other authors (Borst & Conover, 2005) 
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did not find an increase in serurn TNF- a in young rats fed a high fat diet, even though 
the rats became obese. However, soluble TNF- a was increased in muscle and fat. 
Physical activity is associated with decreased levels of inflammatory markers in humans 
(Pischon et A, 2003; Colbert et aL, 2004; Panagiotakos et aL, 2005a). This study did not 
find a significant effect of wheel-running on plasma TNF- a, although concentrations 
were reduced in WH compared with CON mice. The effect of acute treadmill exercise on 
plasma TNF- a in C57BI16 mice has been measured, and the authors found no difference 
from control animals (Colbert et al., 2001). Analysis of various tissues found no increase 
in muscle, liver or brain TNF-a mRNA, although fatiguing exercise produced an increase 
in lung mRNA (Colbert et al., 2001). 
This suggests that either the exercise is not sufficient to reduce TNF- a or that the diets in 
this study were insufficient to induce obesity and stimulate an inflammatory state in the 
animals. A different marker may have been more sensitive, e. g. IL-6 is reduced in 
physically active people (Colbert et al., 2004; Panagiotakos et al., 2005a). This is thought 
to be due to a decrease in fat mass, as IL-6 is released from adipocytes (Pischon et al., 
2003). However, IL-6 was not found to be different in earlier studies in this thesis (ES I), 
perhaps due to the lack of body fat. 
4.6.5 Oestrus cycle 
The links between oestrus and running distance have not been reported previously for 
laboratory mice, although similar studies exist for other species such as the golden 
hamster, which runs further during pre-oestrus and oestrus (Richards, 1966) and lab rats, 
which run most before oestrus and least immediately after (Anantharamanbarr & 
Decombaz, 1989). The experiment in this chapter discovered that mice ran less as they 
were coming into oestrus, with a low post-oestrus, then increased the distance to a high 
pre-oestrus, which is in accord with the findings from the rat. 
The reason for this alteration in running distance is unknown and could be compared with 
total cage activity as measured by the InfraMot. The study in rats (Anantharamanbarr & 
Decombaz, 1989) also measured total energy expenditure by indirect calorimetry, but did 
not find a clear relationship between energy expenditure and day of oestrus cycle in 
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wheel-running rats; however, sedentary rats decreased their activity after oestrus. The 
presence of a running wheel may have marred the measurement of energy expenditure in 
the wheel-running rats, as they may have felt some compulsion to perform extra activity. 
Nevertheless, these results agree with our own and highlight the importance of long-term 
monitoring of wheel running behaviour in female animals to prevent making judgements 
on running ability that may have been influenced by the oestrus cycle. 
4.7 Conclusions 
This study was performed to address a number of hypotheses, and has answered them as 
follows: 
9 Nfice fed high fat diets will have more body fat than those fcd low fat diets. 
Tbc HF dict caused a non-significant increase in body fat. 
* Wheel-mming mice will have less body fat and heavier hearts than controls. 
Whecl-running led to a non-significant decrease in body fat and a significantly 
heavier heart. 
9 HF mice will have higher plasma TNF-a concentrations. 
TNF-a was increased non-significantly in HF mice, and non-significantly decreased 
in WH mice. 
In the context of colon cancer, obesity and chronic inflammation are associated with 
increased risk (Panagiotakos et al., 2005b). Further studies of this nature should use a 
higher fat diet, or a mouse more predisposed to obesity, as AOM treatment in a mouse 
genetically altered to display both obese and diabetic phenotypes (C57BIJKsJ-dbldb) 
developed more pre-malignant colon lesions compared with either heterozygotes or wild 
type animals (Hirose et al., 2004). Crossing oblob mice with Nlin mice may allow closer 
assessment of the effects of obesity on colon cancer development. Different inflammatory 
markers in adipose tissue and muscle could also be measured. There was some variability 
in response to the running wheel, so increased numbers of mice may help to increase the 
number of mice who run well. 
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5 Summary 
The three initial experiments in this thesis demonstrated that exercise does not affect 
tumour number in the Min mouse. This is in agreement with the findings of others 
(Colbert et aL, 2000; Colbert et aL, 2003) and partial agreement with Mehl et aL (2005). 
The lack of effect of exercise in Min mice compared with rats and humans may be due to 
the lack of progression of adenomas to carcinomas, and exercise may be beneficial in 
reducing the progression of adenomas. As no molecular biology was carried out on the 
mucosa or adenoma tissue, it is possible that exercise made changes at the tissue level 
which may not be observed by only assessing the number and size of adenomas. In 
addition, rates of apoptosis as well as proliferation would provide further important 
infon-nation on tissue growth, and further molecular and cytological investigation is 
warranted. 
A constant finding was that neither a low fat diet nor exercise reduced body fat compared 
with high fat diets and/or lack of additional exercise. Differences in NEPA between male 
and female mice, and between exercising and non-exercising mice should also be 
investigated further to assess the impact of the exercise regime on additional cage 
activity. Further experimentation on energy intake and accurate assessment of energy 
expenditure via indirect calorimetry may provide the answer to this finding. 
The lack of change of body fatness in mice in either chapter is important for 
understanding the lack of effect of exercise on tumourigcnesis. The main difference 
between rat and mouse studies to date has been the decrease in body weight and fat mass 
in exercised rats, compared with most studies of exercised Min mice. This inability to 
alter energy balance suggests a different approach is required, as mentioned in earlier 
chapters (3.6.2). The lack of difference in body fat in mice fed diets with different fat 
contents may have been due to increased food intake, as low fat fed control mice also had 
greater NEPA. 
This thesis has shown that the Min mouse model does not demonstrate plasticity in 
tumour number in response to exercise, and different mouse models or exercise regimes 
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may be required to reinforce the observations from rat and human studies of physical 
activity and colon cancer. 
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6 Appendices 
6.1 Genotyping 
6.1.1 Tall Biopsy Sampling 
Appendices 
1. Mice were placed into an induction chamber with 3% isofluorane in oxygen flowing 
tluough. 
2. The drowsy mouse was placed into a face mask until an appropriate level of 
anaesthesia was attained, i. e. loss of pedial and tail reflexes. 
3. O. Scm. of tail was removed using sharp scissors and placed in cell lysis buffer: 
121.14mg I OmM TRIS, 584.4mg 100mM NaCl, 930.5mg 25mM EDTA, 100nil UPW, 
made to pH 8.4. 
4. Bleeding was stopped by hot iron cauterisation and an "AVID" identification microtag 
(AVID Microchip Systems, Folsom, LA, USA) was implanted subcutaneously at hip 
level. 
5. Analgesia (0.5n-A 1: 100 buprenorphine in sodium chloride) was administered 
subcutaneously. 
6. The mouse was allowed to recover in a clean cage. 
6.1.2 DNA Extraction from Tall Biopsy 
I- The tissue sample was placed on Petri dish and covered with cell lysis buffer to 
prevent dehydration and minced using scalpel blades. 
2. The tissue was transferred to an eppendorf and resuspended in 500gl Cetus PCR 
buffer: 
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5nd 5M KCI, 5ml 1M TRIS/HCI, 5ml 0.25M MgC12,2.25nil Nonidet P40,2.25ml Tween 
20, O. 5g gelatin, 480ml UPW. [lM TRIS/HCI = 121g TRIS, 4.9mlConc HCI, 11 UPW, to 
pH 8.0. 
3.50 Proteinase K (20mg/ml) was added, vortexed briefly and placed in heat block at 
55*C for at least 3 h. 
4. The sample was then heated to 95'C for 15 min to inactivate the Proteinase K. 
5. After centrifuging for 5 min, the supernatant was removed to a new eppendorf and the 
pellet discarded. 
6. The supematant was used for PCR. 
6.1.3 MIN PCR 
1. The master mix consisted of 1.5pi Forward primer, 1.5ptl reverse primer (MWG 
Biotech), 19ýd H20 per sample. 
Ntin primer sequences: 
Forward - TCTCGTTCTGAGAAAGACAGAAGCT, 
Reverse - TGATACTTCTTCCAAAGCTTTGGCTAT 
2.30 supernatant containing DNA was added to 22ýd mastermix (using 3ýd H20 for 
negative control and 3gl positive MIN sample for positive control) and added to a PCR 
tube containing a PCR bead consisting of Taq polymerase and dNTPs (PuReTaq Ready- 
to-Go PCR beads, Amersham Biosciences). 
I Samples were run on a Techne Genius PCR machine as follows: 
94'C 4min xi 
[94'C Imin, 55'C Imin, 72'C Imin] x35 
72"C 10min xl 
4'C hold 
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6.1.4 Digestion 
Appendices 
1. Hind III digestion mix consists of 7. Ogl H20,0.2[d BSA, 0.8gl Hindlll, 2.0ýd Buffer E 
(all Promega) per sample. 
2.1 Oýd PCR product was added to I Ogl digestion mix and digested in the water bath at 
37"C for at least 3 h. 
6.1.5 Running gel 
1. Gel components for 8% acrylamide gel: 
20.93ml H20, 
2.4ml I OxTBE, 
0.48ml ammonium persulphate (10%), 
6ml 40% acrylamide (Sigma), 
1.2pd ethidiurn bromide (Sigma), 
192ýtl TEMED (Sigma). 
2. Components were mixed and poured into a gel tray with a comb and left to set. 
3. The gel was covered with I xTBE. 
4.20 dye was added to I OgI digest product, and mixed thoroughly before I OgI PCR/dye 
mix was added to wells. 
5.1 W dye and 5 gI DNA marker (Promega) was used in the last well and the gel was run 
at 75V for 1.5h before being removed and read using a molecular analyst (UVI 
PhotoMW, UVItec Ltd, Cambridge, UK). 
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6.2 Western high-fat diet (Williamson et al., (1999)) 
Appendices 
Ingredient g/Kg SuPplier 
Casein high nitrogen 279.49 ICN (901293) 
Lard 250 Asda 
Cornflour 250 Sigma 
Sucrose 148 Co-op 
Minerals AIN-93-G-MX 35 ICN (960400) 
Gelatine 20 Co-op 
Vitamins AIN-93-VX 10 ICN (960402) 
L-cystine 3 ICN (101454) 
Choline bitartrate 2.5 ICN (101384) 
Cr203 2 BDH (277574Q) 
t-butylhydroquinone 0.014 Sigma (B9161) 
The dry ingredients were added to a mixing bowl as follows: 
1. Least amount first (t-butylhydroquinone), followed by next smallest amount (Cr203) 
etc. and placed on setting 2 (slow speed) of mixing machine (CryptoPeerless ED 12) for 
90 min. 
2. The lard was melted in a microwave and poured slowly into the mixer and left to mix 
for a fin-ffier 30 min. 
3. Mixed diet was scooped into a storage container and stored at -20"C until required. 
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6.3 Soxhlet Procedure 
Appendices 
1.50ml flat bottomed Soxhlet flasks were dried in an oven for I hour and labelled and 
weighed when cool. 
2. Thimbles were labelled in pencil. 
3.2 thimbles and 2 cotton wool plugs were placed on balance and tared. 
4. The freeze-dried carcass was cut into pieces(< lcm) into a beaker. 
5. The cut carcass was divided between thimbles and plugged with cotton wool. 
Forceps, sccateurs and beaker were wiped with cotton wool before using as a plug. 
6. Thimbles were weighed before placing into an extractor and fitted to soxhlet flask. 
I- 7. Petroleum ether (petroleum spirit B. Pt 40"-65', VWR) was added until extractor had 
siphoned twice. 
8. Extractors were attached to cooling condensers and allowed to reflux on hot plates for 
6 h. [The ether evaporates and recondenses in the coils and flushes down through the 
thimbles, extracting fats into the bottom of the flask]. 
9. Solvent was then removed from the extractor until the flask contains only fat. 
10. Flasks were dried for 30 min at 800C to evaporate any remaining ether. 
11. Flasks were cooled in a dessicator before reweighing. 
12. Thimbles were dried overnight at room temperature before the contents were milled 
in a coffee grinder and extracted a second time. 
13. Body fat was calculated thus: 
Body fat content (g) = (dry wt of flask + fat) - (dry weight of flask) 
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6.4 Crypt cell proliferation (Goodlad & Wright, 1982) 
1. Sample was placed initially in Carnoy's fixative and transferred to 70% ethanol after 
24h and stored refrigerated until analysis. [Camoy's = 60: 3 0: 10 
ethanol: chloroform: acetic acid] 
2. A small strip of mucosa was removed and transferred to 50% EtOH for 10 min r. t.., 
then transferred to IM HCI for 10 min 600C to hydrolyse. 
3. Tissue was the transferred to Schiffs' reagent ( Sigma) for 45-60 min r. t. to stain 
DNA then transferred to 45% acetic acid for up to 48h at 4"C. 
4. The sample was placed on a microscope slide under stereodissecting microscope and 
hypodermic needles used to tease off groups of crypts from connective tissue. 
S. A coverslip was placed on top (using a drop of acetic acid to prevent tissue from 
drying out) and pressed fim-Ay to spread crypts. 
6. Position of crypts were located under light microscope xlO. 
7. At x400, lengths and widths of crypts were measured. Crypts were divided into 3 
equal length sections (bottom, middle and top) and the number of mitotic cells 
counted in each. Heavily stained nuclear bodies were usually in mitosis. Telophase 
appears as 2 smaller, separate bodies. 
8. At least 10 crypts per sample were counted (at x400, I graticule mark= 2.525um). 
-257- 
Laura Basterfield Appendices 
6.5 Chromic oxide determination (Mathers & Fotso Tagny, 1994) 
Reagents: 
MnS04.4H20: I OOg/L aqueous solution 
Acid mixture: 30ml MnS04 solution diluted to IL with concentrated orthophosphoric 
aci (H2P04. specific gravity 1.75) 
Potassium bromate (KBr03): 45g/L aqueous solution 
CaCl2: 5.47g CaC12.6H20/L (gives 1 000ppm Ca) 
Sodium metasilicate: 7.55g Na2SiO3.5H20/L aqueous solution (gives 1 000ppm Si) 
Stock potassium dichromate: 2.4194g oven dried K2Cr207 dissolved in 500ml (gives 
1250pprn Cr2O equivalent) 
Preparation of chromium-containing standards (Table 6.1). These are the standard 
solutions for calibration of the atomic absorption spectrophotometer. 
Table 6.1 Standard solutions for calibration of spectrophotometer 
Standard 
(PPM Cr2O3) 
Stock 
K2Cr2O3 (MI) 
Na2SiO3 (nil) KBr03 (nil) Acid mix (nil) 
0 0 10 4 3 
2 2 10 4 3 
4 4 10 4 3 
6 6 10 4 3 
8 8 10 4 3 
10 10 10 4 3 
I. Components were added to 250ml volumetric flask containing 50n-A distilled 
water, made up to 250ml and mixed well. 
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2.25ml of each of the solutions prepared in (1) was taken and pipetted into lOOrnl 
volumetric flasks. I On-d CaC12 solution was added and made up to I 00ml. 
Procedure: The samples were dry ashed to remove the organic matter and the ash 
digested with an acid mixture to solubilise the chromium. 
1.10ml graduated tubes were dried and labelled with china graph pencil. 
2. Sample was weighed into the tubes and dried at 105"C for at least 5 h. The tube 
was reweighed to calculate dry matter content (DM). (This stage was omitted in 
this study as samples were freeze-dried to remove water). 
3. Tubes were placed in a large beaker and ashed overnight at 450"C. 
4. When the furnace had cooled to 100"C, the tubes were removed and cooled in a 
dessicator cabinet and reweighed when cool to calculate organic matter (OM) 
content. 
S. 2-3 anti-biunping granules, 1.2ml acid mix and 1.6ml potassium bromate solution 
were added to each tube. A condensing marble was placed on top of each test 
tube. 
6. Test tubes were heated in a beaker on a hot plate until the colour changed from 
brown to deep clear purple and the volume reduced by about 50%. 
7. Tubes were removed from heat and allowed to cool slightly in a metal rack. 
Before completely cool, distilled water was added and vortexed. When 
completely cool, volume was adjusted to 10ml and mixed thoroughly. 
Dilution for samples: 
0.2ml digest 
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0.1 ml NaSi 
I. Onil CaC12 
3.7ml distilled water 
Appendices 
Standard solutions were used to calibrate equipment before measuring samples in 
triplicate. Equipment was re-calibrated after approximately 10 samples. 
Atomic absorption spectrophotometer adjustment (Pye Unicam, SP9 AAS): 
Wavelength 357.9nm 
Lamp Current 7.5mA 
Burner height 6-8 
Air 30 
Acetylene 25 (9psi) 
Flame rich 
Band pass 1.0 
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6.6 SCFA 
Appendices 
Short chain fatty acid (SCFA) determination (Mathers et aL, 1990; Mathers & Fotso 
Tagny, 1994). 
Deproteinising solution (DPS): 
1.100g metaphosphoric acid (BDH) was dissolved in 350ml distilled H20. 
2. When cold, 2.905g 3-methyl valeric acid (Sigma) was added and mixed well. 
3. The solution was made up to 500ml and stirred for several hours until completely 
dissolved and stored in a glass bottle at 4*C. 
4. The result was a 50mM 3-methyl valeric acid solution. 
SCFA Standards: 
1.0.2M solutions of the following acids were prepared by dissolving the appropriate 
amount in 25ml distilled H20: 
Acetic acid (BDH) 
Propionic acid (BDH) 
Isobutyric acid (Sigma) 
Butyric acid (BDH) 
Isovaleric acid (Sigma) 
Valeric acid (Sigma) 
0.3002g/25ml 
0.3704g/25ml 
0.4405g/25ml 
0.4405g/25n-d 
0.5108g/25ml 
0.5108g/25ml 
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2. A SCFA mixture was prepared by mixing 10ml acetic acid (final concentration 
100mM), 5ml propionic acid (50niNI), I n-d isobutyric acid (I OmM), 2n-A butyric 
acid (20mM), 1 ml isovaleric acid (I OmM) and I ml valeric acid (I OmM). 
3. Standard SCFA were prepared by mixing 2ml of the above SCFA mixture with 
2rnI distilled H20 and lml DPS to give a final concentration of. 
Acetate 40mM 
Propionate 20mM 
Butyrate 8mM 
Isobutyrate 4niM 
Valerate 4mM 
Isovalerate 4mM 
3-MV lomm 
Procedure for SCFA detennination by Gas Chromatography (ES I only) 
Colon contents were weighed into an eppendorf and half the weight by volume of 
DPS added and mixed well before storing at -20"C until required. Samples were 
thawed before use. 
2.200pl dH20 was added to each sample and centrifuged at 15 OOOrpm for 20 min. 
3. The supernatants were transferred to glass GC vials and sealed. 
4. The concentrations of SCFA's in each sample were analysed by gas 
chromatography using a 2mm diameter column packed with a 10% SP- 1200-1 % 
phosphoric acid on 80/100 chromosorb in a PU 4550 gas liquid chromatograph. 
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5. IgI of sample was drawn from the vial into aglass-barrelled needle and injected 
into the GC instrument. 
Chromatography ConditiOns. 
The separation was based on the following conditions: 
Gas-liquid chromatograph 
Detector 
Column oven temperature 
Injection port temperature 
Detector temperature 
Carrier gas 
Carrier gas flow rate 
Column 
Support 
Gas pressure at source 
lonisation and setting 
Phillips PU 4700 
Flame ionisation 
130'C 
175*C 
175*C 
High purity nitrogen 
55-60 ml/min 
Glass 1.5m x 2mm i. d. 
Chromosorb W AW 80-100 
20 psi 
Range 100, attenuation 4 
For ES2 and ES3, SCFA were analysed using a Shimadzu Gas Chromatograph GC-2014 
with AutoIn ector AOC-20i and Shimadzu GC Solution software. Samples were i 
autoinjected and conditions differed as follows. 
Column oven temperature 
Injection port temperature 
Detector temperature 
Carrier gas 
Carrier gas flow rate 
Column 
Gas pressure at source 
Ionisation and setting 
120T 
250T 
275*C 
Nitrogcn/air 
60.2 ml/min 
Alltech EC- 1000, length I Sm x 0.53mm i. d. 
3.9kPa 
Range 100, attenuation 4 
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6.7 NEPA 
Appendices 
The InfraMot device used "passive infra-red sensors" which sense the infra-red radiation 
(body heat) produced by the subject and its movement over time, and in this way 
registered activity. Utilising the detection of infra-red radiation meant that measurements 
could be made in both the light and the dark (when most activity took place). 
The recording interval could be altered from 1-60min, i. e. produce information every 
minute or in multiples of minutes up to an hour. This changes the nature of the 
information produced, as minutely recordings produce more accurate representations of 
activity patterns. 
The data were stored in Excel spreadsheets which allow for easy manipulation. Figure 6.1 
is an example of data recorded every minute. Although periods of activity and inactivity 
can be determined, and comparison between subjects is possible, the picture is not totally 
clear, but can easily be altered. Figure 6.2 shows the same data for the same mice but 
accumulated hourly, making direct comparisons between mice much easier. 
24 hour activity counts recorded every minute 
starting at midnight 
er 
Co 
Time 
U 
. 
Figure 6.1 Activity data for 4 mice (different colours). Peaks of activity and troughs of inactivity are 
clearly visible 
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24 hour activity measurements recorded hourly starting midnight 
250000 - 
w 
200000 
150000 
100000 
50000 
0 
Hour of study 
Figure 6.2 Activity data accumulated hourly 
n 
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6.8 Specimen processing for scanning electron microscopy 
1. Tissue was fixed in 2% gluteraldehyde in Sorensons' Phosphate Buffer (SPB) and 
rinsed in SPB 2x I 5min. 
2. Sample was dehydrated: 25% Ethanol (EtOH) 30mins 
50% EtOH 30mins 
75%EtOH 30rrdns 
100% EtOH 60n-dns 
100% EtOH 60mins 
3. Final dehydration was with C02 in a Samdri 780 Critical Point Dryer. 
4. Sample was mounted on stub and coated with gold using a Polaron SEM coating 
unit. 
Steps 3-4 performed by Biomedical E. M. Unit, Newcastle University. 
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6.9 ELISA protocol 
Appcndices 
Concentrations of IL-6 and IL- 10 in plasma were quantified using ELISA Ready-SET. 
Go! Kits (Insight Biotechnology Ltd, Wembley, UK) as follows: 
Contents: I OX coating buffer (C. B. ); 
Capture Antibody (C. A) - purified mouse IL-6/IL- 10; 
Standard - recombinant mouse IL-6/IL- 10 (1 pg/ml); 
Detection Antibody - biotin-conjugate anti-mouse IL-6; 
Enzyme - Avidin-HRP; 
5X assay diluent; 
Substrate - 1X TMB solution. 
Buffers -wash buffer IXPBS+0.005%Tween-20, stop solution - IMH3PO4, IXPBS. 
1. Coating Buffer was diluted- 2.5n-d IOX C. B. to 22.5ml DI H20. 
2. Capture Antibody was diluted - 48gl C. A. to 12ml C. B. 
3.100ptl/well CA/CB mix was added to 96 well plate. 
4. The plate was sealed and incubated overnight at 4*C. 
5. Wells were aspirated and washed 3X with > 3001il/well Wash Buffer. 
6. Plate was inverted and blotted on absorbent paper. 
7.10ml 5X Assay Diluent was added to 40n-d DI H20. 
8.200ptl/well IX Assay Diluent was used to block the wells. 
9. Plate was sealed and incubated at room temp I h. 
10. Wells were aspirated and washed 3X as step 516. 
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11. Standards were prepared: IL-6 - 5pl standard solution to I Oml IX Assay Diluent 
= top standard (500pglml). IL- 10 -I Optl standard to 5ml IX Assay Diluent top 
standard (20OOpg/ml). 
12.100gl/well standard was added to appropriate wells (triplicate) and 2-fold serial 
dilutions to top standards used to make a standard curve. 
13. Plasma samples were defrosted and added I 00pl/well. 
14. Plate was sealed and incubated r. t. for 2 h. 
15. Wells were aspirated and washed SX as step 5/6. 
16.48ýd Detection Ab was diluted in 12ml IX Assay Diluent. 
17.100ýtl/well of detection Ab solution was added. 
18. Plate was sealed and incubated at r. t. for I h. 
19. Wells were aspirated and washed 5X as step 5/6. 
20.48gl AvidinHRP was diluted in 12ml IX Assay Diluent and I 001il/well added. 
2 1. Plate was sealed and incubated at r. t. for 30 minutes. 
22. Wells were aspirated and washed 7X, soaking wells in wash buffer 1-2 minutes 
before aspirating. 
23.1 00gl/well Substrate Solution was added to each well (already at working 
concentration). 
24. Plate was sealed and incubated at r. t. 15min. 
25.50gl/well Stop Solution was added to each well. 
26. Plate absorbance was read 450nm and also at 570nm. to measure background 
levels (450-570 to give actual absorbance). 
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6.10 Detailed method for isolation of NK cell fraction 
Appendiccs 
1. Scalpel blades and cell filters were used to reduce spleen to a single-cell suspension. 
2. Cells were washed, counted and centrifuged. The supernatant was removed and the cell 
pellet resuspended in 90gl buffer [PBS pH 7.2 supplemented with 0.5% BSA/FCS (cold 
and degassed)] per 107 total cells. When the pellet contained fewer cells 90gl buffer were 
used. 
3.100 of microbeads per 107 total cells were added, mixed well and incubated for 15 
minutes at 10'C. For fewer cells, the same volume of microbeads was used. 
4. Cells were washed by adding 10-20x labelling volume of buffer, and centrifuged at 
300g for 10 minutes. Supernatant was removed completely and cell pellet resuspended in 
500ptl buffer per 108 total cells. For less than 108 cells 500gl buffer was used. 
5. Magnetic separation: 
MS separation column was attached to the MACS multistand. The collection tube was 
placed under column. 
6.500ýd degassed buffer were applied to the top of the column and allowed to run 
through. Effluent was discarded and the collection tube changed. 
7. Magnetically labelled cell suspension containing up to 107 positive cells in maximum 
2xlO8 total cells was pipetted onto the column (up to 108 cells per 500ýd buffer). Cell 
suspension was allowed to run through and total effluent was collected as negative 
fraction. 
8. The column was washed with 3x5OOptl buffer and the total effluent was collected as the 
NK cell-negative fraction. 
9. The column was removed from the stand and placed over a new collection tube. 
Iml buffer was applied to the reservoir of the column and cells were flushed out using the 
plunger provided. 
10. NK cells were counted and volumes required for NK cell assay calculated. 
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6.10.1 Natural killer cell assay 
1. Target cells (K562) were resuspended in fresh RPMl 1640 media (Gibco) and counted. 
2.2xI 06 target cells were incubated in 200pl RPMI with 200gCi 51 Cr (Amersham) for 
60 minutes with agitation every 15 minutes at 37"C. 
3. Cells were washed x3, and resuspended at concentration 2.5 x 104/n-d. 
4.1 00pl labelled target cells was transferred to each well of a U-proftle 96-well plate. 
5. During labelling of target cells, NK cells were MACS-sorted from spleen. 
6. Effector cells (NK) were added to each well at prescribed ratios. 
7. Plate was incubated for 4 hours at 37*C. 
8. The plate was centrifuged for 2 min at 60g. 100ýd supernatant was transferred to 
12x75mm polypropylene tube for y-counting. 
9. "Maximum release" was obtained by lysing target cells via freeze-thaw (2 hr -80"C 
37C). "Spontaneous release" was obtained from supernatant of targets alone. 
10. % specific lysis was calculated by subtracting spontaneous release from maximum 
release. 
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6.11 Dual COX/SDH histochernistry (Old & Johnson, 1989) 
1. The COX incubation medium was prepared: 200ýd cytochrome c were added to 
800pl. diaminobenzidine (DAB) with a small amount of catalase and vortexed. 
2. The entire section was covered with 50-100gl of the medium and incubated at 
37C for 50 min. 
3. Section was washed twice in PBS and any excess carefully removed with tissue. 
4. SDH incubation medium was prepared: to 800pl nitroblue tetrazolium (NBT) 
were added I 00gl sodium succinate, I 00pl phenazine methosulphate (PMS) and 
I OgI sodium azide. 
S. The entire section was covered with 50-100ýtl SDH medium and incubated for 45 
min at 37T. 
6. Sections were then washed twice in PBS and dehydrated in ethanol: 
70%, 95%, 100% and 100% again for I Omin. 
7. Sections were cleared twice in Histoclear and mounted in DPX. 
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